Early events of Jaagsiekte sheep retrovirus infection in the ovine lung by Martineau, Henny
 
 
 
 
 
 
 
https://theses.gla.ac.uk/ 
 
 
 
 
Theses Digitisation: 
https://www.gla.ac.uk/myglasgow/research/enlighten/theses/digitisation/ 
This is a digitised version of the original print thesis. 
 
 
 
 
 
 
 
 
Copyright and moral rights for this work are retained by the author 
 
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge 
 
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author 
 
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten: Theses 
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
Early events of Jaagsiekte sheep 
retrovirus infection in the ovine lung
Henny Martineau 
BVMS MRCVS
Submitted in the fulfilment of the requirements of the degree 
of
Doctor of Philosophy
College of Veterinary, Medical and Life Sciences 
University of Glasgow
September 2010
ProQuest Number: 10754023
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 10754023
Published by ProQuest LLC(2018). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
GLASGOW ^
UNIVERSITY
.LIBRARY:
Abstract
Ovine pulmonary adenocarcinoma (OPA) is a chronic respiratory disease o f adult sheep 
caused by Jaagsiekte sheep retrovirus (JSRV). The primary route o f disease transmission is by 
inhalation o f the virus, which then infects respiratory epithelial cells initiating oncogenesis and 
tumour growth. Clinical signs are seen towards end stage disease and include laboured 
breathing and weight loss. In these animals, the production o f copious amounts o f virus rich 
fluid which pours from the nose when the hind legs are lifted is a common finding and 
pathognomic for OPA. Once these signs are apparent, the disease is invariably fatal.
The worldwide prevalence of OPA has both economic and welfare implications. However, 
there is currently no effective preclinical test or vaccine to control spread o f disease. This is 
primarily due to the lack o f detectable immunological response at any stage o f disease 
pathogenesis. Theories o f central and peripheral tolerance have been proposed as explanations 
for this. OPA is also regarded as a potential model for human lung cancer. As in sheep, 
clinical presentation in humans is not until tumour growth is extensive by which time 
treatment is unsuccessful. This makes it difficult to study the initial stages o f disease, and 
identify potential markers for early detection or targets for therapeutics.
The aim o f this study was to investigate these previously unexplored early stages o f disease 
pathogenesis for OPA. The primary areas o f interest were identification o f the target cells for 
JSRV infection in the lung and analysis of the innate response following this infection.
Samples for analysis were provided by the intratracheal inoculation of specific pathogen free 
lambs with an infectious molecular clone JSRV2 1 . Lambs were euthanased 3, 10 and 72-91 
days following inoculation and lung samples representing different stages o f disease 
pathogenesis were collected from each lamb. Mock infected and non infected lambs were 
included as negative controls at each time point. Immunohistochemistry was used to localise 
virus expression to specific epithelial cell types within the ovine respiratory tract. The same 
techniques also offered a means of studying the postnatal development o f the ovine respiratory
tract. The innate response to infection and subsequent tumour growth was measured in terms 
o f cytokine production. RNA was extracted from adjacent samples to those used for IHC, and 
qRTPCR measured mRNA levels o f a number o f inflammatory cytokines and chemokines at 
each time point.
Immunohistochemical analysis o f the ovine respiratory tract found evidence o f 
cytodifferentiation during postnatal development. This has implications for the susceptibility 
o f lambs to infectious and noxious insults during this period. JSRV was found to target 
multiple cell types in the ovine lung. These included Clara cells, type II pneumocytes and cells 
which did not express either of these mature markers. Analysis of cytokine expression in lung 
tissue both before and during JSRV expression and tumour growth found little evidence o f a 
host response to virus expression. Changes in the levels o f cytokine mRNA were detected for 
those primarily involved in tumour growth and survival. These included IL-8 and IDO, both of 
which have been found to be increased in some cases o f human of lung tumour. These 
findings increase the understanding o f the pathogenesis o f OPA, and improve its validity as an 
animal model for human lung cancer.
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CHAPTER 1 INTRODUCTION
1.1 Lung anatomy
The functional anatomy o f the lung has been a subject o f scientific interest for many years. In 
the early literature of 1497, Alessandro Benedetti described the lung as an organ responsible 
for cooling the blood and ‘changing breath into food  fo r  the vital spirit'. A role in the 
psychology of the human body was also suggested: "with the breath o f  the spirit from  the 
hollow fistulae o f  the lung. Thus anger, otherwise implacable, is easily calmed'. However, it
t V iwas not until the 17 Century that the essential function as we know it today was recognised.
‘Pre-eminence o f  the lung: nothing is especially so necessary neither sensation nor aliment. 
Life and respiratory are complementary. There is nothing living which does not breathe, nor 
anything breathing which does not live ’ (William, 1961).
The anatomy o f the lung is dictated by the efficiency o f respiratory gas exchange required by 
the host. Single celled organisms can survive by simple diffusion o f gases, fish utilise aqueous 
diffusion in their gills and insects have a well-branched respiratory trachea (Warburton et al., 
2000). Birds have a unique system o f lungs and air sacs which maximise gas exchange via 
parabronchi and atria while minimising the weight of the animal (Brackenbury, 1972). Air 
breathing amphibians and mammals have developed lungs which exchange gases with the 
circulation by diffusion through a single cell layer. As the metabolic needs vary between these 
species, so does the detailed anatomy of the lung.
1.1.1 Developmental anatomy
During embryogenesis, the lung arises from a bud in the ventral foregut endoderm, which 
divides and grows as a series o f epithelial tubes and vascular structures (Cardoso and Lu, 
2006). Its development is controlled by cross talk between the invading epithelial cells and 
surrounding mesenchyme and the regulated expression o f numerous transcription factors 
(Cardoso, 2000; Cardoso and Lu, 2006; Deimling et al., 2007). The eventual pattern o f the 
conducting and respiratory airways mimics the trunk and branches o f a tree, hence the term 
bronchial tree (Figure 1.1 A) (Metzger et al., 2008). The largest airway, the trachea, divides 
into two main stem bronchi at the thoracic inlet. These in turn bifurcate into smaller
intrapulmonary bronchi, bronchioles, terminal bronchioles and respiratory bronchioles before 
terminating in pouches called alveolar ducts. These are lined by alveolar sacs which bring 
inhaled gases into close contact with underlying alveolar capillaries so facilitating gas 
exchange.
Trachea
Bronchi
Bronchioles
Alveolar ducts
A B
Figure 1.1 Schematic representation of ovine bronchial tree  (A) and lung (B). Lung lobes (la) left cranial apical, 
(lb) left caudal apical, (2) left diaphragmatic, (3) right apical, (4) cardiac, (5) mediastinal, (6) accessory, (7) right 
diaphragmatic
1.1.2 Gross anatomy
A thorough account of the general anatomy of the sheep lung has been described previously 
(Sisson and Grossman, 1975). It is a paired organ with left and right sides (Figure 1 .IB). The 
left lung is made up o f apical (cranial and caudal) and diaphragmatic lobes. The larger right 
lung is divided into five lobes by interlobular fissures and consists o f the apical, cardiac, 
mediastinal, accessory and diaphragmatic lobes. Notable characteristics include the presence 
o f a tracheal bronchus which branches to the right from the trachea at the level o f the third rib, 
cranial to the division o f the main stem bronchi. It supplies the right apical lobes and is 
common to other ruminants (Sisson and Grossman, 1975).
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Techniques such as corrosion casting and microdissection have been used to study the gross 
anatomy o f the lung (Mariassy and Plopper, 1983; Phalen et al., 1978; Plopper et al., 1983). 
Comparison o f the lungs from five species shows variations in airway length, diameter, 
branching angle and number o f generations (Plopper et al., 1983). For example, 
microdissection of five sheep lungs found there to be an average o f 30 generations o f axial 
pathways before reaching terminal bronchioles, which compares to 22 generations in the 
rabbit and 14 in the bonnet monkey. Differences between lung lobes in the same animal were 
also noted. An asymmetry in airway diameter at each branch point led to the development o f a 
convenient binary system for airway numbering and accurate anatomical localisation within 
the organ (Phalen et al., 1978).
1.1.3 Cellular anatomy
The cellular structure and function o f the mammalian lung was first investigated by light 
microscopists in the early 17th Century. The presence of an epithelial lining of the airways was 
noted by Laurentius in 1602, confirmed by Morgagni in 1712 (Breeze and Wheeldon, 1977) 
and further researched to identify ciliated cells, goblet cells and Clara cells (Clara, 1937; 
Kolliker, 1882). We now know there to be over 40 different cell types within the lung which 
are defined by their embryonic origin into mesenchymal and epithelial types. Epithelial cells 
act as the sentinels o f the respiratory tract. They present a strong defence to inhaled particles 
both through barrier function and their ability to help maintain homeostasis during respiration. 
This preserves the sterile environment necessary for gas exchange. This study focuses on the 
epithelial compartment as it contains the majority o f cells which have specialised functions 
specifically related to the lung (Wuenschell et al., 1996). Those o f particular interest are 
ciliated cells, Clara cells, neuroepithelial bodies (NEBs) and type II pneumocytes.
Studies designed to quantify and locate epithelial cells within the lung are surprisingly scarce.
This is most likely due to the difficulty the pathologist has in anatomical orientation when
presented with a histological section o f the lung, as depending on the cutting angle similar
tubular structures in the lung can appear to be quite different. Before immunohistochemical
techniques were widely available, pathologists had to rely on cell morphology with
Haematoxylin and Eosin (H and E) staining, special histochemical stains and ultrastructural
features to identify specific cell types (Azzopardi and Thurlbeck, 1969; Plopper et al., 1980a;
3
Plopper et al., 1980b; Roth, 1973). It was not until 1983 that a thorough study of the entire 
tracheobronchial epithelium in the sheep was carried out (Mariassy and Plopper, 1983). At 
that time, just two similar studies existed but these described rodent lungs only (Jeffery and 
Reid, 1975; Kennedy et al., 1978). The sheep lungs were examined using light microscopy and 
TEM to identify, quantify and locate eight major epithelial cell groups: four mucus type cells, 
ciliated, basal, Clara and serous cells (Mariassy and Plopper, 1983, 1984). By correlating cell 
type with anatomical location using the binary system, it was concluded that the epithelial 
distribution did not correlate with airway wall components, and that Clara cell distribution was 
based on airway generation and proximity to alveoli (Table 1.1). This was in contrast to the 
rabbit which appeared to have no Clara cells in the distal bronchioles.
Table 1.1 Comparison of epithelial cell distribution in th e  sheep and rabbit lung. Reproduced from Plopper et 
al 1983.
Airway
generation
Basal cell % Ciliated cell % Mucous cell % Clara cell %
Sheep Rabbit Sheep Rabbit Sheep Rabbit Sheep Rabbit
Trachea 28.5 28.2 30.6 43.0 41.0 1.3 0 17.6
1° bronchus 18.0 27.1 48.2 43.0 33.8 1.1 0 21.8
5 18.7 2.3 39.1 49.2 42.3 0 0 41.3
10 16.4 0 48.4 50.0 34.9 0 0 50.0
15 19.2 0 42.6 43.7 38.0 0 0 56.3
20 10.6 0 47.6 46.0 42.0 0 0 54.0
24 0 NA 59.1 NA 19.8 NA 21.0 NA
30 0 NA 32.3 NA 0 NA 67.7 NA
Inspired by the increasing use o f sheep as models o f human disease, a similar experiment was 
conducted in 1993 to examine three sheep lungs with TEM (Bouljihad and Leipold, 1994). 
Instead o f the binary system they applied criteria suggested by (Tyler, 1983). This uses airway 
wall components and proximity to alveoli to identify four types o f bronchioles (Table 
1.2).They found the primary and secondary bronchioles to contain four cell types: basal cells, 
intermediate cells, ciliated cells and Clara cells. The epithelium of terminal and respiratory 
bronchioles was made up o f only ciliated cells and Clara cells, and the alveolar wall was
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covered by type I and type II pneumocytes. The presence o f Clara cells in primary and 
secondary bronchioles conflicts with the data o f (Mariassy and Plopper, 1983, 1984), but both 
agree that terminal bronchioles only consist o f ciliated and Clara cells. Previous publications 
had identified the intermediate cell type as a differentiating cell (Breeze and Wheeldon, 1977).
Tablel.2 Anatomical definitions of airways in th e  lung (Tyler 1983)
Lung airway Description
Bronchus Complete walls formed by irregular plates or plaques of cartilage in loose connective 
tissue with elastic and collagenous fibers and smooth muscle.
Mucous or mixed glands in the lamina propria or submucosa
Ciliated pseudostratified columnar epithelium with mucous (goblet) cells.
Bronchiole Walls of smooth muscle and loose connective tissue. No cartilage, no glands. 
Interalveolar septa attached to their abluminal surface.
Ciliated columnar to  squamous epithelium with no mucous (goblet) cells
Terminal bronchioles are the most distal, highest generation bronchioles which are not
alveolarised. Last of conducting airways.
Respiratory
bronchiole
Transition between conducting airways and respiratory air spaces.
Same structure as nonrespiratory bronchioles, except for the presence of openings in 
the walls for alveoli and shorter epithelium.
Low generation respiratory bronchioles may be 'poorly alveolarised' ie. have few alveoli. 
Higher generation respiratory bronchioles are typically 'well alveolarised' ie. have 
numerous alveoli.
Alveolar ducts Alveoli open into the lumen all around the circumference. 
Spiral smooth muscle and type 1 or II alveolar epithelium.
Interestingly, none o f these studies mention the presence o f neuroendocrine (NE) cells, also 
known as K cells or ‘apparently unrelated endocrine cells4 (APUD) cells (Balaguer and 
Romano, 1991; Breeze and Wheeldon, 1977). Initially identified as ‘clear cells’ due to their 
lack o f affinity for H and E (Feyrter, 1938), they are also found in the gastrointestinal and 
genitourinary tracts and act as part o f the peripheral endocrine epithelial system (Scheuermann 
et al., 1997). In sheep they were first identified in the trachea using TEM, Grimelius’s silver 
nitrate method and fluorescence histochemistry (Cutz et al., 1975), but have since been found 
throughout conducting and respiratory airways as single cells or in groups called
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neuroendocrine bodies (NEBs) (Balaguer and Romano, 1991). Immunohistochemistry (IHC) 
allowed quantification techniques to compare cell numbers in animals o f different ages as well 
as localising them anatomically. Measurements either gave the total number o f endocrine cells 
per surface area o f sheep lung, or calculated them as a percentage o f total number o f cells 
counted. These studies demonstrated age related changes in number and location o f cells 
during fetal and post natal development (Asabe et al., 2004; Balaguer and Romano, 1991; Van 
Lommel and Lauweryns, 1997).
The physiological functions of these different epithelial cell types are better understood for 
some than others. For example, it is well known that the mucous secreted by the goblet cells in 
the larger airways forms a sticky protective layer, the airway surface fluid, over the entire 
respiratory epithelium that captures unwanted inhaled particles (Snyder et al., 2009). These are 
then removed by the beating cilia o f the ciliated epithelial cells, which continually walk the 
mucus carpet up out o f the respiratory tract for external expulsion from the nose or swallowing 
(Corrin 2000). The role o f type II pneumocytes as surfactant producers to maintain the patency 
of the distal airways, and type I pneumocytes as the site o f gas exchange in the alveoli are also 
well recognised (Kotton and Fine, 2008). Clara cells and NEB/neuroendocrine cells appear to 
have a broader range o f functions, not all o f which are fully defined. The progenitor 
capabilities o f these and less differentiated cell types is also a subject o f much debate. The 
following section will discuss these points in more detail.
1.1.3.1 Ciliated epithelial cells
Ciliated cells are present in various proportions in all regions of the conducting airways 
(Plopper et al., 1983). They are easy to identify by using histological stains or IHC to highlight 
the cilia. Antibodies labelling beta tubulin or the transcription factor Foxj 1 are useful for 
specific identification (Dave et al., 2008; Park et al., 2006). The cilia act to transport mucus 
and unwanted inhaled particles out o f the respiratory tract and they decrease in height to 
correspond with smaller airways and a change in viscosity o f mucus (Corrin 2000).
There are conflicting reports regarding the progenitor capabilities o f these ciliated cells.
Lineage labelling techniques have shown them to be terminally differentiated during normal
lung homeostasis (Rawlins et al., 2008). A transient change in morphology following lung
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injury with naphthalene and SO2 has been noted, but this was not accompanied by cellular 
proliferation or transdifferentiation (Rawlins et al., 2007). In contrast, an earlier report 
describes the transformation o f ciliated cells into Clara cells following injury o f the lung with 
bleomycin (Aso et al., 1976). Transdifferentiation and proliferation are also reported in 
another naphthalene injury model (Park et al., 2006). Here they describe squamous metaplasia 
o f ciliated cells which spread beneath injured Clara cells to maintain epithelial integrity. 
Eventually these cells were seen to revert to their original ciliated phenotype (Park et al., 
2006). Similar dynamic changes have been noted in the lung after unilateral pneumonectomy 
(Voswinckel et al., 2004). In models o f acute asthma and viral infection transdifferentiation 
into mucus cells has also been demonstrated (Reader et al., 2003; Tyner et al., 2006). These 
reported variations in progenitor capacity are likely due to the different methods used for lung 
injury and cell identification. Although confusing, they do demonstrate the plasticity of 
ciliated cells in the lung.
1.1.3.2 Clara cells
Originally described as ‘non ciliated, non-mucous and non serous secretory cells’ (Clara, 
1937), Clara cells are essential for normal maintenance and repair o f the lung. They have a 
critical progenitor role and also contribute to homeostasis by secreting substances into the 
airway surface fluid. Ultrastructural characterisation shows them to have discrete electron- 
dense granules within the cytoplasm (Plopper et al., 1980a) which contain a 10-16 kDa protein 
called Clara cell protein -  also known as uteroglobin, Clara cell secretory protein (CCSP), 
Clara cell 10/16-kDa protein, human protein 1, urine protein 1 (Singh and Katyal, 2000). It is 
the major product of these cells and comprises 7% of the total protein found in 
bronchioalveolar lavage fluid (BALF) in humans (Bernard et al., 1992). The precise role of 
this protein remains to be determined (Ryerse et al., 2001) but suggested functions include 
inhibition o f phospholipase A2 and downregulation o f inflammation , anti-viral activity , 
inhibition o f leukocyte chemotaxis and immunomodulation by inhibiting interferon gamma 
(Singh and Katyal, 2000). It has also been shown to regulate cross talk between lung 
epithelium and macrophages (Reynolds et al., 2007). Other roles such as progesterone binding, 
retinoid binding, calcium binding and protease inhibition have been assigned to rabbit 
uteroglobin in the uterus, and are presumably transferable to the lung (Singh and Katyal,
2000).
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Lung disease can affect the expression o f CCSP. In humans, levels in BALF are generally 
increased in patients with sarcoidosis, and those at risk o f or suffering from respiratory distress 
syndrome (Shijubo et al., 2000). In contrast, decreased levels are found in the BALF o f asthma 
sufferers and smokers with normal lung function tests (Shijubo et al., 1997). The actual 
numbers o f CCSP-positive bronchiolar epithelial cells in these patients are also reduced. 
Malignant transformation o f cells tends to reduce expression and this has been shown in 
prostate, uterine and lung tumours (Linnoila et al., 2000; Patiemo et al., 2002). Only 10-30% 
of lung adenocarcinomas were found to express CCSP, which was also at lower levels than 
seen in untransformed cells. In a model o f lung cancer in the hamster, CCSP was only 
expressed during the early stages o f tumour development. An excellent review by Linnoila et 
al details some o f these experiments and proposes that CCSP downregulation contributes to 
carcinogenesis as CCSP antagonises the neoplastic phenotype (Linnoila et al., 2000). Clara 
cells have also been found to secrete other proteins. These are CC 55kDA protein, leukocyte 
protease inhibitor, beta galactosidase binding protein, phospholipase, Tryptase Clara and 
surfactant associated proteins A,B and D (SP-A,SP-B,SP-D) the latter o f which have their own 
immunoregulatory and antibacterial properties (Singh and Katyal, 2000).
1.1.3.3 Solitary neuroepithelial cells and neuroepithelial cell bodies
Pulmonary neuroepithelial (NE) cells are a division o f the diffuse neuroendocrine system and 
exist as solitary cells or in a cluster, termed a NE cell body (NEB). These specialised epithelial 
cells lie on the basal lamina and contact the airway lumen via microvilli in the apical 
membrane (Van Lommel, 2001). They are a primitive cell type and are found in invertebrate 
and vertebrate species (Linnoila, 2006), constituting less than 1 % o f the human airway 
epithelium (Castro et al., 2000). They possess endocrine and paracrine secretory mechanisms 
and are closely associated with intraepithelial nerve fibres (Linnoila, 2006). They are first 
functionally active during fetal development where they regulate lung growth and maturation 
via release o f amine and peptide products (Sorokin et al., 1997). Later in fetal life and 
postnatally, they act as airway chemoreceptors that respond to airway hypoxia (Linnoila,
2006). Other reports emphasise their role in the regulation of airway tone and pulmonary 
blood flow during respiration (Peake et al., 2000).
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Identification o f NE cells by pathologists is both helped and hampered by their large number 
o f secretory products. Immunohistochemical detection uses antibodies raised against 
paraneural activity (neurone specific enolase, synapotophysin, chromogranin A and protein 
gene product 9.5) and regulatory peptides (bombesin/ gastrin-releasing peptide, calcitonin, 
Leu-encephalin, cholecystokinin, serototin and somatostatin). However, the variation in levels 
of secretory products over time and between species may lead to errors in cell recognition 
using IHC. Synaptophysin, which is an integral membrane protein present in presynaptic 
vesicles o f neuroendocrine cells, has been suggested as the most sensitive and specific marker 
for pulmonary NE cells by IHC (Kasprzak et al., 2007). Electron microscopy may be a more 
reliable technique as it recognises the dense core granules which reside in the basal pole, ready 
to discharge substances into the subepithelial corium (Balaguer and Romano, 1991; Van 
Lommel and Lauweryns, 1997). The secreted substances can influence nearby cells, or are 
taken up by the pulmonary capillaries to exert their effect on target cells elsewhere in the body 
(Van Lommel, 2001).
NEBs are often situated in strategic positions at airway birfurcations and bronchioloalveolar 
duct junctions (BADJ). Lung disease has been shown to alter the distribution and number o f 
detectable PNECs. Studies in humans have found increased numbers in chronic lung 
conditions such as bronchial asthma, pneumonia, chronic bronchitis and cystic fibrosis, and in 
sudden infant death syndrome (Linnoila, 2006). Two characteristic patterns o f cell growth are 
seen. One shows increased numbers o f interrupted rows o f cells on the basement membrane of 
the epithelium, and the other appears as large aggregates o f NE cells. This is described as 
neuroendocrine hyperplasia or tumourlets, and their role as a precursor to carcinoid and other 
lung tumours is under investigation (Rizvi et al., 2009).Studies in mice which used 
naphthalene to obliterate Clara cells, demonstrated a marked hyperplasia o f NEBs following 
lung damage (Peake et al., 2000). This contradicts the original theory of these as terminally 
differentiated cells, and autoradiography found them capable o f proliferating. However, they 
were not able to repopulate bronchiolar epithelium and therefore not capable of 
transdifferentiating into other cell types (Peake et al., 2000). Given the role these cells play in 
chemoreception, a body o f literature has investigated cell numbers in humans and animals that 
live at high altitudes. There are mixed reports as to whether the location does or does not 
affect cell number (Gosney, 1990), but one consistent observation was that when cell numbers
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did change, it was only the NEB which increased, not the solitary NE cells. This finding 
suggests the two cell types may have separate functions.
1.1.3.4 Type I and type II pneumocytes
Type I and type II pneumocytes are found in the respiratory airways o f the lung. They 
constitute a continuous epithelial layer which is the final barrier between inhaled gases and the 
host circulatory system (Flecknoe et al., 2003). Type I pneumocytes are attenuated squamous 
epithelial cells with a flattened nucleus and an extremely thin, granular cytoplasm, through 
which the diffusion of respiratory gases occurs. Type II pneumocytes are plump and cuboidal 
and generally positioned in the comers o f alveoli. Their hallmark is the presence o f distinctive 
lamella bodies which contain surfactant. Immunohistochemical identification uses antibodies 
to aquaporin-5 for type I and SP-C or DC-LAMP for type II pneumocytes (Salaun et al., 2004; 
Warburton et al., 2000). They line the alveoli in a 1:2 ratio (type I : type II) although type Is 
contribute to 86% of the total surface area (Otto, 1997).
Conventionally, type II pneumocytes are considered to be the alveolar progenitor cell as 
demonstrated using lung injury models and autoradiography (Evans et al., 1973). In vitro work 
also highlights the propensity of type IIs to produce cells with a type I phenotype. However 
during fetal development this hierarchy can be reversed , and changes in fetal lung expansion 
have been shown to induce transdifferentiation o f type I pneumocytes into type II 
pneumocytes (Flecknoe et al., 2000). In addition, a recent study examining the phenotypes of 
rat type I pneumocytes in vitro, found 99% pure cultures to be capable o f proliferation (50% 
were Ki-67 positive) and to express Oct-4, a potential stem/progenitor cell marker (Gonzalez 
et al., 2009). It was also possible to induce them to express SP-C and CCSP so illustrating 
their phenotypic plasticity. Proof o f these properties in vivo remains to be shown. Also of 
interest is the question o f the type II population homogeneity. Subsets of cells were found to 
be E-cadherin positive and negative (Reddy et al., 2004) and differences were noticed in their 
transgene expression (Perl et al., 2005; Roper et al., 2003). This suggests type II pneumocytes 
could be further categorised according to their different functional or progenitor capabilities 
(Kotton and Fine, 2008). A summary o f the cellular anatomy of the lung is shown in Figure 
1.2 .
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Figure 1.2 Diagram of bronchial tree  (A) and corresponding cellular anatom y (B). The r ed  do t t ed  box in (A)
r ep r e sen t s  t h e  a rea  d e n o t e d  in (B).
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1.1.4 Lung maintenance and repair
1.1.4.1 Lung progenitor cells
The finely tuned architecture o f cells in the lung allows the organ to perform to its maximum 
efficiency for gas exchange. In humans the lungs process 10 000 litres o f air per day, through 
a 300 m epithelial gas interface. During exercise, 2.5 litres o f oxygen are absorbed into the 
blood every minute (Otto, 1997). Any compromise to the functioning anatomy will be 
reflected in a reduced respiratory efficiency which may be life threatening.
The lung must be able to maintain normal architecture and react quickly to repair injuries from 
inhaled or systemic insults. To do this it has a reservoir o f progenitor cells, each responsible 
for maintenance and repair o f specific anatomical regions o f the lung (Rawlins and Hogan, 
2006). The term ‘progenitor cell’ describes all cells that have the ability to proliferate. Further 
classifications can be made when the product o f this replication is examined. Does the cell self 
replicate? Does it produce an undifferentiated or terminally differentiated cell? Can it do both?
These distinctions can be made relatively easily when a tissue with rapid turnover is examined 
such as the gut (Figures 1.3 and 1.4A) (Kotton and Fine, 2008). As the adult tissue stem cell 
actively participates in normal tissue maintenance , a classical stem cell hierarchy based on 
proliferative frequency, self renewal and differentiation potential can be applied (Snyder et al., 
2009). The adult tissue stem cell actively resides at the base o f the crypt in the stem cell niche 
where it is protected from luminal contents. It has a lifelong ability to self replicate or produce 
relatively undifferentiated transit amplifying cells. Transit amplifying cells have a limited 
lifespan, during which they replicate to form terminally differentiated epithelial cells. There is 
constant shedding o f differentiated cells from the tip of the villus which stimulates continuous 
proliferation of stem cells in the crypt, and there is a cell turnover rate o f approximately five 
days (Snyder et al., 2009). This organisation appears fixed and if  the adult stem cells are 
destroyed then the villus is lost. Commonly used stem cell terminology is summarised in 
Table 1.3.
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Villus t ip
Villus c ry p t
| l  T e rm in a l ly  d i f f e r e n t i a t e d  ep i th e l ia l  cell
T ra ns i t  am p l i fy in g  cell
P l u r ip o t e n t  s t e m  cell
Figure 1.3 Schematic representation of proliferative cells in a villus in the  intestine
Figure 1.4 IHC labelling of Ki-67 positive cells in the  intestine (A) and lung bronchiole (B). More  cells a re  
prol iferat ing in t he  intest ine
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Table 1.3 Glossary of stem  cell terminology (Fuchs et al., 2004; Stripp and Reynolds, 2008)
Definition Description
Progenitor cell Describes all cells tha t have the ability to proliferate.
Adult tissue stem cell A relatively undifferentiated cell with the capacity for unlimited self renewal 
through stable m aintenance within a stem cell niche. They have the 
differentiation potential of the tissue in where they are found.
Stem cell 'niche' A specific area which provides the  right environment for viability and 
function of stem cells
Transit- amplifying cell The progeny of a tissue stem cell that retains a relatively undifferentiated 
character, generates specialised progeny for tissue maintenance and has a 
finite capacity for proliferation
Obligate progenitor A cell that loses its ability to  proliferate once it differentiates
Facultative progenitor A cell that has differentiated features in quiescent state, but still retains the 
ability to proliferate for normal tissue maintenance.
In contrast, cell turnover in the lung is relatively slow (Figure 1,4B) and categorisation o f cell 
types to these criteria has been more complicated (Kotton and Fine, 2008). For example, 
bronchial epithelial cells have an average lifespan of 100 days (Snyder et al., 2009), and 
ciliated cells are said to last for 17 months (Rawlins and Hogan, 2008).Clara cells are 
analogous to TA cells in the gut, but they are also able to be quiescent and have a 
differentiated function. Initial work used autoradiography to identify cell types capable of
- j
replicating. In the trachea and bronchi, basal cells were seen to incorporate H thymidine label 
(tritiated thymidine) (Wells, 1970) and were proposed as progenitor cells for ciliated and 
goblet cells (Blenkinsopp, 1967) which was later verified (Hong et al., 2004a, b). In 
bronchioles, injury models were necessary to demonstrate the dynamics o f epithelial repair. 
Influential studies by Evans and colleagues recognised the Clara cell as a type o f progenitor 
(Evans et al., 1976). They used NO2 to damage terminally differentiated ciliated cells in rat 
lungs. Autoradiographic labelling of the remaining dividing cells showed them to be non- 
ciliated Clara cells (Evans et al., 1978). As the lung recovered, label retention was also seen in 
a proportion of newly formed ciliated cells (Evans et al., 1976). This showed Clara cells to be
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capable o f proliferation and differentiation into another cell type, hence their definition as a 
facultative progenitor/stem cell (Rawlins and Hogan, 2006).
Further morphological analysis using EM introduced the concept o f an intermediate type Clara 
cell, which was called a type A cell (Evans et al., 1978). Distinguished by their lack o f 
secretory granules and smooth ER, these were seen to increase dramatically in number 
following injury, and then reduce as more mature Clara cells and ciliated cells were formed. 
Type A cells were defined as a morphological derivative o f the mature Clara cell, and the 
possibility was raised o f it being a unique cell acting as a progenitor for the bronchial 
epithelium.
More recent experiments have created injury models which selectively ablate the Clara cell 
population using naphthalene (Peake et al., 2000; Stevens et al., 1997; Stripp et al., 1995). It 
was anticipated that by removal o f these progenitor cells, a multipotent stem cell type would 
be activated and forced to repair the lung instead. In fact, two unique stem cell populations 
have since been identified in the mouse (Giangreco et al., 2002; Hong et al., 2001; Kim et al., 
2005). The first contributes to the repair o f proximal bronchioles and is located in a stem cell 
niche at the NEB. Commonly found at airway bifurcations, this site was previously identified 
as the first focus o f epithelial regeneration following injury (Hong et al., 2001; Reynolds et al.,
2000). These are variant Clara cells, and are defined by their expression o f CCSP and 
deficiency in the phase 1 enzyme CYP450-2F2, which explains their resistance to naphthalene 
(Reynolds and Malkinson, 2010). Transgenic mouse models were used to demonstrate their 
critical role in facilitating epithelial regeneration after injury (Hong et al., 2001). Interestingly, 
a low proportion of cells in the NEB were seen to express both CCSP and calcitonin gene 
related peptide (CGRP), a NE marker.
The second population o f naphthalene resistant cells was located at the BADJ (Kim et al., 
2005). They were shown to express CCSP (using IHC and in situ hybridisation) and SP-C. 
Immediately after injury, autoradiography showed them to account for all proliferating cells in 
that area and repopulation of the terminal epithelium occurred proximally from this site. 
However, in contrast to the variant Clara cells, colocalisation studies found no association 
with CGRP expressing cells using IHC. They were suggested to be a separate population o f
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stem cells responsible for repairing terminal bronchioles, and have since been named 
bronchioloalveolar stem cells (BASC) (Kim et al., 2005) (Figure 1.5). Cells with this 
phenotype have yet to be described in animals other than the mouse.
j p
AlveolusBronchial gland BronchioleBronchus
Basal cell
Variant Clara cell
BASC
Figure 1.5 Summary of stem cell types at different levels of the respiratory tract as defined in the mouse
The distinction in role between abundant facultative progenitor cells and rare bronchiolar stem 
cells was further defined in an elegant experiment by Giangreco et al (2009). They used 
chimeric mice and a whole lung imaging method to show the relative contributions of each 
progenitor cell type to mouse lung during normal maintenance and following mild or severe 
injury. In normal and mildly injured animals, repaired lung showed chimeric patches to be 
small and randomly located. In contrast, when the lung had healed from a severe injury, large 
clonal patches associated with NEBs and BADJ were seen. This demonstrates the involvement 
of bronchiolar stem cells only when extensive repair is required in the lung (Giangreco et al., 
2009).
Further characterisation o f bronchiolar stem cells in mice has been attempted but with 
inconsistent results (Kim et al., 2005; Teisanu et al., 2009). Initial work used FACS analysis to 
isolate a population of cells which were Sca-1 pos, CD45 neg, Pecam neg, CD34 posand also 
positive for SP-C and CCSP. Immunofluorescence then verified their anatomical location at
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the BADJ. The same cells were shown to exhibit stem cell properties in culture as defined by 
their ability to self renew and have multilineage differentiation potential (Kim et al., 2005). 
However, Stripp and his team claimed that these culture techniques enriched for alveolar 
epithelial cells, and the markers used would be unable to fractionate bronchiolar stem cells 
from a Clara cell rich pool (Teisanu et al., 2009). Instead, they used a lung cell preparation to 
include a broad population o f cells from conducting and respiratory airways which would 
include variant Clara cells, and found that bronchiolar stem cells had a CD45 neg, CD31 neg, 
CD34 neg, Sca-1 low AF low phenotype. They also commented that a proportion o f cells which 
expressed CCSP and SP-C exhibited high autofluorescence, therefore not displaying the true 
BASC phenotype. This questions the use of CCSP/SP-C dual positivity to identify BASCs. 
More doubt has been raised concerning this classification in recent studies by (Rawlins et al., 
2009). Using a ‘knockin’ mouse for lineage tracing CCSP-expressing cells, they suggested 
that there are subpopulations o f Clara cells that differ in their ability to contribute to the 
ciliated cell population. They also queried the involvement o f BASC populations at any stage 
in lung maintenance.
1.1.4.2 Bone marrow derived stem cells (BM DSC)
The bone marrow has also been suggested as a potential source of stem cells to aid in lung 
repair (Sage et al., 2008). An experiment which gave female mice with lethally irradiated bone 
marrow a single haematopoietic stem cell (HSC) from a male mouse, showed engraftment of 
donor-derived cells in the females bone marrow and lung, eventually making up to 20% of the 
parenchyma (Krause et al., 2001). When the experiment was repeated in humans, engraftment 
sites were concentrated to areas o f lung injury, suggesting that BMDSC could repair damaged 
tissue by differentiating into epithelial cells (Kleeberger et al., 2003; Suratt et al., 2003). 
However, subsequent work produced conflicting results, with some studies showing no 
contribution o f adult bone marrow stem cells to the epithelial compartment o f the lung, and 
others suggesting engraftments as other stromal cell types. BMDSC are now thought to be o f 
limited significance in their ability to contribute to epithelial repair in the lung (Sage et al., 
2008).
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1.1.5 Carcinogenesis and the lung progenitor cell
Research into lung stem cells is also fuelled by their associations with lung cancer. In fact, 
BASCs were originally discovered during an investigation o f the cell o f origin o f lung 
adenocarcinoma and stages o f tumour progression (Jackson et al., 2001). An inducible 
oncogenic K-ras mouse model found CCSP/SP-C double positive cells within adenomatous 
lesions which were continuous with the bronchiolar epithelium. They were thought either to be 
the product of transdifferentiated Clara cells following oncogene induced hyperproliferation, 
or the consequence o f oncogene activation in a stem cell with the potential to develop into 
both cell types. Subsequent experiments found BASC hyperplasia and increased 
adenocarcinoma development in several lung tumour mouse models o f disease and a role as a 
lung cancer stem cell was proposed for BASCs (Kim et al., 2005; Ventura et al., 2007; Yanagi 
et al., 2007).
The cancer stem cell (CSC) model was developed to explain the heterogenous nature of 
tumours (Eramo et al., 2010). It proposes that the same cellular hierarchical organisation that 
exists in normal tissues is also present in tumours (Figure 1.6). This means that CSC can self 
renew and produce differentiated progeny, so giving them the ability to initiate tumours and 
promote their progression. Ultimate proof o f CSC identity is one of the most challenging 
aspects o f this area of research. The most convincing experiments transplant CSCs into animal 
models, which then grow into tumours with phenotypic heterogeneity similar to the original 
tumour (Visvader and Lindeman, 2008). These cells must also show self renewing capacity on 
serial passaging. Various markers have been proposed for identifying these cells in solid 
tumours (Visvader and Lindeman, 2008).
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c a n c e r  s t e m  c e l l
t u m o u r
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Figure 1.6 Cancer stem cell model for tum our heterogeneity and propagation. The t u m o u r  conta ins  a cellular 
hierarchy,  but  only CSCs can g en e r a t e  a t u m o u r
Table 1.4 Markers for cancer stem  cells in solid tum ours (Mallick e t  al., 2009;  Visvader and  Lindeman,  2008)
Target Gene Function
CD133 CD133 /prominin- l  is a t r a n s m e m b r a n e  glycoprotein,  which may par t ic i pa te  in 
organisat ion of m e m b r a n e  topology.  Expressed on CD 34" s t em  and  progen i t or  cells in 
fetal liver, endothel ia l  precur sors ,  fetal neural  s t e m  cells and  developing epi thel ium.  
CD133+cells highly expres sed  in cancers  eg. p ro s ta te ,  colon car c inomas and  have 
progen i t or  capabil i t ies in vitro  and  in vivo.
Hoechst  SP Side popula t ion  p he no ty p e  du e  t o  Hoechst  3 3 3 4 2  efflux p u m p  p re sen t  on t h e  plasma 
m e m b r a n e  in diverse  cell types .  Levels a r e  low in s t em  cells
Oct 4 Octamer-bind ing t r anscr ipt ion fac tor  4 + is a s t e m  cell ma rker  protein.  It acts  as a 
mas t e r  switch in di f ferent ia t ion by regulat ing cells t h a t  have  p lur i po t ent  potent ial
ALDH 1 It has  a role in t h e  convers ion of ret inol t o  ret inoic acid which is impor t an t  for 
prol iferation,  di f ferent iat ion and  survival.
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Stem cells in human lung cancer have been isolated both from cell lines and primary tumours 
(Bertolini et al., 2009; Eramo et al., 2008; Ho et al., 2007; Jiang et al., 2009; Levina et ah, 
2008). Properties used for stem cell isolation vary between experiments and included side 
population phenotype (low Hoechst 33342 staining pattern), chemoresistance, Aldehyde 
dehydrogenase 1 (ALDH1) activity, ability to grow as spheres in serum-free medium and CD 
133+ expression. The embryonic genes Oct-4 and Nanog are also expressed by some o f these 
cells, so confirming their undifferentiated phenotype. Functions o f some o f these genes are 
summarised in Table 1.3.
In summary, it is clear that the lung is capable o f efficient repair following a variety o f insults. 
Injury models have shown there to be a hierarchy o f progenitor cells and the severity o f injury 
determines which ‘type’ is stimulated to proliferate. However, the situation is complicated by 
the cell plasticity exhibited in some injury models. Specific identification o f these cells and 
how to define their ‘stem cell’ characteristics is a subject o f much debate. Some are thought to 
be involved in lung carcinogenesis models, but the situation in animals other than the mouse 
has yet to be explored.
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1.2 Ovine Pulmonary Adenocarcinoma
In the UK, the veterinary profession was first alerted to the emergence o f this unique sheep 
disease in 1888 (Dykes and McFadyean, 1888). Mr Dykes was called to examine a flock of 
Oxford Downs where over 100 animals had been lost within the previous year. Some affected 
animals were said to be recumbent with an increased respiratory rate, whilst others died 
without any premonitory clinical signs. Common features at post mortem included generalised 
enlargement of lungs which were ‘ lighter in hue than natural, glistening and resistant to the 
knife\
Initially, the identification o f large numbers of parasitic eggs and larvae within the tissue led to 
the suggestion that Strongylus rufescens (Muelleriis capilariis) was the aetiological agent. 
However, in a later publication when additional samples were taken from affected areas of 
‘ dirty white fleshy tissue’, the histological picture detailed thickening o f alveolar walls and 
transformation o f the alveolar and bronchial epithelium (McFadyean, 1894). Matching 
histological descriptions were found in subsequent reports from different countries. In South 
Africa the disease was named Jaagsiekte, literally meaning driving (jagt) sickness (ziekte) 
(Robertson, 1904); in England it was called white pneumonia (McFadyean, 1920); and in 
Iceland it was named Deildartunga after the farm on which it was first discovered (Dungal et 
al., 1938). Similarities between these findings were recognised by Taylor in 1937 where he 
concluded that ‘ comparison o f  the detailed description o f  the microscopical appearance o f  
lungs affected by this disease... with those o f  Jaagsiekte and with sections o f  lungs affected by 
an epidemic disease o f  Icelandic sheep suggest that all three diseases may be one and the 
same, and that Jaagsiekte has occurred in Great Britain" (Taylor, 1937). OPA has since been 
reported in countries all over the world. Exceptions include Iceland where it was eradicated by 
following a strict slaughter policy in the 1950s (Palsson, 1985), and New Zealand, Australia 
and the Falkland islands, where it has never been described.
1.2.1 Clinical parameters of OPA
As OPA has a long incubation period, naturally infected animals tend not to develop clinical 
signs until adulthood. A survey of sheep in Scotland found infected animals to show clinical
signs between nine months and seven years o f age, with a peak o f disease incidence between 3 
and 4 years (Hunter and Munro, 1983). However, clinical cases have been reported in animals 
as young as 2-4 weeks old (Dungal, 1946; Shirlaw, 1959) and there is unpublished data which 
details tumour in a 3 day old lamb (De las Heras et al personal communication). The average 
mortality within flocks appears to depend on whether the disease is endemic (2% loss) or a 
recently acquired infection (up to 30% loss) (Sharp and Angus, 1990). Infection of goats has 
been reported but it is thought they are more resistant to developing clinical disease (De las 
Heras, 2003).
Clinical signs can be seen following forced exercise o f those in the early stages of disease, or 
in severely affected animals at rest. This latter feature is responsible for the name Jaagsiekte 
(driving sickness), as these animals look like they have been overdriven. Movement of 
affected animals will bring on an exaggerated increase in respiratory rate and effort, causing 
them to lag behind a travelling flock (Robertson, 1904). Increased respiratory recovery time 
and coughing following exertion may also be clinical features. In severely affected animals 
laboured breathing can be accompanied by the sound of moist rales or ‘ boiling porridge’ 
resulting from the build up o f fluid in the airways (Dungal et al., 1938). These animals can 
also have wet shiny nostrils, and in some cases when the head is lowered and hind legs lifted, 
translucent frothy fluid runs from the nares (Figure 1.7A). This manoeuvre is called the 
‘wheelbarrow test’ and it is currently the only definitive way of diagnosing the disease in a 
live individual animal (Voigt et al., 2007). Up to 300 ml can be collected at any one time and 
the fluid has the appearance o f watery egg whites which froth up on agitation (Palmarini and 
Fan, 2001).
Despite these respiratory signs, if  left unstressed many affected animals can remain bright and 
appetent for 2-3 months until a critical tumour mass is reached and gas exchange is hugely 
compromised. Weight loss is marked in the terminal stages (Figure 1.7B), but pyrexia is not a 
noted feature unless secondary bacterial infections complicate. If this occurs, sudden death due 
to an acute bacterial pneumonia in an adult animal may be the first indicator that the disease is 
present in the flock. Concurrent infections with other viruses eg. ovine herpesvirus and maedi- 
visna virus (M W ) have also been recorded, but the disease course still remains chronic 
(Herring et al., 1983).
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Figure 1.7 Clinical signs of OPA in adult sheep. (A) Arrow shows  fluid pour ing f rom nares  in a posi t ive 
w he e l b a r ro w  tes t .  (B) Animals a r e  in poo r  condi t ion but  r emain bright  and ap pe t e n t .
Original observations of the disease by farmers found any form of chill or physical exertion to 
aggravate the condition (Dungal et al., 1938). This theory was reinforced following a clinical 
experiment in 1971 that confirmed cold stressing to be a predisposing factor for onset of 
clinical signs (Mackay et al., 1971). Differences in breed susceptibility have also been 
recorded, for example in Iceland the Gottorp breed was said to be more susceptible than the 
Adalbol breed (Dungal et al., 1938). A more recent study has implicated associations between 
sheep MHC-DRB1 alleles and susceptibility to OPA (Larruskain et al., 2010). Other surveys 
suggest specific breed predilection may be skewed by different management practices (Hunter 
and Munro, 1983) and a definitive survey of modem day breeds is lacking. Despite mention in 
early papers, reports of recovery are limited to one recent publication, but these animals were 
also infected with M W  (Hudachek et al., 2010). In the field, once clinical signs have been 
established the disease is assumed to be invariably fatal. Early attempts at vaccination were 
made using formalinised vaccines prepared from adenomatous lungs (Shirlaw, 1959; Tustin, 
1969). While disease incidence was seen to reduce from 30-1% on some farms, administration 
also coincided with a change in management practice and culling of suspect cases (Shirlaw, 
1959).
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1.2.2 Pathology of OPA
1.2.2.1 Gross Pathology
The definitive diagnosis of this disease in an individual animal still relies on characteristic 
gross and histopathological post mortem findings. There are numerous descriptions in the 
literature (Al-Zubaidy and Sokkar, 1979; Blakemore, 1941; Cowdry, 1925a, b; Cuba-Cuparo 
et al., 1960; Cutlip and Young, 1982; de Kock, 1958; Demartini et al., 1988; Dungal, 1946; 
Nisbet et al., 1971; Nobel et al., 1969) From these it can be seen that there has been little 
change in the pathological presentation over the last 100 years (Sharp and DeMartini, 2003).
A typical post mortem examination of a naturally infected animal in the advanced stages of 
disease will find a thin carcase with frothy fluid exuding from the nares and filling the trachea 
as stable foam. On incision into the thoracic cavity, the lungs will fail to collapse and are 
enlarged, heavy and oedematous (Figure 1.8A, B). Palpation will find a large centre o f 
consolidation in one or more lung lobes, which extends peripherally in a milliary distribution 
(Figure 1.8 C,D,E). Here, there is a clear distinction between normal and diseased lung. 
Neoplastic tissue appears solid, firm and darker in colour than the adjacent normal tissue 
which is often locally over inflated. The cut surface is uneven and granular and frequently 
exudes frothy fluid (Figure 1.8F). In larger masses the centre is more resistant to the knife and 
can feel almost gritty as accurately described by Robertson in 1904 6 in some cases it cuts like 
bacon, and in advanced cases like cartilage\ Sometimes lesions are more focal, with single or 
multiple firm masses found within any lung lobe. The bronchial and mediastinal lymph nodes 
are generally enlarged and oedematous and histological examination has shown that up to 10% 
contain metastases (Demartini et al., 1988). Distant metastases have also been reported in 
liver, kidney, heart and skeletal muscle but are generally rare (Hunter and Munro, 1983). 
Animals which have died often have a secondary bacterial pneumonia (Figure 1.8D). In these 
cases detailed dissection is important as extensive pleurisy and adhesions can mask the 
underlying pathology o f OPA.
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Figure 1.8 Post m ortem  findings in natural field cases of OPA. (A) Exposure of  t h e  thoracic  cavity fol lowing 
removal  of s t e rnum.  Lung lobes have failed to  col lapse as they a r e  o e d e m a t o u s  and  inf il trated wi th  t u m o u r  
(arrows).  (B) Frothy fluid exudes  f rom t h e  t r a chea  (arrow).  (C) T umour  infiltrating caudal  region o f  t h e  right 
diaphragma t ic  lobe (arrow).  (D) Tu mour  infil trat ing left caudal  apical lobe (arrow).  (E) Genera l i sed  en l a r gem en t  
of right d i aphragmat i c  l obe d ue  to  t u m o u r  infiltration. Arrow points  t o  sect ion locat ion for (F), which shows  t he  
grey,  granul ar  a pp ea ra n ce  of t u m o u r  t i ssue ad j acen t  to normal  pink ae r a t e d  lung t issue.
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1.2.2.2 Histopathology
OPA is described as an adenocarcinoma o f mixed subtype when compared to the World 
Health Organisations classification for human tumours (Travis et al., 2004a). Non­
encapsulated neoplastic foci emanate from alveolar and bronchial epithelium forming acinar 
and papillary proliferations which expand into adjacent structures (Figure 1.9A, B). The cells 
vary in shape and malignancy both within and between tumour nodules. Classically, they are 
cuboidal or columnar, with or without cytoplasmic vacuolation, and have a low mitotic index 
of 0.002% in any tumour (Platt et al., 2002) (Figure 1.9 C). In areas o f increased malignancy, 
solid masses o f pleomorphic cells with a high mitotic rate and scattered foci o f necrosis can be 
found.
Neoplastic cells are supported by a fibrovascular connective tissue framework which can 
dominate the centre o f large tumour nodules (Figure 1.9 D). This acts as a scaffold for 
infiltrating inflammatory cells which vary according to the size/age o f the tumour and 
presence of secondary infectious agents. Occasionally, nodules of loose mesenchymal tissue 
appear alone or admixed with classical tumour, and these are also thought to be neoplastic 
tissue (Wootton et al., 2006b) (Figure 1.8 E).
IHC has shown virus expression to be limited to neoplastic tissue only (Figure 1.9 G) 
(Palmarini et al., 1995). Type II alveolar epithelial cells are the principal neoplastic cell type 
(82%) with Clara cells (7%) and undifferentiated cells (11%) making up the remainder (Figure 
1.9 H) (Platt et al., 2002). Frequently, large numbers o f foamy macrophages are seen to 
infiltrate alveolar spaces about mature neoplasms (Figure 1.9 I-K). These are often 
accompanied by neutrophils, assumed to be the result o f secondary bacterial infection, and 
necrotic foci (Figure 1.9 L) (Platt et al., 2002).
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Figure 1.9 Histological findings in natural field cases of OPA. (A) Bronchiole wi th ear ly neoplas t i c  focus in 
lumen,  OM x400. (B) Lepidic sp r ead  of t u m o u r  (arrow) along alveolar  walls, OM xlOO. (C) Ma t u re  t u m o u r  focus 
wi th cytoplasmic vacuola t ion of neoplas t i c  cells, OM x200. (D) Tumour  with p ro m in en t  f ibrovascular  connect i ve  
t i ssue f r amework  (arrow),  OM x 400.  (E) Large nodu le  of neoplas t i c  mesenchyma l  t i ssue  (arrow),  OM x20. (F) 
loose myx oma tous  t i ssue a b o u t  neoplas t i c  focus,  OM x600.
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Figure 1.9 (cont.) Histological findings in natural field cases of OPA (G) IHC using anti-JSRV SU an t i body t o  show 
posi t ive labelling (brown pigment)  of ent i re  t u m o u r  nodule,  OM x200 (H) IHC using anti-SP-C an t i body  to  show 
posi t ive labelling of neoplas t i c  cells, OM x200 (I) Early neop l a sm with occasional  infiltrating m ac r op ha g es  
(arrow),  OM x400.  (J) Growing neop la sms  with a m o d e r a t e  ma c r o p ha ge  infiltration (arrow),  OM x 200 (K) Dense  
infil trat ion of mac ro pha ges  (arrow) ad j acen t  to tum ou r ,  OM x600. (L) Necrot ic t i ssue (arrow) in t h e  cen t r e  of  a 
m a t u r e  t u m o u r  nodule ,  OM x200.
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1.2.2.3 Electron microscopy
Electron microscopy has also been used to document early growth o f the tumour and identify 
ultrastructural characteristics o f neoplastic cells (Payne and Verwoerd, 1984). Tumours are 
said to originate from paired cells resembling foetal pneumocytes, in the comer o f alveoli. 
These proliferate to line alveoli with cuboidal or columnar cells, before forming papilliform or 
varicose clusters, which can extend into bronchioles. The cells have basal or centrally located 
nuclei, microvilli on all surfaces (reduced in older cells) and are connected by desmosomes. 
They contain variable numbers of secretory granules which can appear as electron-dense 
structures or are filled with myelinoid whirls, in comparison to the electron-lucent granules 
found in normal granular pneumocytes. The cells have rough endoplasmic reticulum (RER), 
large numbers o f free polysomes, a well developed Golgi apparatus and hypertrophic 
mitochondria (Perk et al., 1971). Cytoplasmic glycogen granules have also been identified, 
sometimes in large quantities, and confirmed using Periodic Acid Schiff (PAS) staining. The 
macrophages identified on histology are highly ruffled and enlarged, confirming their 
activated status. They either attach to the surface o f normal or neoplastic cells, or form 
separate clusters. As well as containing lysosomes and phagolysosomes, phagocytosed JSRV 
particles, bacteria and mycoplasma like organisms have also been found.
1.2.3 Discovery of the aetiology of OPA
Initial histological examination o f lungs from diseased animals in 1888 found parasitic forms 
to be closely associated with areas o f affected lung tissue. These were identified as Muelleriis 
capillar is, and were suggested to be responsible for the adjacent pulmonary pathology (Dykes 
and McFadyean, 1888). A few years later, 4peculiar crescent shaped bodies ’ were found in 
smears of lung from similarly affected animals, and a protozoal 4malarial-like’ aetiology was 
proposed (Robertson, 1904). However, it was not until the autumn o f 1936 that a thorough 
pathological investigation was performed at the request o f the Icelandic government. This 
followed the importation o f an infected ram from Germany, and the subsequent 50-80% 
mortality within sheep flocks in Iceland (Dungal et al., 1938).
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1.2.3.2 Early transmission experiments
Early experiments followed the lead of Dykes and MacFadyean, but no association was found 
between parasitic burden and disease incidence or the distribution o f both within the lung. 
Bacterial and viral aetiologies were then searched for in vitro and experimental transmission 
studies were also performed (Tables 1.8 and 1.9). These demonstrated disease transmission by 
the respiratory route and also by means o f intrapulmonary injection o f neoplastic lung tissue 
(Dungal, 1946). Injecting lambs with a glycerol saline filtrate which had been breathed into by 
infected animals, was also successful in transmitting disease and supported the theory o f a 
viral aetiological agent (Dungal, 1946).
Table 1.5 Summary of early experiments to determine the aetiology of OPA
Experiment Result Reference
Assessed parasitic (M Capillaris) burden of 
1000 lungs from OPA affected and non 
affected areas.
Parasitic burden similar (Dungal et al., 1938)
Checked stage of larva in lung Not fourth stage ie. not 
more pathogenic
(Dungal et al., 1938)
Bacterial culture of tissue from euthanased 
animal with clinical signs of OPA
No bacterial growth (Dungal e ta l.,1938)
Bacterial culture of tissue animal that died 
with clinical signs of OPA
Cultured Bacillus sp. (Dungal et al., 1938)
Cultivation of tum our tissue in chick 
embryos
No growth over 5-6 days (Dungal et al., 1938)
Cultivation of tum our tissue in chick 
embryos
Evidence of growth (Shirlaw, 1959)
Histochemical staining of sections with 
Giemsa/Castaneda
No protozoa/viral 
inclusions
(Dungal e ta l.,1938)
Dark ground illumination of sections No spirochaetes (Dungal et al., 1938)
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Table 1.6 Summary of early disease transmission experiments
Experiment Result R eference
Hay fed from pastures grazed by infected animals No disease transmission (Dungal et al., 
1938)
Faeces from infected animals fed to  lambs via 
stomach tube
No disease transmission (Dungal, 1946)
Parasite (Melophagus ovinus, Muelleris capillaries) 
transfer from infected to normal sheep
No disease transmission (Dungal, 1946)
Housed eight healthy sheep with 20 sick sheep 7/8 developed disease in 8 
months
(Dungal, 1946)
Sheep exposed to  rear end only of infected sheep No disease transmission (Dungal, 1946)
Sheep housed above infected sheep in same 
airspace
3/5 got disease (Dungal, 1946)
Intrapulmonary injection of homogenised tum our 
tissue into lambs
1/3 developed disease in 7 
months
(Dungal, 1946)
Tumour tissue injected into mice, rabbits and 
guinea pigs
Adenomatous tissue growth in 
rabbit and guinea pig lung
(Cvjetanovic et al., 
1972; Shirlaw, 1959)
Infected sheep breathed into 20% glycerol/saline 
for 30 minutes, injected into x3 lambs
1/4 infected (Dungal 1946)
Addition of lung worms or Bacillus sp. to viral 
filtrate
Greater disease transmission (Dungal e t al 1938)
By this stage, it was clear that Jaagsiekte was an infectious disease o f sheep, most likely o f 
viral aetiology. The variability of successful disease transmission using conditions that we 
now know to be adequate, can be explained by inconsistencies in the age o f animal used for 
infection and inadequate incubation periods. Whilst the virus typically has a long incubation 
period, some animals were only left a few months before being classified as free from disease 
and this may not have been long enough. An interesting observation made by Dungal in 1938 
was that in the natural outbreak in Iceland not all animals exposed to infection developed 
disease. This suggests there may have been genetically related innate resistance or 
development o f immunity in some cases.
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1.2.3.3 Virus identification
Identification o f the virus responsible for OPA was made difficult by the presence o f multiple 
viruses in naturally infected animals. Herpes viral inclusions were frequently identified in 
macrophage cultures from infected animals and this virus was isolated from 24% o f OPA 
cases examined (Malmquist et al., 1972; Martin et al., 1976). Work infecting fetal sheep lung 
cells also identified syncytia formation, a finding more consistent with the already known type 
C virus, maedi visna virus (M W ) (Malmquist et al., 1972). Attempts were made to produce 
disease with herpesvirus alone, but these failed and a multifactorial aetiology o f Jaagsiekte 
was suggested (Cvjetanovic et al., 1972; de Villiers et al., 1975; Mackay, 1969; Martin et al., 
1979). Further analysis using EM found type A and type C viral like particles to be associated 
with transformed epithelial cells (Perk et al., 1971). These were thought to be morphologically 
distinct enough from M W  particles to indicate the presence of a novel virus. In addition, sera 
from OPA sheep were not able to neutralise M W  (De Boer, 1970) and molecular 
hybridisation experiments indicated an absence o f M W  RNA sequences in the polysome 
fraction o f OPA tumours from Awassi sheep (Perk and Yaniv, 1977).
1.2.3.4 Virus classification
A retrovirus was suggested as the aetiological agent, as particles with a 60-70S RNA 
associated with reverse transcriptase (RT) were found exclusively in tumour tissue (Perk et al., 
1974). A similar experiment was used to show the strong association between RT activity and 
the induction of OPA (Martin et al., 1976). Although it proved impossible to culture, in vivo 
transmission of disease using a cell line (JS 15.4) established from infected lung was effective 
(Coetzee et al., 1976). The experiment was successfully repeated using homogenised cells, 
which showed infection was due to actual transfer o f genetic information rather than of 
neoplastic cells (Verwoerd et al., 1980a). Analysis o f lung rinses from these animals by EM 
found electron dense particles with an average size o f 80-150 nm and a close fitting 
membrane, similar in appearance to type B and D retroviruses. By using lung lavages 
concentrated by ultracentrifugation, incubation time o f experimentally-induced OPA was 
reduced from 12 months to 3 weeks. This showed a dose-dependent response to infection, 
increasing the likelihood that the viral particles seen were responsible for disease (Verwoerd et 
al., 1980b).
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Successful isolation and purification o f this virus was achieved by the same group in 1983, 
and it was named Jaagsiekte Sheep Retrovirus (JSRV) (Verwoerd et al., 1983). Efforts to 
further classify it showed an immunological cross-reaction between the 25 kDa mol wt protein 
in OPA tumours and the 27 kDa mol wt core protein (p27) o f Mason-Pfizer monkey virus 
(MPMV) and mouse mammary tumour virus (MMTV) (Sharp and Herring, 1983). 
Morphological comparisons with mouse mammary tumour virus (type B), murine sarcoma 
virus (type C) and squirrel monkey retrovirus (type D) found it to have a relatively electron- 
dense perinucleoidal space in comparison to other retroviruses and the nucleoid was eccentric. 
Surface spikes were longer than those seen on MMTV (Payne et al., 1983).
Up until the 1980’s, the inability to culture the virus and complications with dual infections 
had hampered the progress o f molecular studies. In 1991, York and his co-workers succeeded 
in isolating an 8.7 kb RNA molecule from washes o f experimentally infected lungs (York et 
al., 1991). This was thought to represent the genomic RNA of JSRV, and transmission 
electron microscopy (TEM) o f purified fractions containing this RNA revealed retroviral 
particles identical to those seen in infectious material. They also found sequence markers 
representative o f a retrovirus, although only part o f the genome was characterised. These 
included a polypurine tract, a TATA box, an inverted repeat and a poly A tail. By 1992 the 
complete genome had been cloned and its genomic organisation showed gag, pro  and pol 
regions similar to type D retrovirus and env similar to type B (York et al., 1992).
The aetiological role o f JSRV in OPA was not long to follow. Initially, a full length JSRV 
pro viral clone, PJSRV2 1 , was isolated from a genomic DNA library o f a natural case o f OPA. 
Intratracheal inoculation of PJSRV21 into newborn lambs and subsequent detection of proviral 
DNA in PBMCs demonstrated its infectious nature (Palmarini et al., 1999a). However, in 
order to use it as a source of infectious virus by transfecting in vitro cell lines, modifications 
were necessary. The U3 region of the upstream JSRV promoter was replaced with a powerful 
CMV promoter, to generate a plasmid designated pCMV2JS21. Transfection o f pCMV2JS21 
into human 293T cells resulted in release o f JSRV into culture. This virus rich supernatant was 
used to inoculate three lambs, two o f which developed disease, proving JSRV21 was an 
infectious clone and sufficient to induce OPA in vivo (Palmarini et al., 1999a). This finding 
provided a solid platform on which to base further experiments.
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1.3 Retroviruses
Retroviruses are a well established family o f RNA viruses which comprise some o f the most 
important human and animal pathogens known today (Coffin et al., 1997). They have a huge 
impact on human society worldwide and this has stimulated research into effective therapies 
and vaccine development for infection control. Each virus has a specific host range between 
which modes o f transmission include transplacental, milk, respiratory, blood and sexual 
routes. Common manifestations o f disease incorporate a wide range o f immunological and 
neurological conditions and various cancers (Maeda et al., 2008).
Retrovirus diseases o f animals were first documented in the 19th and early 20th century. Those 
associated with malignant disease were lung cancer in sheep in 1825 (Tustin, 1969), 
lymphosarcoma in cattle (Johnson and Kaneene 1992) and erythroid leukaemia and sarcoma in 
chickens (Ellermann and Bang, 1908; Rous, 1911). It took 40 years for the concept o f viral 
oncogenesis to be truly accepted (Gross, 1951, 1957), but it was finally rewarded with a Nobel 
prize for Rous in 1966. By this time, in vitro methods for studying early stages o f infection, 
cellular transformation and virus quantification were well underway (Temin and Rubin, 1958). 
It was not long before the discovery of reverse transcriptase, an essential enzyme required for 
retroviral replication, revised the Central Dogma theory o f molecular biology (Baltimore,
1970; Temin and Mizutani, 1970). Assays to detect this enzyme as a marker for retroviral 
infection were rapidly developed and led to the finding of the first human retrovirus, Human T 
Lymphotropic virus-1 (HTLV-1) (Poiesz et al., 1981). Following this a novel T-lymphotropic 
retrovirus was detected in a patient with lymphoproliferative disease, and named HTLV-3 
(Barre-Sinoussi et al., 1983). This was the first isolation o f what we now know as human 
immunodeficiency virus (HIV) in humans and the start o f the AIDS pandemic. It re-energised 
the hunt for new human retroviruses, which was enabled by the development o f more 
sophisticated techniques such as bioinformatics and genomics (Voisset et al., 2008). For 
example, claims for a role o f retroviruses in breast cancer, prostate cancer and myalgic 
encephalomyelitis have recently been made (Erlwein et al., 2010; Lombardi et al., 2009; 
Metzger et al., 2010). Proving Koch’s postulates for these is the next hurdle (Voisset et al., 
2008).
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1.3.1 Retrovirus c lassification
Currently, retroviruses are classified according to their sequence similarity within the pol gene 
(Linial et ah, 2005). This system divides the group into two subfamilies and seven genera as 
shown in Figure 1.10. Interestingly, other features such as virion size, structure and protein 
number also correlate well with this phylogenetic analysis. Before molecular details became 
available, viruses were categorised by their appearance on EM, associated disease or 
replication strategy. While these observations are all still valid, overlaps between groups 
reduce their effectiveness as a classification method.
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Figure 1.10 Phylogenetic tree  showing the classification of retroviruses. The family Retrovir idae is divided into 
tw o  subfamil ies:  orthoretrovirinae  (orange)  and  spum aretrovir inae  (yellow). JSRV is a be ta r e t rov i rus  and  is 
highl ighted in blue.  (Griffiths e t  al 2010).
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1.3.2 Retrovirus structure
Despite the variety of clinical disease, all retroviruses share similar structural properties. They 
are enveloped viruses with a diploid, single stranded positive sense RNA genome (Weiss,
2001). They encode only a few genes, and have evolved to maximise the use o f the host cell 
machinery. The structural details o f JSRV are outlined in Figure 1.11 and 12, and details of 
the replication cycle are in Figure 1.13.
C e l l  d e r i v e d  l i p i d  b i l a l y e r  
S U -  s u r f a c e  c o m p o n e n t  
T M  -  t r a n s m e m b r a n e  
M A  -  m a t r i x  p r o t e i n  
C A  -  c a p s i d  p r o t e i n  
N C -  n u c l e o c a p s i d  p r o t e i n  
R N A
P R  -  p r o t e a s e  
I N  -  i n t e g r a s e  
R T -  r e v e r s e  t r a n s c r i p t a s e
Figure 1.11 Schematic diagram of JSRV virion structure. The virion conta ins  tw o  ident ical  copies  of  t h e  RNA 
g e n o m e  which are  assoc ia ted with t h e  NC prot ein  and  enclosed within t h e  virus CA and  MA proteins .  Enzymes 
involved in repl icat ion a re  also p r e sen t  within t h e  viral core  (PR, IN and  RT). The who le  s t ruc tu r e  is enc losed  
within a lipid bilayer enve lope  t h a t  is assoc ia ted  wi th SU and  TM proteins .
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Figure 1.12 Structure of JSRV genom e. The  RNA g e n o m e  of  JSRV (A) is app roxima te ly  7,460 nucleot ides  in 
length.  R r ep r e sen t s  t h e  r e pe a t e d  e l e m e n t s  a t  each  end of t h e  RNA g e no m e .  U5 and  U3 a re  t he  unique  
e l em en t s  close to  t h e  5'  and  3'  termini  o f  t h e  g e n o m e  respect ively.  The 0 e l e m e n t  is t h e  packaging signal and  
PBS is t h e  p r imer  binding si te for initiating rever se  t ranscr ipt ion.  PPT is t h e  polypur ine t rac t  which is t h e  
initiating si te of posi t ive s t r and  synthesis .  The DNA form of  t h e  JSRV g e n o m e  (B) has  long terminal  r epea t s  (LTR) 
a t  e i t her  end.  These  are  m a d e  up of U3,R and  U5 regions and contain p ro m o te r  and en ha nce r  e l ement s .  The 
retroviral  LTR are  g e ne ra t ed  by dupl icat ion of  t h e  end  of t h e  viral g e n o m e  dur ing rever se  t ranscr ipt ion and t hey 
regu la te  virus expression.  The g e n o m e  (B) cont ains  four  main genes  which a re  gag, pro, po l  and  e n v  (York et  al., 
1991,  1992).  Gag  en co des  s t ructural  p rot e ins  matrix (MA), capsid (CA) and  nucleocapsid (NC). pro  and  pol  
enc o de  enzymes  necessary  for repl icat ion including p ro t ea s e  (PR), rever se  t r an sc r i p ta se  (RT) and in t egrase  (IN), 
and  en v  encode s  t h e  sur face  (SU) and  t r a n s m e m b r a n e  (TM) enve lope  proteins .  Env  has  also been  shown  to  be  
an oncogene ,  and is capabl e  of inducing t u m o u r s  in l ambs  (Caporale e t  al., 2006)  and im mu noc om pro m ise d  
mice (Woo t ton  e t  al., 2006b).  A highly conserved  open  read ing  f r ame  (orf-x) also lies within t h e  po l  region but  
t h e  funct ion of this is unkn ow n  (Bai e t  al., 1999;  Mae da  e t  al., 2001;  Rosati e t  al., 2000).
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1.3.3 Retroviral replication
Env forgetting to  plasma 
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Figure 1.13 Replication cycle of JSRV, a general overview. JSRV en try  into t h e  cell is faci l i tated by fusion of viral 
and  cellular m em b ran es .  This is ini t iated by t h e  binding of  t h e  SU subuni t  of t h e  Env glycoprote in to t h e  cell 
sur face  r ecep to r  molecule  Hyaluronidase  -2 (Hyal-2), which induces  a conformat iona l  change  resul t ing in 
endocytos is  of t h e  virus and fusion of  t h e  m e m b r a n e s  to  r e l ease  t he  viral core  into t h e  cell cytoplasm.  The viral 
core  t hen  uncoa t s  and rever se  t ranscr i pt i on is t r iggered . As this complex m a t u re s  and  DNA synthesis  is 
comp le t ed ,  micro tubul es  faci l i tate t r an spo r t a t i on  t h rough  t he  cytoplasm to w ard s  t h e  nuclear  m e m b ra n e .  
Mitosis provides an oppor tun i t y  for nuclear  entry,  and integrat ion of t h e  doub l e  s t r ande d  DNA into t h e  host  
genomic  DNA using t h e  viral i nt egrase  (IN) enzyme.  This "provirus" is slightly longer  t h an  t h e  original RNA 
g e n o m e  as it is f lanked on e i t her  end  by t h e  LTR der ived f rom t h e  5'  and 3'  end s  of t h e  original RNA t e m p la t e  
during rever se  t ranscr ipt ion.  Once t h e  provirus is i n t egra t ed ,  hos t  RNA polymerase  II is u sed to  t r an scr i be  
genomic  length RNA which is packaged  t o  make  t h e  RNA viral g eno me .  Gag, Pro and  Pol a re  t r an s l a t ed  f rom this 
while Env is t r an s l a t ed  f rom a singly spl iced t ranscr ipt .  St ructural  prot eins  ga the r  at  t h e  mic ro tubul es  and  are  
t r an s po r t e d  t o  t he  cell surface,  w h e r e  t hey  a re  packaged  with t h e  remaining p rot eins  and  genomi c  RNA. The 
viral Gag polyprote in med i a t e s  JSRV as semb ly  and  release.  At this point ,  t h e se  imm a t u re  vir ions a r e  non  
infect ious and  larger in size, and  it is not  until proteolyt ic  cleaving of t h e  polyprote ins  by p ro t ea se  (PR) enzyme  
occurs  t h a t  t h e  cor r ec t  morpho logy is a s su me d  and  they a re  infectious.
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1.3.3.1 Cell entry
The presence o f a specific correct receptor on the host cell is the first step necessary for 
successful retroviral entry and replication. Initial work to determine the JSRV receptor showed 
it to be present on a wide variety o f ovine cell types and cells o f various species including 
human, monkey, cow, dog and rabbit cell lines (Holland et al., 1999; Palmarini et al., 1996; 
Palmarini et al., 1999b). However, rodent cell lines were found not to be transducible, and by 
using phenotypic screening o f human/hamster hybrid cell lines, localisation o f the receptor to 
the 3p21.3 region o f the human chromosome was possible (Rai et al., 2000). This region was 
shown to contain a glycosylphosphatidylinositol (GPI) - anchored cell-surface protein called 
Hyaluronidase -2 (Hyal-2). Absolute proof of its receptor function for JSRV was shown by 
expressing Hyal-2 in previously resistant cell lines so rendering them susceptible to JSRV 
vector transduction. Equally, removal o f Hyal-2 from susceptible cells by cleaving GPI 
linkages, blocked JSRV vector transduction (Rai et al., 2001). Hyal-2 has also been implicated 
in the transformation of some cell lines. In the human bronchial epithelial cell line BEAS-2B, 
Hyal-2 acts as a tumour suppressor by binding to the recepteur d ’origine nantais (RON) 
receptor tyrosine kinase and rendering it inactive (Danilkovitch-Miagkova et al., 2003). A 
similar role for RON has been proposed in sheep, although in mice at least, RON expression is 
limited to bronchial epithelial cells (Miller, 2008; Sakamoto et al., 1997). Other GPI anchored 
cell surface proteins have also been shown to participate in cell signalling and mitogenic 
activation, and the role o f Hyal-2 in cell fusion during embryogenesis has been suggested 
(Dunlap et al., 2006).
1.3.3.2 Reverse transcription
Once the virus has gained access to the cell cytoplasm, all intracellular events take place
within the nucleoprotein complex derived from the viral core. Reverse transcription is
triggered by the uncoating o f the viral core, and involves a series o f highly related strand
transfer reactions. The net result is the conversion of the diploid RNA genome to a single
double stranded DNA form. A specific cellular tRNA molecule anneals to a complementary
sequence in the viral RNA at the PBS, and initiates DNA synthesis. This forms the minus-
strand strong stop DNA which contains R and U5 sequences. It is transferred to the 3’ of the
viral RNA genome following RNase H degradation o f the viral genomic RNA. This process is
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called the first strand transfer. The minus strand is then extended to copy the remaining RNA 
sequence, which is degraded by RNase H. The PPT sequence is preserved, and acts as a 
primer for the formation o f the plus-strand strong-stop DNA which extends 18 nucleotides 
into the tRNA primer. The latter is removed by RNase H, and the second strand transfer acts 
to anneal the plus strand strong stop DNA with the 3’ end of the minus strand. Subsequent 
extension o f these plus and minus strands yields a linear ds cDNA which contains a copy of 
U3-R-U5 sequences. These are known as the long terminal repeats (LTRs).
1.3.3.3 Nuclear entry and integration
Integration into the host DNA acts to stabilise the viral DNA and enables efficient 
transcription o f viral DNA into the viral genome and mRNAs encoding viral proteins. For all 
retroviruses, entry into the cell nucleus is essential to allow viral DNA integration. Early 
observations found that apart from lentiviruses, all retroviruses required actively dividing cells 
for efficient integration and replication (Lewis and Emerman, 1994; Temin and Rubin, 1958). 
In vitro work has shown that during mitosis the nuclear membrane is disassembled, and this 
provides the opportunity for viral DNA entry into the nucleus (Harel et al., 1981). Although 
not yet proven, this requirement for cell division is assumed to apply to JSRV, and the 
infection o f quiescent cells is thought to be a rare and inefficient event (Griffiths et al., 2010). 
Once viral DNA synthesis is complete, the viral integrase cleaves the 3’ termini o f the viral 
DNA, exposing OH groups which help to attach the provirus to the host DNA. Integration 
sites for JSRV were investigated in several natural cases of OPA. Most were found to have 
multiple integration sites with a random distribution, although two integration sites from 
independent tumours were found on chromosome 16 (Cousens et al., 2004).
1.3.3.4 Trafficking and assembly
Retroviral assembly and release are both mediated by the viral Gag polyprotein. For
betaretroviruses, immature particles known as Type-A particles assemble at microtubules in
the cytoplasm. They are then transported to the cell surface for envelopment at the plasma
membrane during budding. These immature particles are non infectious. Gag maturation
occurs after assembly and budding, and involves the proteolytic processing by protease o f the
Gag polyprotein to yield the internal structural proteins matrix, capsid and nucleocapsid.
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Figure 1.14 A schematic representation of reverse transcription. Described in sect ion 1.3.2.
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1.3.4 Influential host factors for retroviral replication
A diagram of the JSRV replication cycle is shown in Figure 1.13. As the virus has a limited 
genetic coding capacity, it is highly dependent on the host cell for provision o f some essential 
‘permissive factors’ to enable replication. However, the host has also evolved to produce 
factors that can actively inhibit retroviral replication, denoted ‘restriction factors’. The balance 
between these two influences is a major determinant o f the outcome o f infection.
1.3.4.1 T ranscription factors
Successful retroviral replication is also dependent on cellular transcription factors. These are 
essential host proteins which bind to promoter and enhancer elements located in the U3 region 
of the long terminal repeats (LTR) o f the proviral DNA. They facilitate the transcription o f 
proviral DNA by RNA polymerase II, in order to produce genomic viral RNA (Coffin et al., 
1997). Core transcription factors are required for transcription initiation and bind together with 
RNA polymerase II and other proteins near the TATA box in the promoter region. Regulatory 
transcription factors bind either near to (promoters) or far (enhancers) from this region, and act 
to control the rate o f transcription. Some transcription factors are ubiquitous while others are 
found only in specific cell types and each retrovirus has its own requirements for particular 
combinations. Their presence, along with the differentiation and physiological state o f the host 
cell, will have a major influence on the transcription rate and hence the level o f virus 
expression at a cellular level.
As far as we know, expression o f JSRV is limited to transformed cells within the lung and
occasional lymphocytes (Holland et al., 1999; Palmarini et al., 1999a). To investigate the role
o f transcription factors in this restricted expression, several cell lines were transiently
transfected with a luciferase reporter plasmid driven by the JSRV LTR (denoted pJS21 -luc),
and its activity was determined relative to appropriate controls (Palmarini et al., 2000a). The
experiment showed preferential activity o f the JSRV LTR in murine type II pneumocyte
(MLE-15) and Clara cell (mtCCl-2) lines. In addition, two putative enhancer binding motifs
for Hepatocyte Nuclear Factor (HNF)-3B were identified within the U3 region, and the
addition o f HNF-3 was capable of enhancing pJS21-luc in some cell lines (McGee-Estrada et
al., 2002; Palmarini et al., 2000a). HNF-3B is a lung and liver specific transcription factor
42
(McGee-Estrada and Fan, 2007). Further binding sites for the more ubiquitous transcription 
factors NF-kB and C/EBP alpha were demonstrated in the mid and proximal promoter 
enhancer regions (McGee-Estrada and Fan, 2006). These were also shown to be important for 
LTR activity. In another experiment, the U3 regions o f three closely related betaretroviruses 
(JSRV, ENTV and enJSRV) with different cell tropisms in vivo were aligned and compared. 
The differences that were identified by this experiment, supported the vital role that LTR 
enhancer elements play in tissue specific expression o f betaretro viruses (McGee-Estrada and 
Fan, 2006). The cellular specificity o f the LTR in vivo was studied by generating transgenic 
mice to carry a bacterial B-galactosidase gene under the control o f JSRV LTR (Dakessian and 
Fan, 2008). The authors anticipated that this would identify the target cells for infection in 
mice, but excessive transgene silencing in several generations made it difficult to interpret the 
results meaningfully. From these experiments we can conclude that cell tropism is determined 
by the presence o f specific transcription factors, both in vitro and in vivo. However, only three 
binding motifs have so far been identified, and it is likely that transcriptional control relies on 
additional factors that have yet to be found.
1.3.4.2 Restriction factors
During evolution, retroviral infections have led to the development of protective mechanisms 
in the host to control virus spread and cross species transmission. An example o f these are 
restriction factors (Goff, 2004). They are proteins produced by the cell, some o f which derive 
from inherited endogenous retroviruses (Mura et al., 2004). As they are constitutively 
expressed, they are regarded by some as a form o f intrinsic immunity (Bieniasz, 2003). 
Expression of restriction factors may also be triggered by interferon alpha following viral 
infection. They are therefore considered to be part o f the innate response of the host (Sauter et 
al., 2010).
Work on a number o f retroviruses has discovered a variety of restriction factors including 
APOBEC 3 (A3), TRIM5a (T5), and tetherin. A3 proteins are incorporated into newly 
assembled viral particles, and inhibit infection o f subsequent target cells by a number of 
mechanisms including cytidine deamination o f single stranded DNA. This results in 
hypermutation and instability o f the viral genome (Bieniasz, 2003). T5 blocks infection by
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targeting the incoming capsid for degradation by proteasome, and tetherin blocks the release 
o f newly formed virions. To date, nothing has been published on T5 or A3 and JSRV, but 
ovine tetherin is able to block JSRV release in vitro (Amaud et al 2010). In addition in 
pregnant sheep, tetherin expression is upregulated specifically within the endometrial stromal 
cells by the pregnancy hormone tau interferon, and is capable o f blocking the release of viral 
particles produced by intact enJSRV and exJSRVs (Amaud et al., 2010). In vitro work has 
shown that endogenous JSRV proteins are also capable o f viral interference to protect the host 
from exogenous retrovirus infection (Mura et al., 2004).
1.3.5 Endogenous retroviruses in sheep
Endogenous retroviruses (ERVs) have evolved due to the ability o f retroviruses to integrate 
into the host cell DNA during replication (Amaud et al., 2007a). They result from chance 
infections o f sperm or egg cells with exogenous retroviruses, which stably integrate into 
genomic DNA and are inherited in a Mendelian fashion. ERVs have accumulated over 
millions o f years and now all vertebrate genomes are heavily colonized. In humans they 
account for up to 8% of the genome (Griffiths, 2001) and this degree o f evolutionary success 
was demonstrated in recent experiments where the necessity for ERV expression to allow 
trophoblast cell fusion and placental development in humans, mice and rabbits was recognized 
(Dupressoir et al., 2009; Heidmann et al., 2009; Vargas et al., 2009). Unfortunately, 
occasional negative impacts have also been reported. High levels o f HERV-W Env and 
HERV-H Env expression were detected on the surface o f B cells from patients with active 
multiple sclerosis, suggesting an involvement in disease pathogenesis (Brudek et al., 2009). 
They have also been implicated in some autoimmune diseases, but these are mostly in 
experimental models where specific phenotypes have already been selected for (Varela et al., 
2009).
The ovine genome contains several families o f ERVs related to gamma and betaretro viruses 
(Klymiuk et al., 2003). One o f these is closely related to JSRV and is denoted enJSRV. There 
are at least 27 enJSRV pro viruses, all o f which have been sequenced (Amaud et al., 2007a). A 
majority o f them are unable to express infectious vims or proteins, but a few contain intact 
open reading frames for one or more of gag, pro, pol and env (Palmarini et al., 2004). They
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have a high degree o f similarity with their exogenous counterparts displaying an 85-89% 
identity at the nucleotide level (Varela et al., 2009). Differences are predominantly found in 
the U3 region o f the LTR, and variable regions (VR) 1-2-3 in gag and env (Palmarini et al., 
2000b). Distinguishing between these highly related ex JSRV and enJSRV is an ongoing 
challenge for scientists when developing molecular techniques for genome analysis (Cousens 
et al., 2004). In contrast, the similarities provide an effective assay for gene function analysis 
when different properties of these viruses are compared (McGee-Estrada and Fan, 2006).
Similar to other mammals, enJSRV play a vital role during placental morphogenesis and 
mammalian reproduction in the sheep. Expression is confined to the genital tract during 
oestrus and early pregnancy and transcription appears to be regulated by progesterone levels 
(Palmarini et al., 2001a). enJSRV env mRNA levels are highest in the endometrial luminal 
epithelium, glandular epithelium and trophoblast giant binucleate cells. Peak expression 
coincides with a type I interferon release which is the pregnancy recognition signal released 
from the developing fetus (Amaud et al., 2010; Dunlap et al., 2005). During embryogenesis, it 
is thought that enJSRV binds to Hyal-2 so mediating cell fusion events and the formation of 
trinucleate cells and placental multinucleate syncytial plaques (Dunlap et al., 2006). 
Consequently, experiments which inhibit enJSRV transcription with antisense techniques 
result in compromised trophectoderm growth and fetal death (Dunlap et al., 2006).
Interestingly, proteins encoded by enJSRV have been found to interfere with replication of 
exogenous JSRV in in vitro transfection studies (Amaud et al., 2007b; Murcia et al., 2007; 
Spencer et al., 2003). enJSRV blocks JSRV entry, presumably by binding Hyal-2 and thereby 
reducing receptor availability on the cell surface. This phenomenon is termed receptor 
interference, and has been described for other retroviruses (Coffin et al., 1997). The Gag 
protein o f at least one enJSRV pro vims is able to block JSRV assembly and release. It has 
been proposed that the ability o f enJSRV to block JSRV replication may have been 
responsible for a switch in tissue tropism of ex JSRV from the reproductive tract to the lung 
during evolution o f the vims (Amaud et al., 2010; Palmarini et al., 2004).
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1.3.6 The immune response
While restriction factors are relevant for replication at the cellular level, innate and acquired 
immune responses act to provide protection at the level of the host. The innate response is 
immediate and has no immunological memory. It is triggered by the recognition o f pathogen- 
associated molecular pattern (PAMP) molecules present in a large number o f microorganisms, 
by genetically determined Pattern Recognition Receptors (PRRs). A well studied class of 
PRRs are the Toll like receptors, and these are expressed by innate immune cells including 
macrophages, dendritic cells, neutrophils and lung epithelial cells (Mayer et al., 2008). 
Following infection recognition, these cells release cytokines which further activate 
phagocytes of the innate immune cell population including antigen presenting cells (APC) like 
dendritic cells or local macrophages (Akira et al., 2006).
APCs migrate through afferent lymphatics to the draining lymph nodes to present antigen to 
CD 8+ cytotoxic T cells with MHC class I molecules and CD 4+ T helper cells with MHC II 
molecules (Larruskain et al., 2010). Once activated, the CD4+ helper cells interact with naive 
B lymphocytes or CD 8+ lymphocytes to induce clonal proliferation o f antigen specific 
lymphocytes and production o f antibody (Delves and Roitt, 2000a, b). These CD4 + helper 
cells can be divided into T helper 1 (TH1) and T helper 2 (TH2) cells. TH1 secrete IFN 
gamma IL-2 and GMCSF to drive the clonal expansion o f CD 8 + cells, and TH2 cells secrete 
large amounts o f IL-4, IL-5, IL-6 to drive clonal expansion o f B cells.
The immunological memory o f the acquired response ensures an improved reaction of the host 
to the specific virus on each exposure. The innate and adaptive immune response act together 
to rid the host of infection as quickly as possible, and to prevent reinfection (Kawai and Akira, 
2006). The specific cytokine responses associated with various arms o f the immune response 
can be useful indicators when evaluating immune reactions during disease pathogenesis.
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1.3.6.1 Immunity in the lung
Although this basic process o f immune activation is identical in all areas o f the body, cellular 
responses and their activation thresholds are modified to suit the local environment o f each 
tissue (Raz, 2007). In the lung, the default immune response is non-inflammatory (Holt et al., 
2008). As the microarchitecture is such that the respiratory airways are continually exposed to 
a myriad o f antigens, maintenance o f immunological homeostasis and a sterile environment 
suitable for efficient gas exchange is a priority. This requires a sensitive surveillance system to 
discriminate between the inhaled non-pathogenic and pathogenic particles, and 
immunomodulatory mechanisms to dampen down excessive reactions which might interfere 
with respiratory function. Respiratory epithelial cells are key players in this balancing act. 
They provide a physical barrier to deter incoming pathogens, and secrete an array o f 
regulatory and effector molecules including surfactant proteins, antimicrobial peptides, 
cytokines and chemokines. These act to limit innate inflammation and raise the threshold for 
macrophage activation (Hussell and Goulding, 2010). This immunoregulatory environment is 
overcome by the loss o f epithelial integrity and subsequent release o f inflammatory mediators. 
Local immune cells including lymphocytes and dendritic cells in the bronchial epithelium and 
dendritic cells and macrophages residing in alveoli, are then activated (Guth et al., 2009).
1.3.6.2 Immune response to neoplasia
Similar to a viral infection, the presence o f a tumour activates the host innate and adaptive
immune response (de Visser and Coussens, 2005). Tumour growth is accompanied by release
of a complex cytokine and chemokine network which manipulates the host to recruit
endothelial cells, fibroblasts and inflammatory cells. In order to isolate these different cell
types and understand whether they are pro tumour or host survival, sequential stages o f
carcinogenesis in mouse models have been examined. These experiments show pre-malignant
lesions to be associated with a chronic infiltration of innate immune cells, inhibition o f which
(in knock-out mice) results in reduced tumour growth. Similarly, mice with reduced
macrophage recruitment capabilities developed less malignant tumours with a lower metastatic
potential. In these examples, the innate immune cells appear to promote cancer development.
In contrast, some cancers with high numbers o f infiltrating lymphocytes have a more
favourable prognosis for the host. This was recently highlighted in a study looking at
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colorectal tumours, where they found that the collection o f immunological data ie. number, 
type, location of infiltrating immune cells to be a better predictor o f patient survival rates than 
the standard malignancy criteria (Galon et al., 2006). Collectively, these studies demonstrate 
that tumour growth and metastasis are greatly influenced by the balance between the tumour 
microenvironment and the host immune response. These characteristics will vary between 
different hosts and individual tumour types (Whiteside, 2006).
Again similar to viruses, tumours have developed means o f evading the host immune response 
(Whiteside, 2006). This is achieved either by ‘hiding’ from immune cells or disabling them. 
For example downregulation o f cell surface molecules like tumour associated antigens or 
alterations in antigen processing machinery can prevent recognition by tumour specific T- 
cells. Suppressor cell populations such as regulatory T cells (T reg) also inhibit the reaction of 
T cells specific for autoantigens, and prevent the generation o f immunity to tumour antigens. 
In addition the release of cytokines (TGF beta, IL-10, GMCSF) small molecules (PGE2, 
INOS) or enzymes (IDO) from cells in the tumour microenvironment all act to modulate the 
systemic immune response in some way. Immunosuppressive effects o f tumours are generally 
best seen at the tumour site, and an understanding o f their intricacies will help aid therapeutic 
strategies aimed at combating cancer.
1.3.6.3 Immune response to JSRV
In contrast to infection with many other respiratory viruses, the detection o f an immune 
response following infection with JSRV has proved somewhat elusive. Most experiments have 
failed to identify any JSRV-specific T cell or antibody responses in blood samples from 
experimental or naturally infected animals (Ortin et al., 1998; Summers et al., 2002). Anti- 
betaretroviral Gag antibodies detected by immunoblotting in some studies (Kwang et al.,
1995) are now thought to be due to antibodies to the glutathione-S-transferase fusion partner 
o f the recombinant Gag antigen used in the assays (Ortin et al., 1998). The most popular 
explanation for the lack o f immune response is a mechanism of central tolerance due to 
expression of closely related enJSRV proteins which are expressed in the thymus at the time 
of T lymphocyte development during fetal growth (Palmarini et al., 2004; Spencer et al.,
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2003). This results in any JSRV-reactive T cells being recognised as anti-self and 
subsequently removed (Garcia-Goti et al., 2000; Summers et al., 2005).
However, vaccination studies for JSRV which use recombinant proteins and adjuvants, have 
generated humoral and cellular immune responses to JSRV antigens (Summers et al., 2006). 
Evidence o f an adaptive response was also indicated when increased expression levels o f 
interferon gamma and MHC II upregulation were detected using IHC in experimentally 
induced OPA (Summers et al., 2005). However, this was not accompanied by an increase in 
dendritic cells, B cells or y5 T cells and a minimal CD4 and CD8 T cell infiltrate. This lack of 
expected immune response which commonly follows MHC II upregulation was attributed to 
peripheral tolerance due to local immunosuppressive properties o f surfactant proteins 
(Summers et al., 2005). A more recent study found low levels of anti-JSRV Env antibody in a 
few experimentally infected animals, although they were concurrently infected with M W  
(Hudachek et al., 2010). This suggests that JSRV can actually be recognised by the ovine 
immune system, and questions the central tolerance theory. In support o f this, a role for a T 
cell -mediated immune response against JSRV was suggested following evidence of a marked 
CD3+T cell infiltration in animals with partial tumour regression (Hudachek et al., 2010). 
However, whether this cellular infiltrate was directed against viral expression (JSRV or M W ) 
or tumour growth is still uncertain.
In OPA, as the tumour grows macrophage like cells are the predominant infiltrate (Demartini 
et al., 1988; Dungal et al., 1938; Payne and Verwoerd, 1984; Platt et al., 2002) The precise 
function of these macrophages is unclear but some suggest they are phagocytosing excess 
surfactant produced by the tumour cells (Payne and Verwoerd, 1984). Other experiments have 
noted the presence o f lymphocytes and plasma cells infiltrating mature tumours (Garcia-Goti 
et al., 2000).
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1.3.7 Retroviral oncogenesis
Traditionally, oncogenic retroviruses were divided into two groups according to their 
mechanism o f tumour induction (Maeda et al., 2008). Acute-transforming retroviruses induce 
rapid neoplastic transformation o f host cells in vivo forming tumours o f polyclonal origin. 
Their genome contains an oncogene which is a captured form of a normal gene from the host 
(Coffin et al., 1997; Liu and Miller, 2006) In general, these are replication defective viruses 
because the incorporation of the oncogene sequence almost always results in deletion or 
disruption of viral genes which are essential for replication (Rous Sarcoma virus being one 
exception) (Coffin et al., 1997).
A second group o f oncogenic retroviruses are designated insertional/ cis-transforming 
retroviruses. These integrate close to existing host proto - oncogenes and induce clonal 
tumours as the LTR drives unregulated expression o f the proto-oncogene (Maeda et al., 2008). 
The slow nature o f tumour induction can be explained by the number o f rounds o f infection it 
takes for the provirus to insert in an appropriate location for proto-oncogene activation. The 
importance o f research in this area is reinforced by the fact that several human cancers share 
similar oncogenes and signal transduction pathways (Yeatman, 2004). More recently, a third 
mechanism by which retroviruses induce tumours using expression of the structural Env 
protein was discovered. We now know that Avian Hemangioma virus (AHV), Mouse 
Mammary Tumour virus (MMTV), Enzootic nasal tumour virus (ENTV) and JSRV are all 
members of this group (Maeda et al., 2008). Some rely solely on Env for transformation 
(JSRV, ENTV) while others have additional oncogenic mechanisms (MMTV).
1.3.7.1 JSRV oncogenesis
During JSRV replication, the env gene is expressed as a polyprotein that is glycosylated and
transported through the endoplasmic reticulum (ER) to the cell surface. It is cleaved into SU
and TM, which are connected by disulfide bonds. SU is anchored to the virus by binding to
TM which spans the lipid bilayer o f the plasma membrane into the cell cytoplasm. For JSRV,
proof that the envelope gene had transforming potential was demonstrated using plasmids
expressing JSRV Env where the gag, pol and orf-x coding sequences were deleted.
Transfection into rodent fibroblast cell lines resulted in the formation o f transformed foci
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(Maeda et al., 2001; Rai et al., 2001). Further experiments identified that mutations in the 
cytoplasmic tail o f TM could abolish transformation in rat fibroblasts (Palmarini et al., 2001b). 
The specific region concerned (YXXM motif) was known to be recognised by 
phophotidylinositol 3-kinase (PI-3K) which phosphorylates Akt, and activation o f this 
pathway was proposed as a route o f transformation. However, another study showed PI-3K 
independent transformation o f mouse fibroblasts, and phosphorylation o f Akt following the 
binding of a different protein to the TM tail (Maeda et al., 2003). Interestingly, elimination of 
this binding site in an avian fibroblast line failed to prevent Env-induced transformation (Allen 
et al., 2002), which was also shown to be Akt independent in this cell line (Zavala et al.,
2003).
SU has also been shown to have a role in transformation of cells in vitro, the means of which 
is highly dependent on cell line and available surface receptors (Danilkovitch-Miagkova et al., 
2003; Hofacre and Fan, 2004). In a human bronchial epithelial cell line, binding o f SU to the 
cell surface receptor Hyal-2 was shown to activate RON receptor tyrosine kinase and mediate 
transformation via the Akt and mitogen-activated protein kinase (MAPK) pathways 
(Danilkovitch-Miagkova et al., 2003). However, infection of other epithelial cell lines eg. 
Madin-Darby Canine Kidney epithelial cells and IEC-18 shows similar findings to the rat 
fibroblast cell lines, with receptor independent signalling and activation o f PI-3K/Akt pathway 
(Liu and Miller, 2005; Varela et al., 2006). Recent work using tissue from naturally and 
experimentally infected sheep has identified activated proteins o f the MAPK Erk 1/2 pathway 
using IHC of fixed tissue (De Las Heras et al., 2006).
Whichever pathway is activated, tumourigenesis is a multistep process and mechanisms in 
addition to the initial expression o f JSRV Env are likely to be involved (Hanahan and 
Weinberg, 2000). For example, HTLV-1 has a unique regulatory protein, Tax, which also 
functions as a viral oncogene. While Tax has been shown to be a primary determinant of 
tumourigenesis, further protein interactions are required for late stage and tumour cell 
maintenance (Maeda et al., 2008). With JSRV, the role o f insertional mutagenesis was 
proposed following an analysis o f 70 JSRV integration sites from natural cases o f OPA 
(Cousens et al., 2004). Most were found to have multiple integration sites with a random 
distribution. However, two integrations sites from independent tumours were found on
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chromosome 16, less than 200 kb from the gene MAPK31, activation o f which has since been 
implicated in OPA tumour cells using IHC (De Las Heras et al., 2006). These were not clonal 
suggesting that they may not be involved in tumourigenesis, or that multiple tumours arise 
independently but contain integration sites in a preferred area, (Cousens et al., 2004; Philbey 
et al., 2006). Other mechanisms involving the inactivation of cellular senescence by increased 
telomerase activity have been suggested to maintain tumour growth in OPA (Suau et al.,
2006).
In vivo experiments have successfully used Env, expressed from a replication incompetent 
vector, to induce rapid tumour formation in the lungs o f immunocompromised mice and 
normal lambs within four months o f inoculation (Caporale et al., 2006; Wootton et al., 2005). 
FI progeny o f mice containing the SPA-Env-HA, a transgene of JSRV driven by the SP-A 
promoter, have been reported to develop subdermal lipomas expressing transgene (Dakessian 
et al., 2007). Interestingly the closely related Env protein from Enzootic Nasal Tumour Virus - 
1 (ENTV-1) is also capable o f inducing lung tumours in sheep (Wootton et al., 2006a), even 
though this causes a nasal tumour in natural infection (De las Heras et al., 2003). This suggests 
that the oncogenic mechanisms of Env-mediated transformation are not cell type specific, and 
that Env is not directly involved in tissue specificity o f the tumour.
These experiments have given us crucial information about the behaviour o f JSRV in vitro, 
and provide useful infection assays for future work. While some o f the findings will reflect the 
situation in vivo, the way in which results vary according to the infected cell lines or species is 
confusing. In order to understand the true pathogenesis o f disease there is no substitute for 
looking at disease progression in the natural host itself.
1.3.7.2 OPA as a model for human lung adenocarcinoma
The study o f retroviruses has provided additional tools to use in other experimental areas. For 
example, the ability of retroviruses to stably integrate into the nuclear DNA of target cells has 
been exploited to create retroviral vectors for use in vitro and in vivo, and the reverse 
transcriptase enzyme is widely used in cloning and RNA quantification methods. The 
molecular dissection o f retroviral oncogenesis has also transformed our understanding o f the
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pathogenesis o f non-viral cancer. Through the unravelling of cancer pathways numerous 
proto-oncogenes and potential therapeutic targets have been identified.
Lung cancer has the highest mortality rate o f all cancers worldwide. It has an extremely poor 
therapeutic response with an overall five year survival rate o f less than 15% (Eramo et al., 
2008). Unfortunately, by the time patients show clinical signs and the disease is diagnosed, the 
tumour is already well established and refractory to treatment. If earlier diagnostic tests and 
treatment for lung cancer are to be developed, then the initial pathogenesis o f tumour growth 
must be established.
Cancers are classified by their cell o f origin, and in the lung they are either small cell lung 
cancers (originating from neuroendocrine cells) or non small cell lung cancers (NSCLC). The 
NSCLC are further categorised into squamous cell carcinoma, adenocarcinoma and large cell 
carcinoma (Snyder et al., 2009). Histological similarities between OPA and human lung 
adenocarcinoma were recognised early in disease discovery (Bonne, 1939; Watson and Smith, 
1951 ),and this led to the suggestion of using OPA as an animal model for human disease 
(Momex, 2003; Momex et al., 2003; Palmarini and Fan, 2001; Perk and Hod, 1982). Several 
studies have investigated the involvement o f JSRV in human lung tumours. One study found 
30% of human lung adenocarcinomas to label positively with antisera raised against JSRV CA 
using IHC (De las Heras et al., 2000; De Las Heras et al., 2007). Others looked for JSRV 
related sequences using PCR but the results were inconclusive (Hiatt and Highsmith, 2002; 
Morozov et al., 2004; Yousem et al., 2001). Most recently, a study has confirmed the 
expression of a JSRV Gag-related protein in some human lung tumours using IHC, but was 
unable to provide additional evidence of betaretro viral infection with RTPCR, immunoblotting 
and DNA library screening techniques (Hopwood et al., 2010). The conclusion was that if  a 
retrovirus was involved in disease pathogenesis then it is unrelated to known betaretroviruses. 
Recent experiments have used the OPA model to investigate the effects of Hsp90 inhibitors in 
lung adenocarcinoma (Varela et al., 2008). A summary of comparisons between the two 
diseases are shown in Table 1.7.
Although the mature tumours have several shared characteristics, the difference in precursor 
morphology is interesting to note in the context o f disease pathogenesis. According to the
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WHO, atypical adenomatous hyperplasia (AAH) is a putative precursor o f bronchioloalveolar 
carcinoma (BAC) in humans. It is described as being a ‘ discrete parenchymal lesion arising 
often in the centriacinar region close to respiratory bronchioles. The alveoli are lined by 
rounded, cuboidal low columnar or ‘p e g ’ cells which have round or oval nuclei’ (Travis,
2004). Analysis of mature human adenocarcinomas often finds more than one pattern of 
tumour present, typically more malignant cells in the centre with BAC or AAH towards the 
periphery (Raz et al., 2006). This and recent studies using a mouse model o f disease suggests 
that AAH and BAC may act as precursors to the development o f invasive adenocarcinomas 
(Jackson et al 2001). There is little evidence o f a similar progression in OPA, with epithelial 
hyperplasia being the only precursor lesion noted so far.
In humans, the current WHO lung cancer classification has been deemed inadequate (Chilosi 
and Murer, 2010). There is a move to incorporate immunophenotypic and molecular features 
o f neoplastic cells with classic morphology and relevant stem cell biology information to 
improve the recognition of specific tumour profiles for adenocarcinomas. For example, 
microarrays have been used to further classify tumour subgroups, and additional markers o f 
malignancy/ cellular origin have been identified (Bhattachaijee et al., 2001). Proteomic 
profiling is also being used to identify potential serological antigens which might indicate 
early tumourigenesis (Madoz-Gurpide et al., 2007). Applying these techniques to OPA would 
improve its value as a model for human BAC.
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Table 1.7 General comparison of hum an and ovine lung tum ours. OPA-N natural field cases, OPA-E 
experimental tumours (Bertolini e t al., 2009; Beytut et al.; 2008; Demartini e t al., 1988; Eramo et al., 2008; 
Hudachek et al., 2010; Platt et al., 2002; Travis e t al., 2004b; Verwoerd et al., 1983).
Param eter Human Adenocarcinoma OPA-N OPA-E
Aetiology Multiple factors Viral
Localisation Peripheral, central, diffuse, 
pleural, post fibrosis
Peripheral, central
Number Single/multiple Single/multiple Multiple
Distant metastasis Haematogenous/lymphatic 
20% - brain, bone, adrenal 
gland, liver
Haematogenous/lymphatic 
Rare - liver, kidney, heart
NA
WHO classification Adenocarcinoma (MS) = 80% 
Acinar, Papillary, BAC, solid 
acinar with mucin 
production
Adenocarcinoma mixed subtype (MS)
Fibrosis Yes Yes No
Tumour precursor Atypical Adenomatous 
hyperplasia (AAH), 
Bronchoalveolar Carcinoma 
(BAC)
Not definitively identified
IHC
Capsid protein
CC-10
SP-A
SP-C
TTF
CK7 : CK20
30% 71% tumours 
17%
71%
60% 70% Unknown
60% 80% Unknown
75% in well differentiated Unknown Unknown
High:low Unknown Unknown
Genetic alterations K-ras mut 25-50%
P53 overexpression 35-53% 
Survivin < BAC cv AAH 
Laminin- 5, 38%
E cadherin/B catenin 
decrease as malignancy 
increases.
Ki67 < invasive cancer 
P27 < differentiation
No mutations in tyrosine 
kinase domain of 
epidermal growth factor 
receptor, KRAS codons 
12/13 or DNA binding 
domain of p53 in tum our 
DNA
Unknown
Expression profiles Microarray
SAGE
Proteomic profile
Unknown
Stem cells identified In human tumours only Unknown
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1.3.8 Other exogenous retroviruses in sheep
There are additional exogenous retroviruses capable of infecting sheep and causing chronic 
respiratory disease in the adult animal. These include M W  and ENTV-1, both o f which have 
genetically related forms which are pathogenic in goats (caprine arthritis-encephalitis virus 
and ENTV-2 respectively) (Phylogenetic tree Figure 1.10). M W  is a non-oncogenic 
lentivirus which targets cells o f the monocyte/macrophage and myeloid dendritic system 
(McNeilly et al., 2008). Pathology in the lung is characterised by lymphoid hyperplasia and an 
interstitial infiltration o f mononuclear cells. ENTV-1 is an oncogenic beta retrovirus which 
targets respiratory and olfactory epithelial cells to cause a low grade adenocarcinoma in the 
upper airways (Cousens et al., 1999; De las Heras et al., 2003; Ortin et al., 2003). Genome 
sequence analysis has shown significant genomic stability between isolates and a 75% 
sequence similarity to JSRV (Ortin et al., 2003; Walsh et al., 2010). The cytoplasmic tail o f 
the transmembrane subunit is an area of difference between JSRV and ENTV-1, and it 
influences the low pH requirements for fusion and entry into the target cell when compared to 
JSRV, despite use o f the same surface receptor Hyal-2 (Cote et al., 2009; Van Hoeven and 
Miller, 2005). ENTV Env-positive cells have also been demonstrated in the lung o f some 
affected animals (Walsh et al., 2010). Concurrent infections of JSRV with M W  or ENTV-1 
have been reported and it would be of interest to determine whether coinfection affects the 
host immune response to JSRV (De las Heras et al., 2000; Hudachek et al., 2010; Ortin et al., 
2004; Rosadio et al., 1988a; Rosadio et al., 1988b).
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1.4 Thesis overview
This thesis describes an investigation o f the early interactions between the pathogen Jaagsiekte 
Sheep Retrovirus (JSRV) and its ovine host. Tissues from experimentally infected lambs are 
used to define the target cell for JSRV in the lung, and the host response to viral expression 
and tumour growth in terms of cytokine expression. It is hoped that by examination o f these 
initial stages o f infection, our understanding o f the overall pathogenesis o f OPA will be 
improved.
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CHAPTER 2 MATERIALS AND METHODS
2.1 Experimental infection with JSRV 21
2.1.1 Preparation of JSRV 21
Infectious inoculate was produced by in vitro transfection of the human 293T cell line with a 
plasmid encoding an infectious molecular clone, pCMV2JS2i (Palmarini et al 1999). The 
supernatant was collected 48 hours later and concentrated by centrifugation onto a glycerol 
cushion. Tubes o f concentrated 293T cell supernatant (SN) were made up to 37.8 ml with 
phosphate buffered saline (PBS) and divided into 3 equal aliquots. It was predicted, using 
qRTPCR, that 4 ml o f this solution would contain 1010 RNA copies of JSRV2 1 . Mock inoculate 
was collected from the supernatant of untransfected 293T cells and processed in the same way.
2.1.2 Intratracheal inoculation of lambs with JSRV21
All animal experiments were approved by the Moredun Research Institute (MRI) Ethical 
Review Committee and carried out in accordance with the Animals (Scientific Procedures)
Act 1986. Pregnant ewes were hysterectomised, and twenty six full term Scottish Blackface 
lambs were passed through a disinfectant tank while still in the uterus. Following 
resuscitation, bottle feeding was initiated and animals were separated into two equal groups. 
They were housed in different rooms under specific pathogen free (SPF) conditions. At six 
days old, the lambs were prepared for intratracheal inoculation by shaving the hair thoroughly 
from the xiphistemum to the mandible. Two people were required for adequate restraint. One 
clasped the animal almost vertically under the arm while extending the head back and 
clamping the front legs to the belly, and the second stabilised the rump of the lamb. 18 gauge 
short Intraflon intravenous (iv) cannulae were used to deliver the inoculate. The trachea was 
stabilised between the thumb and forefinger by the injector and punctured with the cannula in 
a downwards direction. The plunger of an attached empty syringe was drawn back to confirm 
correct location in the tracheal lumen by the presence of air, and then quickly replaced with 
one containing the inoculate. Air was drawn back once more before injecting the inoculum 
over a period of 5 seconds. Post injection, the mouth and nose were covered for a few seconds
58
to encourage a deep inhalation on release. In occasional animals, the cannula puncture was 
unsuccessful and a half inch 18 gauge needle was used for delivery o f the inoculum instead.
2.1.3 Post m ortem  procedure
Figure 2 .1 summarises the inoculation and post mortem examination (PME) procedure. In 
Group 1 all twelve animals received 4 ml o f JSRV2 1 . In Group 2 six animals received 4 ml of 
mock inoculate (293T SN). In Group 3 eight were left untreated. Clinical behaviour was 
monitored closely at least twice daily. Euthanasia was performed at 3 (n = 8) and 10 (n = 8) 
days post inoculation (PI), and then when clinical signs became apparent between 72-91 days 
PI (n = 8).
Born
Inoculated
6d
Clinical signs and tumours
► Age
9d 16d 72d 77d 91d
□ □ □  □ □ □ □□n □  □ □
□ □ □□ □ □
■ ■ ■ ■ □
■ m □
G r o u p  1 
J S R V 21 x  1 2
Group 2 
293T SN x 8
Group 3 
Non-inoculated x 6
Figure 2.1 Chart showing timings of lamb inoculations and PME. Each coloured  squa re  r e p r e s en t s  a lamb PME. 
Red : lambs i nocul ated with JSRV21. Blue: lambs  inocul ated  wi th 293T. Green : lambs not  i nocul ated .  Groups  2 
and  3 w e r e  negat ive control  animals .  d : l amb  age in n u m b e r  of days.
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2.1.3.1 Tissue sampling and fixation procedure
All lambs were euthanased by intravenous injection o f barbiturate. The carcass was weighed, 
bled out and the pluck (heart and lungs) removed with the mediastinal lymph nodes attached. 
A photographic record was made for each animal (Figure 2.2, A-C). The procedure for tissue 
collection followed a fixed protocol and was carried out as quickly as possible to minimise 
post mortem artefact. Initially the lung was prepared using a sharp blade to section all lobes 
into thin segments about the horizontal axis (Figure 2.2 D). Tissue was then taken from 24 
fixed sample sites (Figure 2.3). Four sequential tissue segments were taken from each of these 
locations in a cranial to caudal direction, trimmed, and placed in pre-labelled cassettes. These 
were immersed in formal saline (FS), zinc salts (ZS), paraformaldehyde (PF) and liquid 
nitrogen in that order. Additional samples from the mediastinal lymph node, mesenteric lymph 
node, liver (right lobe), spleen and kidney (right) were fixed in the same fashion. Fixation 
times and conditions were strictly adhered to and are shown in Table 2.1.
Table 2.1 Fixation procedure for all lung samples.
Fixative Preparation Procedure
4% buffered formalin (FS) Prepared within last month 7 days fixation
4% paraformaldehyde (PF) Prepared within last 12 hours and 
kept within 4°C
6 hours in fix, then re-trim and 
place in fresh solution for a total of 
48 hours
Frozen (FZN) Liquid nitrogen Stored indefinitely in the -80°C 
freezer
2.1.3.2 Source of adult sheep with and without OPA
Adult animals showing clinical signs o f OPA were collected from local farms. Twenty four 
such animals were examined and tissue was chosen from those with minimal secondary 
bacterial infection on gross inspection. Adult negative control animals were taken from MRI 
stock animals in which no case of OPA has been diagnosed in the previous 5 years.
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Figure 2.2 Photographic record of lungs from SPF lambs. (A) 2841E, g roup 1 infected lamb,  3 days  PI. (B) 2853E 
g roup  2 mock infected lamb,  10 days PI. (C) 2842E g roup  3 control  lamb,  72 days PI. (D) 2865E g roup  1 JSRV2i 
inocul ated  lamb,  90 days PI.
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I S
tar
Date
Cont/lnfect
Eartag
CaseMe no
Samples by
TISSUE Number FS ZS PF FZN
Left Apical 1A
IB
Left Middle 2A
2B
Left Diaphragmatic 3A
3B
4A
4 8
5A
5B
Mediastinal LN
Ileal LN
Liver
Kidney R
Spleen
Tonsil
W eight o f left lung
TISSUE Number FS ZS PF FZN
Right Apical BA
6B
7A
7 8
Right Cardiac 8A
8B
Right Mediastinal 9A
A ccesso ry  lobe 9B
Right diaphragmatic 1QA
10B
11A
118
12A
128
W eight o f lamb
Weight o f right lung
Post mortem comments:
Figure 2.3 PME template for lung sampling. The red dotted lines represent orientation of tissue slices for 
fixation from each of the 24 sites.
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2.2 Slide staining protocols
2.2.1 Histochemical techniques
2.2.1.1 Haematoxylin and eosin
Rehydrated sections were stained with Haematoxylin (H) stain (CellPath) for five minutes, 
washed well in running tap water and differentiated in 1 % acid/alcohol for two seconds. Then 
they were washed in tap water and stained in 1% Eosin (E) stain (CellPath) for two minutes 
before washing in running tap water for two minutes, dehydrating and mounting. An 
automated staining machine, Shandon Varistain 24.4 (Thermo Scientific) was used for all 
sections stained with H and E.
2.2.1.2 Periodic acid Schiff technique
Rehydrated sections were incubated with periodic acid solution (BDH Chemicals) for five 
minutes then rinsed well in distilled water. They were then treated with Schiffs reagent (BDH 
Chemicals) for 30 minutes and washed in running tap water for 5-10 minutes. Nuclei were 
stained with Harris’s haematoxylin solution for two minutes, rinsed with water, then immersed 
in Scott’s Tap Water for one minute before washing in water again, dehydrating and 
mounting.
2.2.1.3 Luxol fast blue
Rehydrated sections were incubated at 71°C in Luxol fast blue (LFB) solution (BDH 
Chemicals) overnight. Slides were then rinsed in distilled water, differentiated in lithium 
carbonate (0.05%) (Hopkin and Williams) for 40 seconds and washed again in water. They 
were counterstained with 1% aqueous neutral red (BDH Chemicals) for five minutes, which 
was differentiated by pouring 80% ethanol over the slides, and finally washed in water before 
dehydration and mounting.
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2.2.1.4 Grimelius silver method for argyrophil cells
Rehydrated sections were incubated in silver solution at 60 °C for three hours. The silver 
solution was drained from the slides before placing them in freshly prepared reducing solution 
at 45 °C for one minute. Sections were then rinsed in distilled water and examined under the 
microscope for the presence o f black deposits. If these were not visible, the process was 
repeated by adding the slides to the silver solution for 5-10 minutes and then reducing them 
until the sections were well labelled. A green counterstain was used before washing the slides 
in tap water, dehydrating and mounting.
2.2.1.5 Mallory’s phosphotungstic acid-haematoxylin (PTAH)
Rehydrated sections were treated with 0.25% aqueous potassium permanganate solution for 
five minutes before washing with water and bleaching with 5% aqueous oxalic acid solution. 
Then they were washed well in tap water, stained with PTAH (Cell Path Ltd.) solution for 12 
hours at room temperature and washed in distilled water, before dehydrating and mounting in 
a DPX-type mountant.
2.2.2 Immunohistochemical techniques
2.2.2.1 Basic immunohistochemical protocol
Tissue sections were cut at 5 pm and placed on Superfrost Plus slides (Thermo Fisher 
Scientific). All sections were dewaxed in xylene and rehydrated through 100%, 75% and 50% 
ethanol to water. Antigen retrieval (AR) was performed at this point if  necessary. Slides were 
then submerged in 3% (v/v) H202/methanol mix to block endogenous peroxidase activity for 
20 minutes, and rinsed in running tap water for five minutes. Each slide was then taken 
individually, dried carefully with a paper tissue, and a Pap wax pen (ImmEdge Pen, Vector) 
was used to draw a continuous ring round the tissue sample. This area was then covered with 
150 pi of 25% normal goat serum (NGS) (Vector) diluted with phosphate buffered 
saline/0.05% Tween 20 (PBST). Slides were incubated horizontally in a moisturising chamber 
for an hour at room temperature. The 25% NGS/PBST was replaced with primary antibody 
(diluted in 25% NGS/PBST) and incubated overnight at 4°C. Following this, individual slides
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were rinsed with PBST three times, dried with paper tissue and incubated with the appropriate 
secondary antibody (goat anti-mouse/rabbit) for half an hour at room temperature. Sections 
were rinsed three times in PBST as before, and incubated with an appropriate antigen 
visualisation system.
2.2.2.2 Optimisation of primary antibodies
As few antibodies are specifically manufactured for use with sheep tissue, methods of 
validation and optimisation were necessary for each antigen labelled in each species. A 
summary o f all conditions and dilutions trialled for each antibody is given in Table 2.3.
2.2.2.3 Positive and negative control tissue
Sections from known positive and negative tissue samples were required to validate the 
specificity o f each antibody, and the non-specificity o f the immune-labelling technique. 
Positive control tissues expressing the antigen under investigation proved the method and 
reagents were working. Sheep tissues were used when possible, but in some cases rabbit or 
mouse tissues were required. Negative controls included samples that were incubated with 
pre-immune/isotype matched/normal serum from the same species in which the primary 
antibody was raised. This allowed assessment o f any non-specific binding or possible cross­
reactivity between the tissue being examined and serum from the species which raised the 
primary antibody. In addition, the primary antibody was omitted to check for non-specific 
staining o f the secondary antibody or the visualisation system. For multiple labelling 
techniques, primary antibodies were omitted from successive layers and substituted with 25% 
NGS/PBST or non-immune serum. The order o f antigen detection was also reversed to ensure 
that antibodies were not masking each other.
2.2.2.4 Antigen retrieval
Tissue fixation processes often result in cross linking between antigens. AR techniques were 
required to break these down and improve antigen access for primary antibodies. Several 
methods were employed to ensure the best possible optimisation o f antibodies in all 
experiments (Table 2.2). For heat induced epitope retrieval, rehydrated slides were placed in a
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metal rack, fully immersed in one litre o f sodium citrate / Tris Ethylenediaminetetraacetic 
Acid (EDTA) buffer, autoclaved at 121 °C for 10 minutes and then left to cool to 50°C before 
blocking endogenous peroxidases. The pH of the buffer was varied from pH3-pH9. For 
enzyme induced epitope retrieval, 2 x 200 ml o f distilled water was warmed in an incubator to 
37°C and the slides were placed in one to warm up. 20 ml of frozen stock solutions o f calcium 
chloride (1%) and trypsin (0.5%) were thawed, diluted in 160 ml o f warmed water and 
adjusted to pH 7.8 with NaOH (1M). This solution was then reheated to 37°C in an incubator, 
and the slides were fully immersed in it for 5-20 minutes. They were then rinsed in running tap 
water before blocking endogenous peroxidases.
Table 2.2 Summary of antigen retrieval m ethods for IHC
Epitope retrieval Buffer Conditions
Heat induced Sodium Citrate buffer (pH6) Autoclave 121 degrees, 10 mins
Heat induced Tris EDTA buffer (pH 3,6,9) Autoclave 121 d eg ree , 10 mins
Enzyme induced 0.1% Calcium chloride solution (pH7.8), 
Trypsin 0.05%, chymotrypsin 0.05%, Tris HCI
Incubator 37 degrees, 5-20 mins
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2.2.3 Antigen visualisation systems
2.2.3.1 Indirect labelling techniques
Indirect labelling techniques were used to detect single antigens. Following incubation of the 
secondary antibody attached to horseradish peroxidase (HRP) enzyme with the section, 
antigens were visualized using the substrate chromogen 3,3’diaminobenzidine (DAB). In the 
presence o f HRP and H2O2 , DAB is converted to an insoluble brown precipitate at the site of 
antigen expression. The supplied secondary antibody (Envision) has a long polymer backbone 
with multiple HRP molecules attached and so for each single antigen binding site, the visible 
signal is amplified.
DAB + H20 2 + HRP DAB ppt + H20
Slides were incubated with DAB for 7 minutes, and then rinsed in water before staining with 
H and dehydrating on the automated machine.
A similar technique, the Tyramide Signal Amplification (TSA) kit (Molecular probes, Inc., 
Eugene, OR, USA) was used for single fluorescent labelling of antigen. In this case, the HRP 
enzyme activates a tyramide substrate which gives an amplified fluorescent signal. Alexa 
fluor® 488 and 568 -  tyramide were used to detect the antigen, and a 4',6-diamidino-2- 
phenylindole (DAPI) counterstain was used to highlight cellular nuclei and as an anti-fade 
mountant (Prolong®Gold antifade reagent, Invitrogen).
2.2.3.2 Direct labelling techniques
In some experiments, fluorescence labelled fragment antigen-binding (Fab) fragments were
used to detect antigen. This involved incubating the primary rabbit polyclonal antibody (anti-
CCSP antibody) with a goat anti-rabbit Fab 649 fragment (Dylight™ 649-conjugated
AffiniPure Fab Fragment, Jacksons Immunoresearch) at a 1:2 ratio for 5 minutes in the dark at
room temperature. This solution was then mixed with 10% NRS (MRI) to bind to any free
Fab, and the solution incubated in the dark for a further 10 minutes. Following this, the
mixture was centrifuged for 10 minutes at 14 000 x g and then 150 pi was pipetted onto the
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horizontal slide prior to overnight incubation at 4°C. Slides were washed three times in PBS 
before mounting and examining with the appropriate filter set.
2.2.3.3 Multiple labelling techniques
Combinations o f these techniques were employed to label multiple antigens in one section. For 
double labelling using the indirect technique antibodies raised in different animals were used, 
e.g. mouse monoclonal and rabbit polyclonal antibodies. The experiment followed the same 
procedure as detailed previously for the first primary antibody, and was then repeated on the 
same slide for the second primary antibody. Conditions were re-optimised to determine in 
which order to use the antibodies and whether their concentrations required altering. Antigen 
visualisation was achieved using a combination of the chromogens DAB and VECTOR® VIP, 
or Tyramide Alexa Fluor 488 and Tyramide Alexa Fluor 568.
Triple labelling combined both direct and indirect techniques. Initially double labelling was 
performed as detailed above. Then the section was incubated overnight with CCSP antibody 
labelled with Fab 649 before rinsing and mounting.
2.2.3.4 Image acquisition and analysis
Images for bright field microscope were examined using an Olympus BX51 microscope and 
photographs were captured with an Olympus DP70 camera with analysis software. The 
fluorescent microscope was a Zeiss Axiovert 200M. Z stacking facilities and apotomes were 
used when necessary.
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2.2.4 IHC quantification
Areas o f DAB labelling for all antibodies were quantified using the deconvolution macro in 
Image J. This is a Java-based image processing programme developed at the National Institute 
o f Health (Rasband W, 1997-2009). The colour deconvolution plug-in implements stain 
separation using the Ruifrok and Johnston method (Ruiffok and Johnston, 2001).
2.2.4.1 Beta tubulin
One sample site, 5a, was examined from each animal. From this section, the epithelium of 
four separate cross/longitudinal sections of each anatomical region (bronchus, bronchiole, 
terminal bronchiole, respiratory bronchiole) was outlined and an area measurement made. The 
percentage o f this area that labelled positively for beta tubulin antibody was then calculated 
(Figure 2.4).
2.2.4.2 Clara cell secretory protein
Two sample sites, lb  and 5a, were examined from each animal. From both o f these sections, 
the epithelium of four separate cross/longitudinal sections o f each anatomical region 
(bronchus, bronchiole, terminal bronchiole, respiratory bronchiole) were outlined and an area 
measurement made. The percentage o f this area that labelled positively for CCSP was then 
calculated.
2.2.4.3 Surfactant protein C
Type II pneumocytes were identified as cells in the alveolar region which labelled positively 
with SP-C. Images o f six fields from the alveolar region o f one section per animal were taken 
at x 400 magnification. Over 100 cells were examined per field. The number o f cells labelling 
positively for SP-C were given as a percentage o f the total number o f nuclei counted in all 
fields.
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Figure 2.4 Image J m easures area of IHC labelling. (A) Area for measur ing  is p h o to g r ap he d  with scale bar.  (B) 
The epithelial  region is isolated and  t h e  a r ea  meas u red .  (C) The image  is deconvolu t ed .  (D) The a r ea  posi t ive for 
IHC labelling only is isolated.  (E) A to t al  m e a s u r e m e n t  for ar ea  of posi t ive IHC is calcula ted by Image J. (F) The 
a rea  of posi t ive labelling is c alculated as a pe r cen t a ge  of t h e  total  epi thel ium.
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2.2.4.4 Neuroepithelial bodies
Two sections per animal (lb  and 5a) were examined for the presence of NEBs. Photographs 
were taken of the fixed tissue, and the gross area measured using Image J. The total number of 
NEBs labelling positively with synaptophysin antibody per whole section were identified 
microscopically. A final figure was given as the average number of NEB per cnT per animal.
•V •*£
Figure 2.5 NEB num ber calculation. (A) The total  sur face  a r ea  of fixed t i ssue was  me a s u r ed  using Image J. (B) 
IHC an ti -synaptophys in ant ibody,  t h e  total  n um b e r  of NEBS per  c m 2 of  t i ssue w e r e  calculated.
2.2.4.5 Ki-67, a proliferation marker
An antibody to Ki-67 was used to label the nuclei of all cells that were not in the GO resting 
phase of the cell cycle, i.e., those that were proliferating. For each section examined (2-5 
locations per animal), the lung was divided into five anatomical regions: bronchus, bronchiole, 
terminal bronchiole, respiratory bronchiole and alveolus. A total of 800 cells were counted per 
region per slide, and the percentage of these that labelled positively for Ki-67 was given as the 
proliferation index for that anatomical region (Figure 2.6).The mean per animal was 
calculated.
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Figure 2.6 Procedure for calculating proliferative index. (A), (C), (E): all nuclei w e r e  coun ted .  (B), (D), (F) all Ki
67 posi t ive nuclei w e re  cou n t e d  (brown labelling, marked  with yel low stars).  Prol iferat ive index is t h e  
pe r ce n t age  of  t he  total  n u m b e r  of nuclei coun t ed  t h a t  a r e  posi t ive for Ki 67. (A) Bronchial  epi thel ium,  total  
nuclei = 94. (B) Bronchial  epi t he l i um,  total  Ki67 +ve = 12.Prol iferat ion index = 13%. (C) Bronchiolar  epi t he l i um 
total  nuclei =100.  (D) Bronchiolar  epi t he l i um,  total  Ki 67 +ve =12.  Prol iferation index = 12% (E) Alveolar region : 
total  nuclei =163, (F) Alveolar region,  total  Ki 67+ve =19. Prol iferation = 12%.
75
2.3 Quantitative reverse transcriptase polymerase chain reaction
2.3.1 Preparation of samples for RNA extraction
2.3.1.1 Experimental samples
Samples were taken from JSRV21 infected and control animals as detailed in section 2.1 of this 
chapter. Four adult sheep with OPA and four without were also sampled in the same way. 
Tissues were placed in labelled plastic histological tissue sample cassettes, immediately 
immersed into liquid nitrogen and stored at -80 °C prior to analysis. When required, tissues 
were transported on dry ice to the cryostat machine (Thermo Scientific) and placed in the 
cutting chamber for 10 minutes for acclimatisation (chamber temperature: -22°C, specimen - 
16°C and cryobar -22°C). The machine had been thoroughly cleaned and fumigated prior to 
use and a fresh blade was used for each case. For the purposes o f this study, only tissues from 
sites la, lb, 2a, 2b and 5a in the lung and the mediastinal lymph nodes were examined. Each 
block of tissue was glued to the chuck using Optimal Cutting Temperature (OCT) compound 
(Bright Cryo-M -Bed, Embedding compound, Bright Instrument Company Ltd.) and trimmed 
until the cut surface was parallel to the blade. Between 5-10 cryostat sections of 20-40 pm 
thick slices o f tissue were collected depending on the cellular density o f the tissue.
2.3.1.2 Positive control samples
Positive controls for cytokine primer analysis were obtained from several sources. 
Concanavalin A (Con A) stimulated peripheral blood mononuclear cells (PBMCs) were a 
source o f IFN gamma, TGF beta, IL-lBeta, IL-2, IL-4, IL-10, IL-18 and MCP-1. Plasmid 
DNA constructs were available for IL-8, TGF beta and IL-6 (McNeilly et al., 2008) and 
transfected Chinese Hamster Ovary cell lines expressed ovine IL-8, ovine TNF alpha and 
ovine GM-CSF (kindly gifted by Sean Wattegedera).
PBMCs were extracted from venous blood samples collected into 10 ml heparin tubes from 
healthy sheep. Each blood sample was transferred into a 50 ml tube with equal volumes o f 
cold PBS, mixed and centrifuged at 623 x g for 20 minutes at 4°C with the brake off. The 
resultant buffy coat layer which collected on top o f the red blood cells was aspirated using a
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1 Oml pipette and transferred to a universal container with 7 ml o f wash buffer. Any clots were 
broken up by pipetting the solution against the side o f the universal. This solution was then 
layered onto 10 ml of prewarmed Lymphoprep™ (Axis-Shield) and centrifuged at 1107 x g 
for 30 minutes with the brake off. This produced an interface layer o f the mononuclear cells 
which was transferred into a tube containing 5 ml o f wash buffer. Cell clumps were disrupted, 
and wash buffer added to bring the volume up to 30 ml. This suspension was centrifuged at 
276 x g for 10 minutes with the brake off. A cell pellet was formed which was resuspended 
and washed twice with 10 ml of RPMI (Roswell Park Institute medium) 1640 and again 
centrifuged at 276 x g for 10 minutes at 4°C. The pellet was resuspended in 2 ml of RPMI 
1640, followed by a further 8 ml before introducing the suspension in to a flask. 50 pi o f Con 
A was added to half o f the samples, and then all were placed in an incubator at 37°C 
overnight. 12-15 hours later, the flasks treated with Con A were examined under the 
microscope to check for activation and PBMC by raft formation. All 10 ml o f media with cells 
was removed from each flask, placed in a universal tube and centrifuged at 376 x g for 6 
minutes. The supernatant was discarded, and the pellet resuspended in 10 ml o f RPMI and 
centrifuged as before. This process was repeated twice before resuspending the pellet in 5 ml 
o f RPMI. The concentration o f cells was estimated by adding 90 pi of trypan blue to 10 pi of 
cell suspension and transferring this to a haemocytometer for counting. The solution was 
diluted to 1 xl 07 PBMC prior to RNA extraction.
Chinese Hamster Ovary (CHO) cell lines stably expressing ovine cytokines were taken from 
liquid nitrogen and defrosted. The solution was placed in a chilled universal tube, and 9ml of 
cold culture medium slowly added. This was centrifuged at 4°C for 10 minutes at 276 x g. The 
culture medium was discarded and the cell pellet loosened by flicking the tube.
2.3.1.3 RNA extraction and purification
RNA extraction was performed on all samples using a commercially available kit (RNeasy 
mini kit, Qiagen) according to the manufacturer’s instructions. Cryostats were immediately 
placed in Ribolyser tubes (Lysing Matrix D MP Bio) containing 800 pi of Buffer RLT 
(RNeasy kit) and beta mercaptoethanol. These tubes were shaken manually to ensure all tissue 
was covered by fluid and then stored on ice (maximum 1 lA hours) until all the tissue from the
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same animal was collected. Samples were then rotated in a ribolyser for 40 seconds and placed 
in a chilled centrifuge for three minutes at 12 000 x g. The lysate was removed from the beads 
and mixed with equal volumes of 70% ethanol in a 1.5 ml tube. 700 pi of this was pipetted 
onto an RNeasy column and centrifuged for 15 seconds at 10 000 x g. The filtrate was 
discarded and the remaining amount filtered in the same way. 350 pi o f RW1 was filtered 
through the column by centrifuge (15 seconds at 10 000 x g), and then DNAse digest (RNase- 
Free DNase Set, Qiagen was pipetted onto the column and left for fifteen minutes at room 
temperature. Another wash with 350 pi of RW1 was followed by 500 pi of RPE for 15 
seconds at 10 000 x g, and then 500 pi for 2 minutes at 10 000 x g. Then the tubes were spun 
into an empty eppendorf at full speed to remove excess ethanol. Finally, 50 pi and then 30 pi 
o f RNase free water were centrifuged through the membrane in turn, and the filtrate placed on 
ice before long term storage in -80°C freezer.
Cell pellets were resuspended in 600 pi of buffer RLT and beta mercaptoethanol and 
thoroughly mixed. The solution was homogenized with a 20 gauge needle attached to a 5 ml 
syringe before adding one volume of 70% ethanol and mixing. 700 pi of this was transferred 
to an RNeasy spin column which was placed on a 2 ml collection tube and centrifuged for 15 
seconds at 9000 x g. This step was repeated with any residual sample. The remaining 
procedure is identical to that for RNA extraction from tissue detailed in the section above.
2.3.1 .4  RNA validation analysis
A small aliquot o f all samples was analysed by the Nanodrop machine. This uses the 
absorption of UV radiation at 260 nm to determine the concentration o f nucleic acid in a 
sample. The ratio o f sample absorbance at 260 and 280 indicates the purity o f RNA with a 
ratio of about 2 being accepted as pure for RNA. The Agilent 2100 bioanalyser was also used 
to obtain an RNA integrity number (RIN) for the sample. It estimates the integrity of total 
RNA samples by microcapillary electrophoretic RNA separation. This integrity is determined 
by the entire electrophoretic trace o f the RNA sample, which includes the presence or absence 
o f degradation products. Only those with a RIN above 8 were accepted. The stock RNA was 
diluted to 50 ng/pl and stored at -80°C until required.
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All these processes aimed to maximise RNA yield and purity, so eliminating unwanted 
changes in the gene expression profile. Specific steps which ensure this are summarized in 
Table 2.5.
Table 2.4 Twelve steps taken to  maximise RNA yield and purity from tissue samples
Action Effect
1 Environment preparation RNAase ZAP all surfaces and equipment
2 Tissue preparation and 
handling
Immediate freezing and never let tissue samples thaw. Handle 
with gloves or sterile forceps. Process negative control tissues 
first, then mock and finally infected ones.
3 Cryostat machine Cleaned and fumigated before use. Use a fresh blade for each 
animal.
4 Sample size Under 30mg of tissue so as not to overload RNeasy column
5 Ribolyser beads These simultaneously disrupt and homogenize tissue to 
maximise RNA release and reduce lysate homogeneity which 
increases column binding efficiency
6 Buffer RLT Contains guanidine thiocyanate which inactivates RNases
7 Beta mercaptoethanol Denature RNases
8 Ethanol Promotes selective binding of RNA to RNeasy column
9 Silica based m embrane on 
column
Removes DNA. Binds RNA over 200 nucleotides long, enriching 
mRNA quantity and eliminating shorter contaminants
10 On column DNA digestion Eliminates DNA contamination from sample
11 Nanodrop 260/280 identifies contaminants
12 Agilent RIN number indicates integrity of the  sample
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2.3.2 qRTPCR procedure
Quantification o f virus and cytokine expression was determined using qRTPCR. Primers and 
probes for reference and target genes were selected from published literature Table 2.6 
(Budhia et al., 2006; Garcia-Crespo et al., 2005; Harrington et al., 2006; Li et al., 2008; 
Palmarini et al., 1996). qRTPCR was performed using the ABI 7000 in 96 well plates 
(Applied Biosystems) with either Power SYBR® Green RNA-to CT™ 1-Step Kit (Applied 
Biosystems) or TaqMan® one step RTPCR Master mix reagents kit (Applied Biosystems). All 
samples were run in duplicate with 100 ng of RNA in a 20 pi final reaction volume. 
Amplification conditions were 30 minutes (min) at 48°C for reverse transcription, 10 min at 
95°C to activate the DNA polymerase and 40 cycles of 15 seconds (s) at 95°C (denature) and 
1 min at 60°C (anneal and extend) unless otherwise stated. All SYBR runs included a melt 
curve to confirm the specificity of the amplicons (95°C for 15 s, 60°C for 20s and 95°C for 
15s).
2.3.2.1 Primer and Taqman probe optimisation
Standard curves constructed from 10 fold serial dilutions o f positive control mRNA were used 
to determine the primer set efficiency and replicate quality (R ). In some cases, further 
optimisation was necessary as the required efficiency o f 70-110% with an R value o f 0.99 
was not achieved with the published conditions. This involved altering primer concentrations, 
reaction conditions, reagents and occasionally primer sequences. In addition, it was ensured 
that the level o f gene expression in experimental samples lay within the limits o f the standard 
curve. Some examples o f the optimisation process are given in Figure 2.7. Table 2.6 lists the 
final sequences and conditions used for each gene.
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Pipetting technique
Poor replicates ^
R squared  < 0 .9 9  Machine error
Check no bubbles in tro duced  
Check no e v a p o ra tio n  o f sam ple  
Check p ip e tte  accuracy
Clean th e  w e lls  on th e  ABI 7 0 0 0
Check flu o res c e n t bulb
M o v e  sam ples fro m  edge o f  p la te
Efficiency < 70%
Poor annealing and 
extension
Standards not 
accurate
Not enough target 
RNA in standard
M o d ify  cycle p a ram e te rs  
Change p r im e r sequences
Redo s tan dard  concen tra tions
Increase RNA co n c e n tra tio n  o f  
stan dard  sam ples
Efficiency > 100%
M ultiple m elt  
products
DNA
contamination of 
sample
Primer dimer 
formation
Poor primer 
specificity
R e-ex trac t RNA  
DNAse tre a t  sam ple
Run on gel to  see n u m b er and  
size o f  products  
Reduce p r im e r c o n cen tra tio n  
In tro d u ce  e x tra  m e ltin g  step  a t 
end o f cycle
Increase ta rg e t RNA in sam ple  
Use T aq m an  p rob e
M o d ify  cycle p a ram e te rs  
C hange p r im e r set
Figure 2.7 Methods for optimisation of primers and probes using the standard curve
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2.3 .2 .2  Selection of optimal Reference g en es
In order to obtain accurate gene expression measurements for target genes, stable reference 
genes for data normalisation were required. Primer sequences for five common reference 
genes were selected from published data (Table 2.6). Genes were chosen from different 
functional and abundance classes in order to avoid co-regulation. qRTPCR was used to obtain 
crossing threshold (Cj) values for each gene in six samples o f lung and lymph node tissue 
from normal and infected sheep .The stability in expression for each reference gene between 
normal/diseased tissue was determined using the programme geNorm. For each reference 
gene, this calculates the pairwise variation with all other reference genes as the standard 
deviation of the logarithmic transformed expression ratios. A reference gene stability value, 
the M value, can then be determined. The two reference genes with the lowest M value for 
each tissue were chosen for use in future experiments.
2.3.2 .3  qRTPCR procedure for analysis of JSRV and cytokine expression
Expression of virus and cytokines were compared between four infected, two mock infected 
and two control animals at three time points following experimental infection with JSRV 2 1 . A 
group o f eight adult animals with and without OPA were also examined. qRTPCR o f all lung 
samples for each gene o f interest at a single time point was performed in a single 96-well 
plate. These contained replicate samples o f RNA from five fixed sites in the lung per animal 
(80 wells), 10 fold serial dilutions o f positive control mRNA (12 wells) and a water negative 
control (2 wells). The reaction efficiency (E) was calculated from the slope o f the standard 
curve and incorporated into the final equation for relative quantitation o f each gene o f interest.
E = 10 ‘1/slope
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2.3 .2 .4  Relative quantification of gen e expression
The Pfaffl method was employed to quantify cytokine expression levels (Pfaffl et al 2002). 
This measures the relative change in mRNA expression levels between infected and control 
animals whilst taking into account the efficiencies o f both reference and target genes. Two 
housekeeping genes (see section 4.5.6) were used to normalize data and control for 
experimental error. The relative expression software tool REST was used to analyse the data 
using the following equation:
Ratio = (Efficiency GOI)ACT501<eo"tro,-infected) 
(Efficiency HKG)ACT HKG (controMn,ected)
The programme also provides a statistical test o f the analysed C t values using a Pair-Wise 
Fixed Reallocation Randomisation Test© (Pfaffl et al 2002). This test calculates the effect on 
expression ratio o f randomly reallocating C t values to the control or infected group. This is 
done over 2000 times, so providing a good estimate o f P value (standard error < 0.005 at 
P=0.05).
Table 2.5 Details of primers selected for reference genes for GeNorm analysis
Gene Accession numbers Primers
Amplicon 
size (bp)
Prim er 
cone n M
Reference
ACT B N M _001009784
f- CTG AGC GCA AGT ACT CCG TGT 
r -  GCA TTT GCG GTG GAC GAT
125
300
300
(Garcia-crespo et al., 2006)
SDHA
NM_AY970969  
bases 1-90 part cds
f- CAT CCA CTA CAT GAC GGA GCA 
r- ATC TTG CCA TCT TCA GTT CTG CTA
90
200
200
(Garcia-crespo et al., 2006)
YWHAZ
AY970970  
bases 1-102 part cd
f- TGT AGG AGC CCG TAG GTC ATC T 
r- TTC TCT CTG TAT TCT CG A GCC ATC T
102
100
100
(Garcia-crespo et al., 2006)
Beta 2 
MCG N M _001009284
f- AGA CAC CCG CCA GAA GAT GG 
r -  TCC CCG TTC TTC AGC AAA TC 98
900
900 (Harrington et al., 2006)
GAPDH AF 030943/A F035421
f- GCA TCG TGG AGG GAC TTA TGA 
r-GCCATCACG CCA 92
900
900 (Chris Cousens, MR!)
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Table 2.6 Primers and probes for qRTPCR analysis of candidate genes
Gene Accession numbers Primers Tm  (*C)
Amplicon
size
Reference
IFN
gamma
X 52640
f- TTC TTG AAC GGC AGC TCT GAG 
r- TGG CGA CAG GTC ATT CAT CA
59.8
57.3
127 (Budhia et al., 2006)
GM-CSF N M _0 0 1009805
f- GAT GGA TGA AAC AGT AGA AGT CG 
r- CAG CAG TCA AAG GGA ATG AT
58.9
55.3
261 (McNeilly et al., 2008)
IL-8 S74436
f- CAC TGC GAA AAT TCA G AA ATC ATT GTT A 
r- CTT CAA AAA TGC CTG CAC AAC CTT C
59.3
61.3
53
(Leutenegger et al., 
2000)
TGF-beta N M _0 0 1009400
f- GAA CTG CTG TGT TCG TCA GC 
r- GGT TGT GCT GGT TGT ACA GG
59.4
59.4
169 (McNeilly et al., 2008)
TNF
alpha
N M _001024860
f- GCC CTG GTA CGA ACC CAT CTA 
r- CGG CAG GTT GAT CTC AGC AC
61.8
61.4
82 (Lieta!., 2008)
IL-6 N M _  001009392
f- TCC AGA ACG AGT TTG AGG 
r- CAT CCG AAT AGC TCT CAG
53.7
53.7
236 (McNeilly et al., 2008)
IL-2 N M _0 0 1009806
f- TGA AAG AAG TGA AGT CAT TGC TGC 
r- GAT GTT TCA ATT CTG TAG CGT TAA CC
59.3
60.1
138 (Li et al., 2008)
IL-4 N M _  001009313
f- ACC TGT TCT GTG AAT GAA GCC AA 
r- CCC TCA TAA TAG TCT TTA GCC TTT CC
58.9
61.6
79 (LietoL, 2008)
IL-10 N M _001009327
f- AGC AAG GCG GTG GAG CAG 
r- GAT GAA GAT GTC AAA CTC ACT CAT GG
60.5
61.6
90 (Li etal., 2008)
IL-18 N M _001009263
f- ACT GTT CAG ATA ATG CAC CCC AG 
r- TTC TTA CAC TGC ACA GAG ATG GTT AC
60.6
61.6
100 (Li et al., 2008)
MCP-1
Predicted sequence in 
Dunphy
f- GCT GTG ATT TTC AAG ACC ATC CT 
r- GGC GTC CTG GAC CCA TT 
Probe AAA GAG TTT TGT GCA GAC CCC AAC C
58.9
57.6
63
-
(Dunphy et al., 2001; 
Kawashima et al., 
2006)
IFN
alpha
AY 802984
f- GCA CTG GAT CAG CAG CTC ACT G 
r- CTC AAG ACT TCT GCT CTG ACA ACC T
64
63
188 (L ietal., 2008)
IL-1 B N M _001009465
f-CCT AAC TGG TAC ATC AGC ACT TCT CA 
r- TCC ATT CTG AAG TCA GTT ATA TCC TG
63.2
60.1
95 (L ietal., 2008)
IDO N M _001141953
f- CAG AAG GCA CTG CTT GAC ATA TCT 
r- GGT TTG GGT CCA CAT ATT CAT GA
61
58.9 -
(Sean Wattegedera, 
MR!)
ACT B N M _001009784 f- CTG AGC GCA AGT ACT CCG TGT 
r -  GCA TTT GCG GTG GAC GAT
61.8
56
125
Garcia-crespo et al 
2006
SDHA
NM _AY970969  
bases 1-90 part cds
f- CAT CCA CTA CAT GAC GGA GCA 
r- ATC TTG CCA TCT TCA GTT CTG CTA
59.8
59.3
90
Garcia-crespo et al 
2006
YWHAZ
AY970970  
bases 1-102 part cd
f- TGT AGG AGC CCG TAG GTC ATC T 
r- TTC TCT CTG TAT TCT CGA GCC ATC T
62.1
61.3
102
Garcia-crespo et al 
2006
Beta 2 
MCG N M _001009284
f- AGA CAC CCG CCA GAA GAT GG 
r -  TCC CCG TTC TTC AGC AAA TC
61.4
57.3 98 Harrington et al 2006
GAPDH AF 030943/A F035421
f- GCA TCG TGG AGG GAC TTA TGA 
r- GCC ATC ACG CCA
-
92 Chris Cousens MR!
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Table 2.7 Reaction conditions for primers and probes. TCHO -  transfected Chinese hamster ovary cell lines
Gene +ve control
Prim er/
probe
concentrations
Reaction conditions
Dissociation 
m elting  
te m p  °C
R2 Efficiency
IFN gamma PBMC + Con A
f  300nM  
r3 0 0 n M
30 min 45°C, 10 min 95°C, 
(15s 95°C, 1 min 60 °C) x40
79 0.99 -3.15
GM-CSF TCHO
f 500nM  
r 500nM
30 min 45°C, 10 min 95°C,
(20s 94°C, 30s 57°C, 30s 72°C) x40
85.8 0.99 -3.4
IL-8
Plasmid DNA 
TCHO
f 500nM  
r 500nM
30 min 45°C, 10 min 95°C,
(20s 94°C, 30s 55°C, 30s 72°C) x40
76.8 /77 .3 0.99 -3.9
TGF-beta
Plasmid DNA 
PBMC + Con A
f  500nM  
r5 0 0 n M
30 min 45°C, 10 min 95°C,
(20s 94°C, 30s 55°C, 30s 72°C) x40
83.6 0.99 -3.1
TNF alpha TCHO
f 200nM  
r 200nM
30 min 45°C, 10 min 95°C, 
(15s 95°C, 1 min 60 °C) x40
80.3 0.99 -3 .4
IL-6
Plasmid DNA 
PBMC + Con A
f  500nM  
r 500nM
30 min 4 5 *0 ,1 0  min 95°C,
(20s 94°C, 30s 52°C, 30s 72°C) x40
80 0.98 -3 .7
IL-2 PBMC + Con A
f  200nM  
r 200nM
30 min 45°C, 10 min 95"C, 
(15s 95°C, 1 min 60 °C) x40
76.4 0.99 -3.5
IL-4 PBMC + Con A
f  200nM  
r 200nM
30 min 45*C, 10 min 95°C, 
(15s 95°C, 1 min 60 °C) x40
76 0 .99 -3.6
IL-10 PBMC + Con A
f 200nM  
r 200nM
30 min 45°C, 10 min 95°C, 
(15s 95°C, 1 min 60 °C) x40
77.7 0 .99 -2.9
IL-18 PBMC + Con A
f 200nM  
r 200nM
30 min 45°C, 10 min 95°C, 
(15s 95°C, 1 min 60 °C) x40
75 0 .99 -3.7
MCP-1 PBMC + Con A
f 900nM  
r4 0 0 n M  
Probe 900nM
30 min 45°C, 10 min 95°C,
(20s 95°C, 30s 58°C, 30s 60°C) x40
NA 0.99 -3.7
IFN alpha PBMC + Con A
f 200nM  
r 200nM
30 min 45°C, 10 min 95°C, 
(15s 95°C, 1 min 60 °C) x40
- - -
IL-1 B PBMC + Con A
f 200nM  
r 200nM
30 min 45°C, 10 min 95°C, 
(15s 95°C, 1 min 60 °C) x40
0.99 -4.1
IDO Plasmid DNA
f 900nM  
r 900nM
30 min 45°C, 10 min 95eC, 
(15s 95°C, 1 min 60 °C) x40
76.5 0.99 -4.7
SDHA Reference gene
f  200nM  
r 200nM
30 min 45°C, 10 min 95°C, 
(15s 95°C, 1 min 60 °C) x40
81 0.99 -3.15
ACT B Reference gene
f  300nM  
r 300nM
30 min 45°C, 10 min 95°C, 
(15s 95°C, 1 min 60 °C) x40
84.3 0.99 -3.3
YWHAZ Reference gene
f  lOOnM  
r lOOnM
30 min 45°C, 10 min 95°C, 
(15s 95°C, 1 min 60 °C) x40
78.8 0.99 -3.2
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CHAPTER 3 IMMUNOHISTOCHEMICAL ANALYSIS OF THE OVINE 
LUNG DURING POSTNATAL DEVELOMENT
3.1 Introduction
During evolution the structure o f the lung has developed to fulfil the specific requirements o f 
each species. Subsequently, variations can be seen between mammals in the level of maturity 
o f the lung at birth and the intricate anatomy in adulthood (Warburton et al., 2000). Early
thdescriptions o f lung anatomy date back to the 15 Century, and it is testament to its complex 
nature that we are still puzzling over details 500 years later. Popular areas o f current research 
include lung morphogenesis studies to identify regulatory transcription factors, and injury 
models to analyse repair mechanisms and the role o f progenitor cells (Stripp et al., 1995; 
Warburton et al., 2000). Much of this research is performed in mice and it is reliant on the 
availability o f a robust panel o f antibodies with which to identify specific cell types using 
immunohistochemical techniques (Dave et al., 2008; Lange et al., 2009).
A sound knowledge of the working anatomy in the lung is essential if  lung development and 
the pathogenesis o f respiratory disease are to be properly understood. Postnatal maturation is a 
critical stage o f lung development. At this time cells are still differentiating and proliferating, 
and there is an increased vulnerability o f the organ to injury from infectious or noxious insults 
(Castleman, 1984; Castleman and Lay, 1990; Fanucchi et al., 1997a; Plopper et al., 1994; 
Smiley-Jewell et al., 1998).In the sheep, there is no comprehensive account o f lung cellular 
anatomy during this period. This is in part due to a lack o f antibodies to identify specific cell 
types.
The studies described in this chapter aimed to characterise the postnatal development of the 
ovine lung using IHC to see how epithelial cell differentiation, distribution and proliferation 
varied between anatomical regions o f the lung and different ages o f lamb. Following 
optimisation o f a panel o f antibodies to identify specific epithelial cells, the results provided 
valuable information on the anatomy of the maturing lung. In addition, techniques developed 
were applied in subsequent chapters to increase our knowledge o f the pathogenesis o f OPA in 
the sheep lung.
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3.2 Results
Lung tissue for histological analysis was taken from 6 SPF lambs aged 9, 16 and 91 days. Two 
animals were euthanased at each time point and a fixed post mortem procedure was followed 
(see section 2.4). Tissues were sampled from 24 sites per lung, immediately placed in labelled 
cassettes and fixed in buffered formalin for 7 days before further routine processing. The aim 
was to analyse the main epithelial cell types lining the conducting and respiratory airways, and 
to determine how these populations varied with age.
3.2.1 Histological categorisation of the lung
A standard H and E stain was used for basic microscopical analysis o f lung sections to provide 
a means of localising each cell type to particular anatomical regions. The organ was divided 
into five distinct regions defined by airway wall components and proximity to alveoli as 
suggested by Tyler (1983) (Table 1.2). These were the bronchi, bronchioles, terminal 
bronchioles, respiratory bronchioles and alveolar regions, the histological appearance o f which 
is shown in (Figure 3.1A-G).
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Figure 3.1 Histological categorisation of the  lung into five anatomical regions.(A) Bronchus  : ep i t he l ium with 
under lying cart i lage (c) and  mucous  gland (arrow),  OM x20. (Al)Bronchial  epi thel ium:  cil iated pseudos t r a t i f i ed  
co lumna r  epi t he l i um with goble t  cells (arrow),  OM x400.  (B) Bronchiole:  walls of sm o o t h  musc l e  and  loose 
connec t ive  t issue.  No cart i lage or glands,  OM xlOO. (Bl)  Bronchiolar  epi t he l i um from B : ci l iated co lu mn a r  to  
sq u a m o u s  epi thel ium,  OM x600.  (C) Terminal  bronchiole:  mos t  distal region of conduc t i ng  airways,  OM xlOO. 
(Cl)  Terminal  bronchiole  fr om C: ciliated co lumnar  to  s qu a m ou s  epi t he l i um,  OM x600.  H and  E stain.
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Figure 3.1 (cont). Histological categorisation of the  lung into five regions. (D) Respiratory bronchiole:  t rans i t ion  
b e tw e e n  conduct i ng  and respi ra tory  airways,  OM xlOO. (Dl)  Respiratory epi t he l i um f rom D, i n t e r rup t ed  by 
openings  into alveoli (arrow),  OM x400. (E) Alveolar region,  OM x200. (El) alveoli lined by t ype  I and  t ype  li 
pneumocy te s ,  OM x600.  (F) Mouse  lung showing  a b r u p t  j unc t ion  of te rminal  b ronchiole  with alveoli (arrow).
LFB stain,  OM x400.  (G) Ovine lung, showing  respiratory bronchiolar  epi t he l i um (ar rows)  b e t w ee n  t erminal  
bronchioles  and  alveolar  region.  IHC ant i -pancytoke ra t i n  ant i body.
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3.2.2 Histochemical analysis of the lung
Histochemical stains were used to further aid the recognition o f ciliated cells, Clara cells, 
neuroepithelial bodies (NEBs) and type II pneumocytes in these anatomical regions. These 
cells were chosen as they have specialised functions specifically related to the lung 
(Wuenschell et al., 1996). Staining methods were taken from published literature (Bancroft 
J.D., 1994) (see section 2.5) and five stains were used to analyse tissue . Some o f these had 
been specifically adapted for use in the lung (Azzopardi and Thurlbeck, 1969).
The results o f histochemical analysis are summarised in Table 3.2 and displayed in Figure 3.2. 
Cilia were clearly visible in all regions using Grimelius (Figure 3.2A), PTAH and Luxol fast 
blue stains. PAS only highlighted the longer cilia in the bronchi. The distinctive domed 
cytoplasm of Clara cells stained strongly in all levels of bronchioles with PTAH, Luxol fast 
blue and PAS (Figure 3.2 C,E and G). Grimelius silver stain showed black stippling o f 
occasional cells deep within the bronchial and bronchiolar epithelium (Figure 3.2A). These 
cells were assumed to be NE cells. No NEBs were detected in the alveolar region in any age o f 
animal. Type II pneumocytes did not label specifically with any o f the histochemical stains 
employed. From these results it was concluded that histochemical staining was only useful for 
detecting Clara cells and ciliated epithelial cells. However, while the Clara cell cytoplasm was 
highlighted with PAS, PTAH and LFB, the type of staining was not distinct enough to allow 
accurate quantitative analysis o f specific cell types throughout the lung. Cilia were only 
detectable when at their longest in the bronchi, and NEBs and type II pneumocytes were not 
conclusively identified using any o f the histochemical staining methods.
Table 3.2 Summary of histochemical stains used on ovine lung tissue
Stain What does it stain Ciliated cells Clara cells NEBs Type II 
pneumocytes
H and E Basophilic blue, 
acidophilic pink
Pink
cytoplasm
Pink
cytoplasm
Pink
cytoplasm
Pink cytoplasm
PAS Glycogen, neutral mucins and 
carbohydrates stain pink
Yes in 
bronchus
Yes No No
Grimelius Argyrophil granules stain 
brown /black
Brown No Black
stippling
No
PTAH Many tissue structures Yes Yes No No
LFB Phospholipids dark blue Yes Yes No No
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Figure 3.2 Histochemical staining in the sheep lung (left) and positive control tissue (right). (A) Bronchus,  
Grimelius silver stain:  black s t ippled staining of NE cells (ar row) and  b rown cilia, OM x600. (B) Pancreas :  black 
labelling of argyrophylic cells in t h e  islet of  Langerhans  (arrow),  OM x600.  (C) PTAH, bronchiole:  stains pu rp l e  
d o m e d  cytopl asm of Clara cells (arrow),  OM x400.  (D) Mouse  lung: shows  staining of a var iety of  s t ruc tu res ,  OM 
x400.  (E) PAS, bronchiole:  stains pink d o m e d  cytopl asm of Clara cells (arrow),  OM x600. (F) Calf thyroid,  pink 
colloid mater ial  in thyroid follicles, OM x200.  (G) LFB, bronchiole  : s tains purpl e d o m e d  cytopl asm of Clara cells 
(arrow),  OM xlOOO. (H) Mouse  brain:  purpl e  staining of myelin.
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3.2.3 Immunohistochemical analysis of the lung
3.2.3.1 Primary antibodies
Immunohistochemistry was used to improve the ability o f identifying different epithelial cell 
types. This method is based on the binding o f antibodies to specific antigens in the tissue 
(Ramos-Vara, 2005). Both commercially available and custom made monoclonal and 
polyclonal antibodies were optimised to label all epithelial cells, ciliated epithelial cells, Clara 
cells, NEBs and type II pneumocytes in the sheep lung (see Table 2.3). Immunohistochemistry 
was performed using the Envision™ system and indirect labelling techniques (see section 2.1). 
The final working dilutions and experimental conditions for each antibody are shown in Table
3.3. In order to minimise variations in antibody binding and visualisation between batches, all 
slides for each antibody were stained simultaneously.
Table 3.3 Optimised conditions for antibodies to  label epithelial cells in the ovine lung
Cell phenotype Primary antibody Dilution AR Incubation Source
Epithelial cells
Monoclonal mouse
anti-human
pancytokeratin
1/1000 Autoclave in citrate buffer pH6 Overnight 4°C
Dakocytomation
M3515
Clone AE1/AE3
Ciliated 
epithelial cells
Monoclonal mouse
anti-rat
beta -tubulin
1/30 000 Autoclave in citrate buffer pH6 Overnight 4°C
Abeam 40862 
Clone 3F3-G2
Clara Cells
Polyclonal rabbit 
anti- bovine 
CCSP
1/20 000 Autoclave in citrate buffer pH6 Overnight 4°C
Custom made
Neuroepithelial
cells
Polyclonal rabbit
anti-human
Synaptophysin
1/50 Autoclave in 
citrate buffer pH6
Overnight 4°C Vector VPS284
Type II
pneumocytes
Polyclonal rabbit
anti-human
proSP-C
1/4000 Autoclave in citrate buffer pH6 Overnight 4°C
Gift from 
J W hitsett 
R09337
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Figure 3.3 IHC to  identify specific cells in the  ovine lung (left) and positive control tissues (right). (A) ant i -pan-  
cytokera t i n ant i body,  labels respiratory ep i t he l i um (arrow),  t ype  f j ^ and  t ype  II £=> pneum ocy te s ,  OM x400. 
(B)ant i -Pan-cytokerat in ant i body:  s t rong labell ing of b ronchiola r  epi thel ium,  OM x40. (C) an t i - be t a  tubul in 
an t ibody  bronchiole  : cytoplasmic labelling o f  cil iated epi thelial  cells, OM x400. (D) an t i - be t a  t ubul i n  ant i body  
bronchus :  labels long cilia of bronchial  ep i t he l i um,  OM xlOOO.(E) anti-CCSP an t ibody  b ronchiole  : labels Clara 
cells, as identif ied on his tochemical  s ta ining OM x600.  (F) Bronchus:  une xpec t ed  CCSP exp re ss ion  within 
mul t iple  epithelial  cells in t h e  b ronchus  (car t i lage present ) .
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Figure 3.3 (cont). IHC to  identify specific cells in the  lung. (G) ant i - synaptophys in  an t i body  labels tw o  NEBs in 
a lveolar  region and  o n e  NE cell within bronchial  epi t he l i um (arrow),  OM x200.  (H) ant i -synaptophysin  ant i body  
labels large NEB in alveolar  region,  OM x600. (J1-3), posi t ive cont rols  for  synap tophysin  ant ibody.  (Jl) Ovine 
intest ine,  villus crypt ,  labelling of ent er chromaf f i n  cells. (J2) Ovine cer ebe l l um,  posi t ive label of  mo lecu la r  layer. 
(J3) Ovine panc reas ,  posi t ive labelling of islet of Langerhans .  (K) anti-SP-C an t i body  alveolar  region labels t ype  II 
pne um o cy te s  in a lveolar  walls. (L) Respiratory bronchiole:  SP-C expres s ion  a t  BADJ (arrow).  Type II pn eu mo cy te  
acts  as posi t ive controls  (ar row head) .
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3.2.4 A natom ical localisation  of cell typ es
Using these antibodies, it was now possible to accurately assign different cell types to an 
anatomical location during post natal development (Table 3.4). For IHC interpretation, it was 
assumed that the proteins detected had been expressed by the cell in which they were 
localised. Cytokeratin labelling was found in the cytoplasm of epithelial cells throughout the 
respiratory tract from the bronchial epithelium to the type I pneumocytes (Figure 3.3A,B).
Beta tubulin labelling was most intense in the cytoplasm of ciliated cells (Figure 3.3 C,D). 
Although there was faint cytoplasmic labelling in many other cell types, for the purposes of 
this study only ciliated epithelial cells were examined. CCSP labelling was cytoplasmic and 
found in characteristic dome shaped cells within the bronchioles (Figure 3.3E). These cells 
had the same morphology as those identified using histochemical stains (Figure 3.2 C,E,G). 
Unexpectedly, positive cells were also seen in the bronchial epithelium (Figure 3.2 F). 
Synaptophysin expression was strong in the cytoplasm of single (NE) cells and groups of cells 
(NEBs) in the conducting airways, although the presence of these cells was very sporadic, 
varying hugely between slides and animals. NEBs were more consistently found in the walls 
of alveolar ducts, and varied in size from 2-30 cells (Figure 3.2 G, H). SP-C labelling was seen 
in the cytoplasm of plump cuboidal cells in the angle of alveolar walls (Figure 3.3K). 
Occasional positive cells were also seen in sections of respiratory bronchial epithelium in all 
ages of lamb (Figure 3.3L).
Table 3.4 Summary of epithelial cell location in the ovine respiratory tract during postnatal developm ent.
g  : posi t ive labelling for an t i body : - no labelling
Location Cytokeratin Beta tubulin CCSP NE cells NEBs SP-C
Age days 9 16 91 9 16 91 9 16 72 9 16 91 9 16 72 9 16 91
Bronchus 1
Bronchiole 1 1 1 - - -
T Bronchiole - - -
R Bronchiole 1
Alveolus 1 1
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3.2.5 Numerical quantification of IHC labelling
As these slides were being examined to identify the distribution o f cell types in the lung, 
protein expression o f CCSP and beta tubulin was seen to vary between different ages o f lamb. 
In order to quantity this observation numerically, Image J deconvolution macro was used to 
measure the area o f phenotypic protein expression as a percentage o f the total epithelial area 
(see Figure 2.4). Image J software offered a consistent method for taking accurate 
measurements and providing numerical data for comparison between subjects. NEBs and type 
II pneumocyte numbers were counted manually.
3.2.5.1 Quantification of ciliated epithelial cells
Anti- beta tubulin antibody was used to label ciliated epithelial cells. The percentage o f 
positive labelling was estimated in each o f four regions o f the lung: bronchus, bronchiole, 
terminal bronchiole and respiratory bronchiole at a single sample site (5a) from all 6 animals. 
For each anatomical region, labelling o f four bronchi/bronchioles/terminal bronchioles and 
respiratory bronchioles was assessed. Image J software was used to calculate the area o f 
positive labelling, and this was expressed as a percentage o f the total epithelial area. An 
angular transformation o f the data was performed to avoid misleading visual conclusions from 
error bars due to the original scale. This was because there was a tendency for animals with a 
higher mean percentage to show more variability between replicates. Error bars that represent 
95% confidence interval o f the mean were calculated. If these error bars do not overlap, then 
differences between data are considered to be statistically significant (P<0.05). The data are 
presented in Figure 3.4.There was a significant increase in beta tubulin expression at 91 days 
in all four regions o f the conducting airways when compared to the earlier time points. A 
representative photograph of IHC for beta tubulin expression is shown in Figure 3.5.
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Figure 3.4 Graph showing the variation in beta tubulin expression in four anatomical regions of the lung in 
different ages of lamb. An angular  t r an s fo rma t ion  was  carr ied out  on t he  original da ta ,  and  t h e  y axis 
r ep r e se n t s  t h e  m ean  of t h e  t r an s f o r med  da ta .  The e r ror  bars  r ep r e sen t  t h e  95% con fidence  interval of t he  
mean .  Higher levels o f  be t a  tubul in express ion w e re  found  in 91 day old lambs t han  in younger  animals  (P<0.05) 
in all f our  anatomical  regions.
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Figure 3.5 IHC using anti-beta tubulin antibody to label ciliated cells in bronchiole from 9 (A) and 91 (B) day 
old lambs. Increased labelling can be  s een  in t h e  older  animal  (B).
97
3.2.5.2 Quantification of Clara cells
Clara cell protein percentages were estimated at two sites (lb  and 5a) in each of four regions 
of the lung: bronchus, bronchiole, terminal bronchiole and respiratory bronchiole. This gave a 
total of eight observations per animal and all 6 animals were examined. The predicted mean 
percentages of Clara cell protein expression from the transformed scale are shown in Figure 
3.6. Significant increases in CCSP expression in lambs between 9 and 91 days old are seen in 
bronchi, terminal bronchioles and respiratory bronchioles (P<0.05). Increases in CCSP levels 
between 9 and 16 days are seen in the bronchiole and terminal bronchiole only (P<0.05).
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Figure 3.6 Graph showing the variation in CCSP expression from tw o sites (lb , 5a) in four anatom ical regions 
of the  lung in different ages of lamb. An angular  t r an s fo rma t ion  was  carr ied ou t  on t h e  original da t a ,  an d  t h e  y 
axis r ep r e sen t s  t h e  m e a n  of  t h e  t r an s fo r med  da ta .  The er ror  bars  r ep r e sen t  t h e  95% conf idence interval of  t h e  
mean .  An increase  in CCSP express ion was  found  in t h e  bronchi ,  t erminal  bronchioles  and  respi ra tory  
bronchioles  in 91 day  old lambs w h en  co mp ar ed  to  in 9 day old lambs (P<0.05). The large e rror  ba rs  indicate  t he  
high variability in CCSP express ion within t h e  s a m e  anatomica l  region a t  t he  s a m e  site.
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Figure 3.7 IHC using anti-CCSP antibody to  show labelling in the  respiratory bronchioles of 9 day (A) and 91
day (B) old lambs. Increased labelling is s een in t h e  olde r  animals .
3.2.5.3 Neuroepithelial cells
NEB were identified using an antibody to synaptophysin. Numbers were estimated at one or 
two sites (lb  and 5a) in the lung from all 6 animals. Only those in the alveolar regions were 
counted, as those in the conducting airways were too sporadic to assess meaningfully. The 
final value was expressed as the total number of NEBs per cm" of fixed lung tissue (Figure 
3.8). There was no consistent change in NEB number with age of lamb.
3.2.5.4 Type II pneumocytes
Type II pneumocytes were identified by their expression of SP-C. Between 500-1200 nuclei 
were counted in the alveolar region of a single site (5a) for each animal. The percentage of 
these cells that labelled positively for SP-C was calculated. The percentage of Type II 
pneumocytes were slightly higher at day 9, but this difference is marginal (Figure 3.9).
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Figure 3.8 Graph showing variation of NEB per cm 2 in a total of six lambs ages 9,16 and 91 days. Red /b lue 
r ep r e sen t s  a di f ferent  animal  a t  each t ime  point .
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Figure 3.9 Graph showing variation in % SP-C num bers in a total of six lambs aged 9,16 and 91 days
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3.2.6 Effect o f age  on proliferative index
Ki-67 antibody was used to identify the proliferative state of cells, in order to assess the 
growth rate o f different anatomical regions of the lung during postnatal development. Ki-67 is 
a nuclear antigen expressed by cells which are not in the GO/resting phase of the cell cycle.
The antibody was optimised by labelling tissue with known differences in proliferation such as 
the intestine and the lung (Figure 3.10).
Figure 3.10 IHC using anti-Ki 67- antibody to  com pare proliferative index betw een intestine and lung.
Intestinal epi t he l i um (A) lots of Ki-67 posi t ive cells, lung (B) few Ki-67 posi t ive cells.
The proliferative index of the epithelial compartment from five regions o f the lung was 
calculated in different ages o f lamb. These were the bronchus, bronchiole, terminal bronchiole, 
respiratory bronchiole and alveolar region. . In each of these regions, a total of 200 cells from 
each of four bronchi/bronchioles/terminal bronchioles and respiratory bronchioles were 
analysed. In the alveolar compartment, six fields of 200 cells were analysed. This took place in 
two sites (lb  and 5a) from all 6 animals. The number of positive labelling nuclei for Ki-67 was 
recorded and expressed as a percentage for each 200 cells to give the proliferative index.
An angular transformation was carried out on the data (Figure 3.11). Reductions in 
proliferative index with age are seen between 16 and 91 days in bronchus, bronchiole, terminal 
bronchiole and alveolar region. The biggest change is seen in the alveolar region (Figure 
3.12).
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Figure 3.11 Graph to  show the proliferative index of five anatomical regions in the lung in lambs aged 9,16 
and 91 days. An angular  t r an sforma t ion  was  carr ied ou t  on t h e  original da ta ,  and  t h e  y axis r ep r e sen t s  t he  m ean  
of t he  t r an s fo rmed  data .  The e rror  bars r e p r e sen t  t h e  95% conf idence  interval of t h e  mean .  There  is a 
significant reduct ion  in prol iferat ive index b e t w e e n l 6  days and  91 days in t h e  bronchus ,  bronchiole,  te rminal  
b ronchiole  and  alveoli.
Figure 3.12 Comparison of num ber of Ki-67 positive cells in the  alveolar region of a 9 day (A) and 91 day old 
lamb (B). Green,  anti-Ki-67. Grea te r  n um be r s  of posi t ive cells in t he  younge r  lamb (Red, anti-SP-C).
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3.3 Discussion
This study provides data regarding the normal postnatal development o f the respiratory 
epithelium in SPF lambs. It validates antibodies to identify specific epithelial cell types in the 
ovine lung, and uses immunohistochemical techniques to locate and quantify these cells and 
their proliferative state in predefined anatomical regions. Studies in other species have shown 
these parameters to vary according to the maturity o f the neonate (Fanucchi et al., 1997b; 
Plopper et al., 1992). More accurate comparisons can now be made between these species and 
the sheep lung.
This analysis was performed in growing lambs which were 9, 16 and 91 days old. Clara cells 
and ciliated epithelial cells were detected in the bronchi, bronchioles, terminal bronchioles and 
respiratory bronchioles o f all animals. Neuroepithelial cells and NEBs were found in 
conducting and respiratory airways. Type II pneumocytes were found predominantly in the 
alveolar compartment but were also detected in occasional areas o f respiratory bronchiolar 
epithelium. As the animals aged there was an increase in detection of beta tubulin in the 
epithelium of all four regions o f the lung (P<0.05) (Figure 3.4). Increased CCSP was found in 
the bronchi, terminal bronchioles and respiratory bronchioles in 91 day old lambs when 
compared to 9 day old lambs (P<0.05) (Figure 3.6). Numbers o f NEBs and the % of type II 
pneumocytes showed no trend in variation over time. The proliferative index was seen to 
decrease in lambs between 16 and 91 days, with the biggest reduction in the alveolar 
compartment. This suggests that during postnatal development, there is maturation o f the lung 
as defined by cytodifferentiation, and a reduction in proliferative index which is most apparent 
in the alveolar compartment.
Classification o f cell phenotype using IHC to analyse protein production is a widely used 
technique (Ramos-Vara, 2005). Its reliability is dependent on the use o f consistent tissue 
processing and antigen detection techniques, and the absolute specificity o f antibodies. In this 
study, the strict tissue sampling and analysis protocols combined with appropriate positive and 
negative controls for IHC ensured that changes in protein expression were the result of 
biological variations only.
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The use o f Image J to provide numerical quantitative values for protein expression was 
another effort towards standardising these results. Traditionally, pathologists examine the 
tissue by eye and use a 3 or 4 point subjective scoring method to record the degree o f positive 
labelling (Cregger et al., 2006). However, automated analysis offers a more objective means 
for quantitative scoring and increases the accuracy o f data comparison between studies.
Several methods have been used for quantification for IHC labelling in the lung (Arsalane et 
al., 2000; Bolton et al., 2008; Coppens et al., 2007; Fanucchi et al., 1997b). They include 
estimating the area o f protein expression (by eye or automated analysis) as a fraction o f the 
total epithelial area (Bolton et al., 2008; Coppens et al., 2007), or counting the number o f 
positive cells in a given area (Arsalane et al., 2000; Bolton et al., 2008). For this study the 
former technique was applied. As the process o f postnatal maturation in the sheep has not been 
fully defined, it was thought that assessing the overall amount of protein production would 
include both increased numbers o f expressing cells and increased expression o f protein by pre­
existing cells, so being a more sensitive measure o f cytodifferentiation. In addition, the 
complicated anatomy of the lung which leads to unavoidable tangential sectioning of 
respiratory epithelium in all levels of the tract, prevents an accurate assessment o f cell number.
In the sheep existing histological studies on the lung use ultrastructural and histochemical 
staining techniques to analyse the process o f cytodifferentiation and distribution of different 
cell types at maturity (Alcorn et al., 1981; Bouljihad and Leipold, 1994; Kikkawa et al., 1965; 
Mariassy and Plopper, 1983, 1984; Orzalesi et al., 1965; Plopper et al., 1980a). However, as 
changes in cellular morphology do not necessarily correlate with protein production (Coppens 
et al., 2007) the accuracy of these findings is questionable. They also mainly focus on the 
anatomy o f fetal development and the adult animal, omitting the important process of 
postnatal maturation while cells are still differentiating and dividing.
Postnatal maturation in the lung has been examined in the mouse, hamster, rat, rabbit, rhesus 
monkey and human (Plopper et al., 1992). In the conducting airways, work has shown that 
fetal respiratory epithelial cells are typically filled with glycogen (Pinkerton and Joad, 2000). 
As the cells mature, this is gradually lost and expression o f proteins associated with the 
differentiated phenotype increases. For example in the bronchioles, cytodifferentiation is 
characterised by a general loss of glycogen from undifferentiated cuboidal cells, and the
104
development o f cilia which grow from basal bodies in the apical cytoplasm or an increase in 
Clara cell protein production (Marei and Abd el-Gawad, 2001). In the Clara cell, this 
corresponds with the formation o f abundant amounts of smooth and rough endoplasmic 
reticulum in the basolateral and apical regions o f the cell cytoplasm. The P450 isoenzymes 
which are involved in bioactivation and detoxification o f xenobiotic compounds also develop 
postnatally (Fanucchi et al., 1997b). The type II pneumocyte is the only cell type which has 
been studied in detail during maturation o f the sheep lung (Meyerholz et al., 2006). Here, 
glycogen loss was found to correlate with an increase in CD208 expression and the 
development o f lamellar bodies and surfactant production.
The timing and pattern o f epithelial differentiation is species specific (Cardoso, 2000; 
Castleman and Lay, 1990; Fanucchi et al., 1997b; Hyde et al., 1983; Pinkerton and Joad,
2000). For example in the rat and rhesus monkey Clara cells are fully differentiated by 1 week, 
but in the rabbit and calf this takes 4 weeks (Castleman and Lay, 1990). In the mouse, levels 
o f CCSP and beta tubulin expression reach maturity by 14 days post partum (Fanucchi et al., 
1997b). In the present study on ovine lung, beta tubulin expression did not increase until after 
16 days in all regions o f the lung. For CCSP, there was an earlier increase between 9-16 days 
in the bronchioles, and terminal bronchioles. No further change in the bronchioles suggests 
mature levels o f CCSP expression were reached by 16 days, but in the terminal bronchioles 
expression had increased again by 91 days. In the respiratory epithelium CCSP expression did 
not increase until after 16 days. This indicates a proximal/distal graded maturation within the 
conducting and respiratory airways, although samples from additional time points are needed 
to see how protein expression varies within and after these time points.
These species specific timings are most likely influenced by the stage o f lung development 
reached during gestation. Prenatal development o f the lung goes through four stages of 
maturation: the pseudoglandular stage, the canalicular stage, the saccular stage and the 
alveolar stage. For example, marsupials are bom with relatively primitive lungs in the 
canalicular or saccular stage and require significant postnatal maturation (Burri, 2006).
Humans are bom in the saccular stage, where airspaces are simple and their walls are thick 
septa with connective tissue and two capillary networks. The formation of alveoli 
(alveolarisation) occurs in the first 6 months and is followed by microvascular maturation for
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up to 3 years. In contrast, the lamb is bom with a more mature lung which is already 
alveolarised and the degree of postnatal microvascular maturation is unknown (Alcorn et al., 
1981). Proportions o f type I to type II pneumocytes are influenced by fetal lung expansion, 
and studies have shown a predominance o f type I pneumocytes before birth, and type IIs after 
(Flecknoe et al., 2000; Flecknoe et al., 2003). In the present study the proportion of type II 
pneumocytes to other cells in the alveolar region o f the ovine lung, showed little change with 
age increase. The finding that there was no postnatal increase in type II pneumocyte formation 
detected supports the theory o f complete alveolarisation in the lamb.
This study identified additional locations for cells expressing CCSP and SP-C protein when 
compared to existing literature. CCSP expression in the bronchi has not been recorded in 
sheep (Figure 3.3A). Similar cells found in rat and human studies do not share the proliferative 
characteristics of Clara cells in the more distal conducting airways (Barth et al., 2000; Boers et 
al., 1999). Expression o f SP-C in bronchioles is also a new finding. In mice, cells which 
express SP-C and CCSP called BASCs have been found at the BADJ (Jackson et al., 2001; 
Kim et al., 2005). Occasional SP-C positive cells in this study were also found in this 
anatomical region (Figure 3.3L). The absence o f an obvious trend in NEB numbers during 
maturation is in contrast to other studies on the ovine lung where numbers are reported to 
reduce during maturation (Van Lommel and Lauweryns, 1997). This discrepancy may be due 
to the use of different antibodies for detection. It has been proposed that the endocrine 
function o f these cells reaches maturity at birth, but the chemoreceptor function shows 
maturation in the postnatal period. In the sheep lung, variation in expression o f specific 
markers with age has been recorded for NEBs (Asabe et al., 2004; Balaguer and Romano,
1991; Van Lommel and Lauweryns, 1997).
In this study, changes in proliferative state were used to assess the growth rate o f separate 
anatomical compartments in the lung. The proliferation o f cells during postnatal development 
was measured using Ki-67, which is a nuclear structure present exclusively in proliferating 
cells (Scholzen and Gerdes, 2000). It is a reliable indicator o f cell proliferation and expression 
is closely correlated with other similar markers including thymidine labelling, 
bromodeoxyuridine incorporation and flow cytometry (Hall and Levison, 1990). The 
proliferative index is difficult to study in the normal lung as the cell turnover is so slow
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(Kauffman, 1980). Therefore it is most commonly investigated in tissues during development, 
following injury or as a prognostic indicator in tumour biology (Hall and Levison, 1990). In 
this study, the largest reduction in PI was detected in the alveolar region. Here, as the 
measurement o f Ki-67 expression potentially included type II pneumocytes, endothelial cells, 
fibroblasts and infiltrating leukocytes, it was not possible to pinpoint the phenotype 
responsible for this decrease in turnover. However, extrapolation of data from other animals 
indicates that microvascular maturation, which involves restructuring o f the capillary network 
from double to single form, is the final stage o f lung maturation (Burri, 2006). Measurement 
o f Ki-67 expression in other areas o f the lung directly reflects the proliferative capacity o f 
epithelial cells lining the airways only as the epithelium is morphologically distinct. More 
subtle changes were seen in the conducting airways, with reductions in PI detected in the 
bronchi, bronchioles and terminal bronchioles between 16 and 91 days. Additional samples 
from between and outside these time points would help to map the proliferative state o f these 
anatomical regions in the lung more thoroughly.
In summary, this study shows that in the lamb there is significant postnatal cytodifferentiation 
o f Clara cells and ciliated epithelial cells in the respiratory airways. This may have 
implications for the pathogenesis o f respiratory disease, as differentiation in other species 
coincides with development o f lung xenobiotic metabolising enzyme systems (Pinkerton and 
Joad, 2000). This was demonstrated in studies on adult and neonatal mice and rabbits which 
exposed all animals to the same noxious insult and found injury to undifferentiated cells to be 
more severe. Subsequent maturation processes in the lung were also impaired (Fanucchi et al., 
1997a; Plopper et al., 1994; Smiley-Jewell et al., 1998). Given the variation in timing and 
location o f cell maturation in the lamb described in this study, particular regions o f the lung 
may be more susceptible to injury at certain times than others. However, the data from this 
study must be interpreted with caution. Only a few animals were examined, and they were 
housed in an SPF environment where normal exposure to inhaled allergens was minimal. This 
may have affected the process of cell maturation. Analysis of many more lungs would 
overcome this problem.
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CHAPTER 4 IDENTIFICATION OF THE TARGET CELL FOR JSRV
INFECTION IN THE OVINE LUNG
4.1 Introduction
Initial interactions between virus and host have been poorly defined for OPA. As a first step 
towards investigating these early stages o f disease pathogenesis, this chapter aimed to identify 
the target cell for JSRV infection in the ovine lung. Current theories on target cell identity for 
JSRV infection in the lung are based on the anatomical location and heterogenous phenotype 
o f the resultant mature tumours. Such tumours are reported to emanate from bronchiolar and 
alveolar epithelium, and IHC shows the majority o f the neoplastic cells to express SP-C or 
CCSP (see Figure 1.9H). Therefore, Clara cells, type II pneumocytes and an unidentified Tung 
progenitor’ cell have all been suggested as potential targets for JSRV (Platt et al., 2002).
Efforts to confirm these theories using experimental models o f infection have been 
challenging. In vitro experiments were confounded by the difficulty o f maintaining the 
required ovine cell phenotypes in culture (Archer et al., 2007; Jassim et al., 1987). Mouse 
models o f OPA have only shown expression o f JSRV in type II pneumocytes which does not 
accurately mimic natural disease in the sheep (Chitra et al., 2009; Dakessian and Fan, 2008; 
Wootton et al., 2005). Due to the lack of a pre-clinical diagnostic test for OPA, the study of 
OPA-N seldom provides tissues from an early enough stage o f infection to identify the target 
cell in the lung.
In the present study lung tissue from experimentally infected lambs provided a source of 
material for analysis. Samples were taken shortly after inoculation before significant tumour 
growth occurred, and immunohistochemical techniques developed in the previous chapter 
were applied to identify the phenotype of single cells expressing viral protein. These 
pulmonary cells were assumed to be the target cell for JSRV in the lung.
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4.2 Results
4.2.1 Experimental infection of neonatal lam bs with JSRV 21
SPF lambs experimentally infected with JSRV21 were used to provide lung tissue to identify 
cell types infected by JSRV at early stages post-infection (Figure 4.1). Twelve SPF lambs 
were challenged intratracheally with JSRV21 (4 ml ~ 10l(l RNA copies of JSRV2 1) at 6 days old 
(Group 1). Four animals were euthanased at 3 and 10 days post-inoculation and the remaining 
four when clinical signs of disease were detected (72 -91 days). Age matched mock infected 
(Group 2) and non-inoculated (Group 3) lambs were included as negative controls. Samples 
collected at post-mortem were analysed as detailed in Materials and Methods (2.1).
Born
Inoculated
6d
Group 1 
JSRV21 x 12
Group 2 
293T SN x 8
Group 3 
Non-inoculated x 6
Clinical signs and tumours
► Age
9d 16d 72d 77d 91d
□  □ □  □ □ □ □
□  □ □  □ □
□ □ □
□ □ □
E □ □ ■ ■
□ ■ □
Figure 4.1 Timing of experim ental infection and euthanasia. The let ter  d = days.  Each coloured  box r ep re sen t s  
a lamb p os t -m or t em  examinat i on .  Red: lambs JSRV2i inoculated.  Blue: mock inocul ate  ( negat ive control )  Green:  
no inoculate  (negat ive control) .
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4.2.2 Post-m ortem  validation of experim ental m odel
PME was used to confirm the efficacy of this experimental model. Lungs from all groups at 3 
and 10 days post infection had similar gross appearances (Figure 4.3 A,B), and there were 
minimal differences in lung weight as a proportion of body weight between treatment groups. 
By 72-91 days post-inoculation infected lungs were enlarged and fluid filled (Figure 4.3 D,F). 
Frothy fluid exuded from the trachea of one animal (2863 E) which is a common finding in 
OPA-N (Figure 4.3 D). Lung surfaces were mottled in colour, and some contained multiple 
subpleural pale foci surrounded by overinflated tissue (Figure 4.3 F). These were suspicious of 
neoplastic foci. Lung weight as a proportion of body weight was greater in infected animals 
when compared to mock and control (Figure 4.2). Histological examination confirmed the 
presence of tumour to be in infected animals only (Figure 4.4).
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Figure 4.2 Summary of lung weight as a proportion of bodyweight for all lambs 72 - 91 days PI. Red: JSRV2i 
infected lambs.  Blue: mock infected control  lambs.  Green :  non  infected control  lambs.
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Figure 4.3 Gross appearance of lungs from experim ental lambs. (A) mock infected l amb 2853 E and  (B) JSRV 2i 
infected l amb 2854E lungs 10 days PI with a similar gross  appea ran ce .  (C) Control  lung f rom lamb 2864E, 77 
days  post  non inoculat ion.  Note  uniform colour  and  col lapsed na tu r e  of lung t issue.  (D) Lung f rom lamb 2863E , 
77 days post  inoculat ion with JSRV 2 i . Note  f roth at  t r achea l  open ing  and  en larged lung ( co mp a re  wi th C using 
backg round  grid) which is mo t t l ed  in colour .  It fai led t o  col lapse on opening  of thoracic  cavity.  (E) Lung from 
lamb 2862E, 91 days post  mock inoculat ion.  Note  uni form colour  and  smal ler  size w h e n  c o m p ar ed  to  (F) using 
t h e  backg round  grid. (F) Lung f rom lamb 2865E, 91 days pos t  inoculat ion wi th JSRV 21. No te  suspicious 
neoplas t i c  dark foci sur round  by over inf la ted lung t i ssue (arrow).
I l l
Figure 4.4 A whole transverse section of lung from case 2863 E, site 5a. The dark pu rp l e  foci a re  neoplas t ic  
nodu le s  which a re  cons i s t en t  with a diagnosis of OPA. H and  E stain,  OM x20.
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4.2.2.1 Comparison of experimental and natural OPA tumour phenotypes
In order to validate this experimental model o f disease, the phenotype o f experimentally 
induced tumours (OPA-E) were compared with those from natural field cases o f OPA (OPA- 
N). Labelling for cytokeratin, SP-C, CCSP and synaptophysin proteins were assessed using 
previously optimised antibodies (see Figure 3.3). Similar labelling was seen for all except 
synaptophysin, which was not readily detectable in cases o f OPA-N (Figure 4.5 A-H).
4.2.3 Proliferative cells in the sheep lung during postnatal development
Most retroviruses require actively dividing cells for efficient integration and replication 
(Coffin et al., 1997). Experiments on rodent lungs indicate that Clara cells, NEBs and type II 
pneumocytes are able to replicate (Evans et al., 1978; Evans et al., 1973; Peake et al., 2000). 
To confirm this in the ovine lung, expression o f Ki-67 was colocalised with phenotypic 
markers (CCSP, synaptophysin, SP-C) using dual IHC labelling and the substrate chromogens 
DAB (brown) and VIP (purple). Optimisation o f antibody concentration, sequence o f 
incubation and substrate colour was necessary (Figure 4.6). Numbers o f Ki-67 positive cells 
were then compared between different combinations o f antibody incubation and visualisation 
substrates in serial sections of bronchiole to determine the optimal experimental procedure.
Dual labelling o f Clara cells and NEBs with Ki-67 was successful (Figure 4.7 A-D). Detection 
o f SP-C protein was masked by Ki-67 using DAB and VIP substrates, so immunofluorescent 
techniques were used (Figure 4. 7 E, F) (see 2.3.5). There was dual labelling o f Ki-67 with the 
phenotypic marker for all three cell types in the lungs of lambs 10 days PI. This demonstrated 
the ability o f Clara cells, NEB cells and type II pneumocytes to proliferate in the ovine lung, 
and hence their potential as a target cell for JSRV.
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Figure 4.5 IHC analysis of tum ours from OPA-N and OPA-E. (A;B) Diffuse labelling of t u m o u r  acini with anti-  
pancy tokerat i n  an t ibody in OPA-N (left) and  OPA-E (right), OM xlOO. (C,D) anti-SP-C an t i body  labels neoplas t ic 
cells and  normal  type  II pne um ocy te s  in OPA-N (left) and  OPA-E (right) (arrow).(E) anti-CCSP an t i body  shows 
weak  labelling of t u m o u r  and s t rong labelling of Clara cells in bronchial  epi t he l i um,  OPA-E OM xlOO, OM x200.  
(F) ant i - synaptophys in an t i body shows  focal labelling wi thin t u m o u r  nodu le  of OPA-E. OM x200.
114
A*  *  -
•  v. *  * <:
* ‘V />  *
f  A -  ».«*> t j .
V  • **r -* -«
• J f ;  »  ' ' . . .  .  ..
1  v. V *
• f
*• •*
" V - / v .  '
<  V f
, ,  V .*< ?
* « » -  * & ^  -■»
"  *♦> 5 ^  ,«y
m ' . b  ,^r t :  .- •*> . ,
»*K
**
T A
v *
% r
m \ .
Figure 4.6 Optimisation of dual labelling IHC using anti-CCSP antibody (1/20 000) and anti-Ki-67 antibody 
(1/1000). (A) Bronchiole:  anti-CCSP an t i body  VIP, anti-Ki-67 an t i body  DAB. Arrow points  to  single cell labelling 
for bo th  ant igens.  (B) Bronchiole:  anti-CCSP ant i body  DAB, anti-Ki-67 an t ibody  VIP. Arrow points  t o  single cell 
wi th faint  labelling wi th bo th  ant igens.  (C) Bronchiole:  ant i -  Ki-67 VIP, anti-CCSP ant i body  DAB. 4 cells labelling 
wi th bo th  ant i gens  (arrows).  (D) Bronchiole:  anti-Ki-67 an t i body  DAB, anti-CCSP an t i body  VIP 4 cells show 
labelling for bo th  ant igens.  The mos t  sensi t ive m e t h o d  which was  eas i es t  to  visualise used t h e  weak es t  an t i body  
first (Ki-67 1/1000)  wi th t h e  s t r onges t  subs t r a t e  (DAB) sh ow n  in (D).
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Figure 4.7 IHC to identify proliferative capacity of Clara cells, NEBs and type II pneum ocytes on OPA-E 10 days
PI. (A) Bronchiole:  dual  labelling of cell wi th anti-Ki-67 (DAB) and  anti-CCSP (VIP) (ar row) OM x600.  (B) 
Respiratory bronchiole  dual  labelling of cell with anti-Ki-67 (DAB) and anti-CCSP (VIP) (ar row) OM xlOOO. (C) 
NEBs: dual  labelling of  mul t iple cells in two  NEBs with anti-Ki-67 (DAB) and  ant i -synaptophys in  (VIP) (ar row) OM 
x400.  (D) Detail of (C) OM x600.  (E): Alveolar region.  Green:  anti-Ki-67. Red:, anti-SP-C . Only occasional  cells 
show  dual  labelling of Ki-67 and  SP-C. OM x200.  (F) Detail of  (E) showing dual  label led cell (ar row) OM x400.
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4.2.4 Validation of JSRV SU antibody using IHC.
To identify viral protein expression using IHC, a panel o f anti-JSRV antibodies was tested on 
positive and negative control tissue (see Table 2.3). O f these, the anti-JSRV SU monoclonal 
pool gave the most satisfactory results (Figure 4.8 A, B). It was tested on OPA-N, and even in 
the presence o f necrosis and mixed inflammatory cells labelling was highly sensitive and 
specific for neoplastic cells only (Figure 4.8 C, D). OPA-E tumours from animals 72 days post 
inoculation also labelled positively for JSRV SU (Figure 4.8 E, F).
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Figure 4.8 IHC using anti-JSRV SU antibody on cases from OPA-N and OPA-E. (A) OPA-N showing  specific 
labelling of t u m o u r  foci (brown)  bu t  not  normal  bronchial  epi t he l i um (arrows) OM x 20. (B) Negat ive control  
ovine lung t u m o u r  f rom aged  s h e e p  no t  i nfected wi th JSRV, no labelling OM x20. (C) OPA-N t u m o u r  with central  
necros is  showing  specific labelling of per i phera l  neoplas t i c  t i ssue only OM xlOO. (D) OPA-N showing specific 
labelling of neoplas t ic  cells but  no t  su rrounding  i n f lammatory  cells. OM x400. (E) OPA-E showing  st rong labelling 
of mul t iple t u m o ur  foci. (F) OPA-E with labelling of early t u m o u r  in bronchiole.  No te  cell sur face  s taining pa t t e rn  
OM x400 .
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4.2.4.1 Detection of single cells expressing JSRV SU
To identify single cells expressing JSRV SU protein, and hence the target cell for JSRV, the 
optimised anti-JSRV SU Mab was used to label lung tissue from lambs 10 days post­
inoculation with JSRV2 1 . The sensitivity o f JSRV SU antigen detection was compared 
between tissues fixed in ZS and FS. As formalin can mask antibody binding sites with cross 
linking, antigen retrieval (AR) methods were required to break these down before antibody 
incubation in FS tissue (see Table 2.2). The total number o f single cells and clusters (two cells 
or more) visualised with DAB chromogen were counted for each animal. Initially all 24 ZS 
fixed sections from each lung were examined (96 slides in total). Very few single positive 
cells were detected and there was increased background and non specific labelling of some 
normal epithelial cells. The experiment was repeated using formalin fixed tissue with AR. 
This method proved to be more sensitive and specific, and as a result only five slides per lung 
were needed to provide adequate numbers o f positive single cells for analysis (Table 4.1).
Formalin fixed tissue with AR was used for all further IHC experiments. All 96 sections of 
lung tissue from animals 3 days PI, and 10 sections from negative control mock and non- 
inoculated lambs from 3 and 10 days PI were also examined for JSRV SU protein expression, 
but none was found (Table 4.2).
Table 4.1 Comparison of fixation methods and detection of single/clusters of cells expressing virus in OPA-E 
lambs, 10 days PI using IHC.
Fixative
2852 E 2858 E 2854 E 2856 E
Single Cluster Single Cluster Single Cluster Single Cluster
Zinc fixed
24 slides per animal
0 0 0 11 3 29 2 36
Formalin fixed + AR 
5 slides per animal
3 2 2 14 12 20 10 15
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Table 4.2 A summary of positive labelling for SU antibody on formalin fixed tissue from lambs 3 and 10 days 
PI.
Time PI Total number of sections 
examined from all 8 animals at 
each time point
Number of sections with 
positive foci
Total number of 
positive single 
cells
Total
number of
positive
clustersInfected Mock No
inoculate
Infected Mock No
inoculate
3 days 96 10 10 0 0 0 0 0
10 days 20 10 10 13 0 0 27 51
4.2.4.2 Location of cells showing JSRV SU protein expression 10 days post 
inoculation
In order to obtain a more detailed phenotypic identification of JSRV SU positive cells, the 
location o f single and clusters o f cells were assigned to one of the five regions in the lung: 
bronchus, bronchiole, terminal bronchiole, respiratory bronchiole and alveolar region (Table
4.3, Figure 4.9 and 4.10.). No JSRV SU positive cells were found in the bronchi. Single and 
clusters o f JSRV SU positive cells were found in all remaining regions o f the lung. Both 
location and number o f positive cells was seen to vary between the four JSRV21 infected 
lambs (Figure 4.9).
These findings indicate that JSRV is expressed by single cells in all levels o f conducting and 
respiratory airways. Previous work shows epithelial cells lining the tract in these areas to 
include ciliated epithelial cells, Clara cells, NE cells, NEBs and alveolar type I and type II 
pneumocytes (Table 3.3). Cells located at the BADJ, shown to harbour BASCs in mice (Kim 
et al., 2005), also appeared to be targeted on occasion (Figure 4.10 E,F).
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T able 4.3 S u m m a ry  of size a n d  locat ion of pos i t ive  labelling cells in fo u r  lam b s  10 d ays  PI
Location
Number of positive single cells Number of positive clusters
Bronchus 0 0
Bronchiole 10 4
Terminal b ronchiole 4 6
Respiratory
bronchiole
6 24
Alveolar region 7 18
Location of  SU posit ive foci 10  days  post  inoculation with  
JSRV
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Figure 4.9 Variation in location of JSRV SU expression both within and betw een animals.
Note: JSRV SU expressing  foci include single cells and  clus ters .
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Figure 4.10 IHC using anti JSRV SU Mab to  label cells in lung tissue from lambs 10 days post inoculation. (A)
2858E: positive c lus ter  in te rm ina l b ronchiole .O M  x 100. (B) Positive single cells in bronchio le .O M  x600. (C) 2856 
E: positive c lus ter  in re sp ira to ry  bronchiole .O M  x200. (D) 2856 E: positive single cells in resp ira to ry  bronchiole. 
(E) 2854E: positive clus ters  in resp ira tory  bronchio les  at BADJs. (F) 2854 E Positive single cell in resp ira tory  
b ronchio le  a t  BADJ.OM x600. (G) 2854E: positive cluster  lining th e  alveolar du c t  wall.OM x600. (H) 2856 E 
Positive cells lining th e  s m o o th  muscle  ring on th e  free  ed ge  of an  alveolar sep ta .O M  x400.
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4.2.5 Identification of JSRV target ceil using serial sections
Serial sections were cut from blocks showing JSRV SU positive cells. These were then 
labelled with cell specific markers to try and localise the presence o f viral protein to cell type. 
Figure 4.12 shows that larger groups o f cells were identified on multiple sections. However, 
even though tissue sections were thin (5 pm), it was rare to see the same cell in adjacent 
sections due to small changes in anatomy.
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Figure 4.11 IHC of serial sections stained with anti-JSRV SU Mab (A,B), anti-DC-LAMP antibody (C,D) and anti- 
pancytokeratin antibody (E,F). The s a m e  cluster  o f cells (arrow) is visible in each  of th e  t h r e e  serial sec t io ns  
(A;C,E) and  B,D,F). (A,B) Cells labelling for JSRV SU label faintly in (C,D) for DC LAMP (a ty p e  II p n e u m o c y te  
marker).  (E,F) show  m o d e r a te  labelling for pan cy tokera tin  (an epithelial cell m arker) .O M  x400.
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Figure 4.12 IHC of serial sections labelled with anti-JSRV SU, anti-DC LAMP, SP-C and anti-pancytokeratin 
antibodies. (A) A JSRV SU positive focus in t h e  resp ira to ry  bronchiole .  OM x400. (C) S am e  focus labels positively 
with anti- DC LAMP in serial sec t ion .  OM x400. (E) Partial labelling of sa m e  focus in serial sec tion  with anti- 
cy tokera tin .  OM x 600. (B) A single JSRV SU positive cell in th e  resp ira to ry  bronchiole . .  Focus lost on serial 
sec t ion ing  in (D) anti-DC-LAMP and  (F) an ti-cy tokera tin .O M  x200.
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4.2.6 Identification of JSRV target cell using dual labelling
To enable better localisation o f multiple antigens to a single cell, sections were labelled with 
two antibodies using DAB and VIP chromagen substrates to distinguish between the different 
antigens (see 2.5.3). To avoid cross reactions, only antibodies raised in different species were 
used together. FS sections from animals 71-92 PI were used to validate the technique, as JSRV 
SU positive cells were abundant in most o f these sections. The weakest antibody (ie. the one 
used at the highest concentration) was incubated first for each experiment (Table 4.4).
Dual labelling with anti-JSRV SU and anti-CCSP antibodies showed that tumour foci and 
individual cells were positive for JSRV SU but not CCSP (Figure 4.13, 4.14). Comparison of 
the distinct labelling patterns o f different cell types showed JSRV SU protein located 
predominantly on the surface o f cells, and CCSP in the cytoplasm (Figure 4.13 C,D). Dual 
labelling for synaptophysin and JSRV SU showed virus to be associated with NEBs in the 
alveolar region, but not single NE cells in the bronchiole (Figure 4.15 A,B). As CCSP and SP- 
C antibodies were both polyclonal reagents from rabbits, tissues were incubated with another 
type II pneumocyte marker, anti-DC-LAMP antibody (rat monoclonal) instead o f SP-C. 
(Salaun et al., 2004). These were shown to colocalise in a previous experiment (Appendix 2). 
In some sections, single cells in the bronchiolar epithelium and tumour foci were seen to label 
strongly for both JSRV SU and DC-LAMP proteins (Figure 4.15 C,D). One of these cells was 
located at the BADJ (Figure 4.15G). Cells labelling for SP-C in this region were previously 
identified (Figure 3.3L) and it is where BASCs have been found in mice (Kim et al., 2005). In 
other sections, cells labelled only for JSRV SU and not DC-LAMP, both in the bronchioles 
and the alveolar region (Figure 4.15A, B).
Table 4.4 Summary of antibodies used for dual labelling
First primary 
antibody
Dilution Substrate Second primary 
antibody
Dilution Substrate
anti-SRVSU 1/400 VIP anti-CCSP 1/20 000 DAB
anti-
synaptophysin
1/50 DAB anti-JSRV SU 1/400 VIP
anti-DC-LAMP 1/200 DAB anti-JSRV SU 1/400 VIP
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Figure 4.13 Dual IHC on lungs from experim ental infections. Anti-JSRV SU an tibody , VIP s u b s t r a te  (purple) and 
anti-CCSP antibody , DAB su b s tra te  (brown). (A) Bronchioles w ith  tu m o u r ,  OM xlOO. (B) Respiratory  bronchio le  
with early tu m o u r ,  OM x400. (C) Bronchiole with tu m o u r  in lum en  displaying su r face  staining p a t t e rn  of JSRV 
SU, OM x400. (D) Section com par ing  th e  labelling p a t t e rn s  b e tw e e n  JSRV SU (s trong surface  labelling, faint 
cytoplasm ic  label) and  CCSP (s trong  g ranu la r  cytoplasmic). OM xlOOO.
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Figure 4.14 Dual labelling with anti-CCSP antibody (brown) and anti-JSRV antibody (purple). (A) Respiratory  
bronchio le  with ad jacen t  JSRV SU (purp le  arrow) and  CCSP (b row n arrow ) positive cells, OM x400. (B) 
Respiratory  bronchio le  with s e p a r a te  JSRV SU (purple  arrow) and  CCSP (brow n arrow) positive cells, OM x600. 
Due to  th e  in tensity  of th e  purp le  stain, it is no t possible to  identify if th e s e  cells a re  also expressing  CCSP.
128
<*mrn I) 
%
I
 ^ • Jfc'
*  \  m 
* > 0 » * ^
1
A
/
*
- M
v ^ ~ ~
\
B
- J V *  +  T  '  f t
\
C
i
t
m * ■ * ^
D
Figure 4.15 Double IHC to determ ine the  phenotype of single and clusters of cells positive for JSRV SU. (A)
Alveolar duc t wall: NEB (purple ,  a rrow ) with a s soc ia te d  JSRV SU (brown, arrow) label, OM x600. (B) Bronchiole: 
s e p a r a te  synaptophysin  positive NE cell (purp le  a r ro w  ) and  JSRV SU positive cells (b rown arrow). OM x600. (C) 
Respiratory  bronchiole: DC-LAMP (brown) an d  JSRV SU (purple) bo th  labelling cluster, OM xlOOO. (D) 
Respiratory  bronchiole: DC-LAMP (brown) an d  JSRV SU (purple) bo th  labelling single cell (arrows), OM xlOOO.
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Figure 4.15 (cont.) Double IHC to  determ ine the  phenotype of single and clusters of cells positive for JSRV SU
(E) Bronchiole , c luster of epithelial cells labelling with anti- JSRV SU an tib od y  (purple) bu t no t  anti-DC-LAMP 
an tib od y  (brown), OM x400. (F) Alveolus, single cell labelling for anti-JSRV SU an tibo dy  (purple  arrow ) b u t  not 
anti-DC-LAMP an tibo dy  (brown), OM xlOOO. (G) BADJ: single cell positive for anti-JSRV SU (purp le  a rrow ) and 
DC-LAMP (brown arrow), OM xlOOO
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4.2.7 Identification of JSRV target cell using immunofluorescence
4.2.7.1 Antibody optimisation
While the dual labelling techniques using DAB and VIP chromogens for antigen visualisation 
were effective for detecting antigens in separate cells, the similar hue (brown and purple) 
made it difficult to definitively identify one cell labelling for two antigens. 
Immunofluorescence was chosen as a more sensitive and specific technique to detect multiple 
antigens in the same cell. It also provided the opportunity to localise antigens within the cell 
using a Z stack o f optical sections. Two o f the three primary antibodies of interest were 
derived from the same species (CCSP and SP-C) and so both indirect single colour labelling 
and primary antibody-Fab fragment complexes were used (see section 2.5). Fluorescent labels 
from separate ranges of the spectrum were chosen, and conditions for each antibody were re­
optimised separately (Table 4.5). Multiple labelling was optimised on tissue from JSRV 21 
infected lung 72-91 days PI (Figure 4.16).
Table 4.5 Optimised concentrations of antibody and fluorescent substrates /  Fab fragm ents used for 
visualisation
Primary antibody Original dilution Antigen
visualisation
Dilution for 
immunofluorescence
Antigen visualisation
anti-JSRV SU 1/800 DAB/VIP 1/400 Tyramide Alexa 
fluor®-488
anti-CCSP 1/20000 DAB/VIP 1/1000 Dylight™ 649 Fab
anti-SP-C 1/4000 DAB/VIP 1/2000 Tyramide Alexa 
fluor® 568
anti-
synaptophysin
1/50 DAB/VIP 1/50 Tyramide Alexa 
fluor®-568
Using combinations o f these antibodies, it was anticipated that the phenotypic protein 
expression of single cells expressing virus would be identified. The unexpected type II 
pneumocyte protein expression in cells o f the respiratory epithelium from previous 
experiments (see Figure 3.3L) also raised the question of whether anti-JSRV SU antibody 
might be targeting these cells. Only one cell in all o f the sections examined was found to 
express SP-C and CCSP. It was located at the BADJ o f a respiratory bronchiole in a negative 
control animal (Figure 4.17).
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Figure 4.16 Optimisation of fluorescent antibodies for single and multiple labelling techniques in OPA-E lambs 
72-91 days PI. (A) Respiratory  bronchiole ,  cytoplasm ic labelling of Clara cells. Red: anti-CCSP/Fab 649 frag m en t  
complex.OM  x400. (B) Alveolar region, labelling of NEB. Red: a n t i - sy n ap to p h y s in  visualised with Tyramide- 
56 8 .0M x 40 0 .  (C) Alveolar region, labelling of typ e  II pn eu m o cy te s .  Red: anti-SP-C, visualised with Tyramide-568. 
OM xlOO. (D) OPA tu m o u r  foci. G reen : anti-JSRV SU visualised with T yram id e-48 8 .0 M  x400. (E) OPA in 
bronchio lar  lum en. G reen: anti-JSRV SU, red: anti SP-C, blue:anti-CCSP. OM x200. (D) OPA focus. G reen: anti- 
JSRV SU, red: anti-SP-C, blue: anti-CCSP, yellow: colocalisation of SP-C and  JSRV SU. OM x400.
Figure 4.17 BADJ showing BASC-like cell in a negative control lamb. Red: anti-SP-C. Light blue: anti-CCSP. (A) 
Low p o w er  view to  allow o r ien ta t io n  of th e  resp ira to ry  bronchio le .  Light blue highlights a length of resp ira tory  
ep ithelium .O M  xlOO. (B) is detail of (A), show ing  dual labelling of on e  cell with SP-C (red) and  CCSP (light blue) 
a t  th e  BADJ (arrow).OM xlOOO. Nuclei, DAPI (dark blue).
133
4.2.7.2 Tissue sectioning
SU,SP-C, CCSP
SVN.SU,CCSP
SU,SPC, CCSP
Figure 4.18 Sequential sectioning of lung tissue for multiple labelling using immunofluorescence. Slides from  
sites l a , l b , 2 a , 2 b  and  5a (red dots) w e re  exam in ed  for JSRV SU expression  using DAB su b s tra te .  T h ree  serial 
sec t ions  w e re  cut from th o s e  with JSRV SU expression , and  tr iple labelled with SU, SP-C, CCSP/SYN, SU, 
CCSP/SU, SP-C, CCSP using im m unof luo rescence .
In order to identify suitable tissue sections for immunofluorescence, sections were first 
screened for JSRV SU expression using DAB substrate. Five sections from each of the four 
JSRV2i infected lambs at 10 days post inoculation were examined. Sequential sections were 
cut from those with more than one single cell expressing virus (Figure 4.18). Three serial 
sections were labelled with multiple fluorescently labelled antibodies (Figure 4.16 E,F). The 
aim was to identify the same cell expressing virus in adjacent sections, and determine the 
expression of SP-C, CCSP and synaptophysin proteins.
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4 .2 .7 .3  Results of immunofluorescence
Results are shown in Figures 4.19-4.23. The phenotypes o f a total o f 13 single cells expressing 
JSRV SU were examined. 4/13 of these cells were examined for the expression o f all three 
mature phenotypes, CCSP, SP-C and synaptophysin. O f these 3 labelled for JSRV SU only, 
and one labelled for JSRV SU and CCSP. 2/13 were examined for the expression o f the two 
mature phenotypes CCSP and synptophysin. O f these, both labelled for JSRV SU only. 7/13 
were examined for the expression o f the two mature phenotypes CCSP and SP-C. O f these, 
two labelled for JSRV SU only, two labelled for JSRV SU and CCSP only, one labelled for 
JSRV SU and SP-C only, and one labelled for JSRV SU, CCSP and SP-C. In summary, single 
cells expressing virus either labelled with no other marker, with CCSP, with SP-C or with 
CCSP and SP-C. None o f these single cells labelled with synaptophysin.
Videos o f the Z stacks which correspond to the following figures are shown in the 
accompanying CD. Z stacks are obtained by taking a series of photographs through the section 
at specified thickness intervals. An apotome grid is used for measurement. This enables a 
detailed analysis o f the precise location o f protein expression within the cell. Video 1 
corresponds with Figure 4.19 B/C. Green, anti- JSRV SU. Light blue, anti-CCSP. Dark blue, 
DAPI nuclei. The slide is also labelled with anti-synaptophysin but no positive labelling is 
shown in this section. As the video runs, watch the green labelled cell in the centre. There is 
no evidence o f light blue labelling, in contrast to the adjacent cells lining the respiratory 
epithelium. Video 2 corresponds with Figure 4.21. Green, anti-JSRV SU. Light blue, anti- 
CCSP. Dark blue, DAPI nuclei. Watch the green cell, and colocalisation of JSRV SU with 
CCSP. Video 3 corresponds with Figure 4.22. Green, anti-JSRV SU. Red, anti-SP-C. Viral 
expression is limited to a single cell expressing SP-C in the alveolar region. Video 5 has no 
corresponding figure. It shows another example o f a single cell expressing JSRV SU (green) 
and SP-C (red).
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Figure 4.19 JSRV SU positive cell in respiratory bronchiole, which does not label with CCSP, SYN or SP-C. Serial 
sec t ions  (A) and  (B) from lam b 2852 E. (A) G reen : anti JSRV SU. Red: anti-SP-C. Light blue: anti-CCSP. OM x400. 
(B) G reen : anti-JSRV SU. Red: an ti-synap tophysin .  Light blue: anti-CCSP. OM x400. (C) Detail of B show ing  single 
cell express ing  JSRV SU. OM xlOOO. All nuclei DAPI (blue).  Z stack section on CD: AVI video 1.
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Figure 4.20 Single cell in terminal bronchiole with positive labelling for JSRV SU and CCSP only. Serial sec t ions  
from 2858 E w e re  cut. (A) Terminal b ronchiole .  Red: an ti-synap tophysin .  G reen: anti-JSRV SU. Light blue: anti- 
CCSP. OM xlOO. (B) Red: anti-SP-C. G reen: anti-JSRV SU. Light blue: anti-CCSP.OM x400. (C) Red:anti- 
synap tophysin .  Green: anti- JSRV SU. Light blue: anti-CCSP, OM x400. (D) Detail of (C) OM xlOOO. CCSP 
colocalises with JSRV SU. All nuclei DAPI (blue).
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cFigure 4.21 Single cell in terminal bronchiole expressing JSRV SU and CCSP only. Single sec t ion  from 2856E. 
(A)Light blue: anti-CCSP. (B) Green: anti-JSRV SU. (C) G reen : anti-JSRV SU, light blue: anti-CCSP, red: anti-SP-C 
blue: DAPI nuclei.OM xlOOO. Z stack section on CD:Video 2.
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BFigure 4.22 Single cell in alveolar region labels positively for JSRV SU and SP-C. (A) Alveolar region. G reen  : 
anti-JSRV SU. Red: anti SP-C. The location of th e  JSRV SU positive cell can be clearly seen .  (B) is detail of (A) 
show ing  clear colocalisation of JSRV SU (green) and  SP-C (red) to  a single cell. This sec t ion  w as  ta ken  from a 
lam b 72 days PI as it w as th e  bes t  ph o to g rap h ic  exam p le  of JSRV infecting a typ e  II p n eu m o cy te s .  However, o n e  
similar cell w as seen  in lamb 2856 E 10 days PI. Z stack section on CD: Video 3.
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Table 4.6 Summary of the protein expression of single SU positive cells in lambs 10 days PI. Yes/No d e n o te s  
ex press ion  of p ro te in  as d e te rm in e d  with IHC. Yellow highlight d e n o te s  cells exam ined  for th e  express ion  of all 
t h r e e  ph eno ty p ic  m arkers .  G reen  highlight d e n o te s  cells ex am in ed  for CCSP and  synap tophysin  expression . Blue 
highlight d e n o te s  cells exam ined  for express ion  of CCSP and  SP-C. nd -  no t  d e te rm in ed .  NB. 2844 is a lamb from 
72 days PI. Z stacks can be seen on accompanying CD.
Number Cell
num ber
Location SU CCSP SP-C SYN Figure Z stack
2852 1 R bronchio le Yes No No No 4.19 Video 1
2858 1 T bronchio le Yes No No No
2858 1 T b ronchio le Yes No No No
2858 1 T bronchio le Yes Yes No No 4.20
2858 1 R Bronchiole Yes SI H ■
2854 1 A D Wall Yes B Si
2858 1 R bronchio le |Y|S No No ■
2854 1 T bronchio le Yes Yes j m nd
2856 1 R bronchio le Yes Yes No fid 4.21 Video 2
2856 1 Alveolar d u c t  wall Yes Ife Yes - low Nd
2856 1 Term bronch io le Yes Yes Yes - low Nd
2856 1 Alveolar d u c t  wall Yes No No Nd
2856 1 R bronchio le Yes Yes n| nd
2844 1 Alveolar region Yes No Yes n8 4.22 Video 3
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4.2 .7 .3  Analysis of the phenotype of clusters of JSRV SU positive cells
The phenotype o f clusters of cells (2 or more) found in these slides was also recorded (Figures 
4.23-4.25 and Table 4.7). Clusters o f cells in the bronchi were seen to label for SU and not 
CCSP or SP-C. In the terminal bronchiole clusters were positive for SU and CCSP but not 
synaptophysin (not labelled for SP-C). The respiratory bronchioles contained clusters labelling 
for SU only, SU and SP-C and SU and Synaptophysin.
Z stack sections can be seen on Video 4. This corresponds with Figure 4.23. Green, anti- 
JSRV.Light blue, anti-CCSP. Red, anti-SP-C. The two cells expressing virus do not label for 
the other two markers.
141
Figure 4.23 Respiratory bronchiole showing tw o cells expressing JSRV SU only. Lamb 2854E. G reen  (anti JSRV 
SU). Light blue (anti-CCSP). Red (anti-SP-C). Dark blue (DAPI, nuclei).OM xlOOO. The sec t ion  show s tw o  cells 
express ing  JSRV SU on cell surface  ad jac e n t  to  a Clara cell in a resp ira tory  bronchiole .  A norm al ty p e  II 
p n e u m o c y te  (red) can be se e n  to w a rd s  th e  b o t to m  of th e  sec t ion . Red blood cells a re  show ing  mild g reen  
a u to f luo re scence .  Z stack section on CD: video 4.
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Figure 4.24 Respiratory bronchiole showing tw o cells adjacent to  BADJ (arrow) expressing JSRV SU only. Lamb 
2858 E. Green, anti-JSRV SU. Light blue, anti-CCSP. Red, anti-SP-C. Dark blue, DAPI n u c le i . (A) Low po w er  view 
to  sho w  location of JSRV SU positive cells. OM x 400, (Al) Detail of A. OM xlOOO.
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Figure 4.25 Phenotypic expressions of JSRV SU positive clusters. (A, A l)  Single sec tion from lam b 2856 E of 
resp ira to ry  b ro nch io le /a lveo la r  region show ing  JSRV SU labelling of NEB. Red, an ti-synaptophysin .  G reen, anti- 
JSRV SU. Arrow points  to  NEB to  dis tinguish it from background  a u to f lu o re scen se  of red b lood cells. (B) JSRV SU 
c lus ter  of cells in resp ira to ry  b ronchio le  from  2854E nega tive  for synaptophysin .  G reen, anti-JSRV SU. Red, anti- 
synap tophysin .  Light blue anti-CCSP. (C) Serial sec tion  to  B, show ing  SP-C labelling of s a m e  JSRV SU positive 
c luster. Green, anti-JSRV SU. Red, anti-SP-C. Light blue, anti-CCSP. Dark blue, DAPI nuclei.
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Table 4.7 Summary of protein expression of clusters of cells expressing virus in lambs 10 days PI
Case
number
Number 
of cells 
in
cluster
Location SU CCSP SP-C SYN Figure Z stack
2852 6 R bronchiole Yes Yes
faint
Yes nd
2858 2 R bronchiole Yes No No nd
2858 20 R bronchiole Yes No Yes nd
2858 12 R bronchiole/ADW Yes No No nd
2858 3 Bronchiole Yes No No No
2858 4 R Bronchiole Yes No nd No
2854 3 Alveolar cells Yes No nd No Yes
2854 7 T bronchiole Yes Yes
faint
nd No Yes
2854 2 R bronchiole Yes No nd Yes Yes
2854 2 R bronchiole Yes No No nd 4.24
2854 3 R bronchiole/ADW Yes No nd No
2854 18 R bronchiole/ADW Yes No nd Yes
2854 4 R bronchiole/alveoli Yes No Yes nd
2854 2 R bronchiole/alveoli Yes No nd No
2854 2 R bronchiole Yes No No nd 4.23
2854 4 R bronchiole Yes No Yes No 4.25 B/C
2856 4 R bronchiole/ADW Yes No No Yes 4.25,A/A1
2856 2 Alveolar duct wall Yes No Yes nd
2856 5 R bronchiole/ADW Yes No nd Yes
2856 10 Alveolar duct wall Yes No Yes nd Yes
2856 16 Alveolar duct wall Yes No No nd
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4.3 DISCUSSION
This study has characterised JSRV target cells in vivo, and the results suggest that the virus 
infects multiple cell types within the ovine lung. It is the first experiment to demonstrate in 
vivo expression o f JSRV SU in single epithelial cells and to identify their phenotype. This 
information adds to the understanding of the early stages o f pathogenesis of OPA.
JSRV SU expression was identified in single cells in the respiratory tract 10 days post 
intratracheal inoculation with JSRV21 (Figure 4.10). These cells were located in conducting 
and respiratory airways which included the bronchioles, terminal bronchioles, respiratory 
bronchioles and alveolar ducts. Some cells expressed JSRV SU only and did not co-label with 
the phenotypic markers used (CCSP, SP-C, synaptophysin) (Figure 4.20). Others co-labelled 
with SU and CCSP, with SU and SP-C or with SU and CCSP and SP-C (Figures 4.21-4.23). 
This suggests that JSRV2 ] can infect Clara cells, type II pneumocytes, cells expressing CCSP 
and SP-C, and a cell type which does not express the lineage specific lung markers used in this 
experiment.
Early speculation regarding JSRV target cells was based on the location of tumour nodules. 
These were identified as glandular epithelial cells arising from bronchi, bronchioles, alveolar 
ducts and alveoli (Cowdry, 1925a, b; Cuba-Cuparo A, 1960; de Kock, 1958; Wandera, 1968). 
The later development o f antibodies to label viral proteins and lung epithelial cells allowed 
colocalisation o f virus expression in tumour nodules with SP-C and CCSP. As a result o f this, 
some authors proposed type II pneumocytes and Clara cells as the tumour cells o f origin 
(Beytut et al., 2008; Palmarini et al., 1995; Platt et al., 2002). This principle was explored in 
transgenic mouse models o f lung adenocarcinoma where oncogene expression is linked to SP- 
C or CCSP promoters (Wikenheiser et al., 1992; Wikenheiser and Whitsett, 1997). However, 
unpredictable results which showed varied correlation between promoter phenotype and 
mature tumour protein expression reduce the validity o f this concept (Hicks et al., 2003). 
Nonetheless, the present study found single cells to express JSRV and CCSP or SP-C 
indicating both cell types are targets for the virus.
In order to improve the understanding of lung homeostasis, some studies have concentrated on 
further categorisation of these mature cell phenotypes according to their progenitor potential.
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Lung injury models in mice have identified a subpopulation of ‘variant Clara cells’ which are 
found in stem cell niches at NEBs and the BADJ (Giangreco et al., 2002; Hong et al., 2001; 
Kim et al., 2005; Reynolds et al., 2000) (see section 1.1.5). These cells express CCSP, but 
unlike classical Clara cells they are resistant to naphthalene and have the ability to repopulate 
the damaged epithelium. They also lack the cytochrome p450 enzyme which metabolises 
xenobiotics in normal Clara cells (Singh and Katyal, 2000). Another study in mice which used 
lineage tracing techniques, noted variations in the ability o f Clara cells in postnatal and mature 
animals to give rise to ciliated cells (Rawlins et al 2009). More detailed investigations are 
needed to confirm this finding. Differences between subpopulations o f SP-C expressing cells 
have also been identified (Peers et al., 1990; Perl et al., 2005; Reddy et al., 2004; Roper et al., 
2003; Sigurdson and Lwebuga-Mukasa, 1998). One study used FACS analysis o f rat type II 
pneumocytes following hyperoxic injury to isolate two populations o f cells distinguished by 
their expression o f E-cadherin. E-cadherin negative cells appeared damage resistant, 
proliferative and exhibited high levels o f telomerase activity when compared to E-cadherin 
positive cells (Reddy et al., 2004). It was proposed that they represented a transit amplifying 
population o f type II pneumocytes, which would be responsible for the repopulation and repair 
o f damaged epithelium Additional work is required to see if  any comparable subpopulations 
o f Clara cells and type II pneumocytes exist in the sheep, and if they are specifically targeted 
by JSRV.
Another interpretation o f the mixed tumour phenotype followed the cancer stem cell 
hypothesis (Eramo et al., 2010) (see section 1.1.6) and took this to indicate a stem cell origin 
for OPA (Platt et al., 2002). The theory was strengthened by evidence in mice where an 
oncogenic K-ras model o f lung adenocarcinoma was shown to develop from BASCs residing 
at the BADJ (Jackson et al., 2001). Hyperplasia of these cells was also noted prior to tumour 
development (Kim et al., 2005). The possibility that JSRV might provide a tool to specifically 
target such vital cells in the sheep lung was an exciting concept and led to the search for JSRV 
infected BASC-like cells in sheep. Despite previous evidence o f cells labelling with SP-C in 
respiratory bronchioles where BASCs might be expected (see Figure 3.4B), in these 
experiments very few BASC-like cells were identified (Figure 4.23) and only one cell in over 
30 sections examined was found to express SP-C, CCSP and JSRV SU. This suggests that the 
availability of BASC-like cells in the sheep will not have a big influence on JSRV infection.
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In addition there was no evidence o f preneoplastic BASC hyperplasia which was seen in the 
mouse model (Kim et al 2005). Interestingly since this study began, multiple publications have 
questioned the validity o f SPC/CCSP expression as a method for identifying cells with true 
stem cell properties (Giangreco et al., 2009; Kim et al., 2005; Rawlins et al., 2009; Stripp and 
Reynolds, 2008; Teisanu et al., 2009).
It is important to realise that the cancer stem cell does not have to originate from the 
endogenous stem cell o f the tissue it is growing in (Visvader and Lindeman, 2008). While the 
permanency o f a tissue stem cell does lend itself to an increased risk o f mutation and 
oncogenic transformation, it is also possible that differentiated cells in the tumour can re­
acquire self renewal capacity and stem-cell like properties from later mutations (Clarke et al., 
2006). It could be that the single cell identified which expressed SP-C, CCSP and JSRV SU 
was actually in the process o f dedifferentiating following viral infection. During embryonic 
development in the mouse, progenitor cells in the lung have been shown to express multiple 
lineage markers prior to restricted protein expression in the more differentiated cell lineages 
(Wuenschell et al., 1996). In the context o f OPA both cell origins are possible and further 
investigations are limited until specific markers to identify stem cells in the ovine lung are 
better defined.
A proportion o f the single cells expressing JSRV SU found in this study did not label for any 
o f the three phenotypic markers (Table 4.6). Several hypotheses can be made regarding the 
identity o f these cells. Firstly, they could represent infected Clara cells which are in the 
process o f dedifferentiation and transformation. CCSP is thought to antagonise the neoplastic 
phenotype and reduced expression has been found in multiple solid tumours (Linnoila et al., 
2000). Secondly, they could be an example o f an immature progenitor type cell, as respiratory 
epithelium in the lungs of 16 day old lambs is still in the process of differentiating (see Table 
3.4). Comparable cells may have been identified in the mouse lung following injury (Evans et 
al 1978). In that study, a population o f intermediate type A Clara cells, distinguished by their 
lack o f secretory granules and smooth ER, were identified and seen to increase dramatically in 
response to injury. As ciliated and Clara cells repopulated the epithelium, their numbers 
subsequently declined (Evans et al 1978). A final theory is that they could be an example of an 
as yet undefined population o f progenitor cell in the ovine lung. Recent work with human lung
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cancer has used the membrane antigen CD 133+ to isolate a rare population of cells with stem 
cell properties from tumours. These cells also lacked any lineage-specific lung cell markers 
(Eramo et al., 2008). In the current study, efforts were made to optimise antibodies to label the 
potential stem cell proteins CD34, Oct-4 and CD 133+. Unfortunately it was not possible to 
optimise any of these on sheep tissue (see Table 2.3). A summary of possible cellular 
transformation events following JSRV infection of target cells is shown in Figure 4.26.
JSRV
JSRV in fec ts  Clara cell 
or type II p n eu m ocyte
©
2 .
D ed ifferen tia tion  in to BASC cell
3.
D ed ifferen tia tion  into stem  
cell and tu m our grow th  w ith  
SP-C exp ression
Figure 4.26 Schematic diagram to show possible target cells for JSRV infection in the ovine lung. 1. JSRV 
infects d if fe ren t ia ted  cells with p rog en i to r  capabilit ies Clara cells and  ty p e  II p neu m o cy te s .  2. JSRV infects BASCs 
3. JSRV infects s te m  cell with no phen o typ ic  m arkers .  Infection of all th e s e  po ten t ia l  ta rg e t  cells resu lts  in cancer  
s tem  cell fo rm ation  and  tu m o u r  g row th  with SP-C expression .
The phenotype of neoplastic clusters were also interesting to examine as they differed from
some o f the published literature on OPA. Over half of the 21 foci between 2-16 cells in
diameter did not label with other differentiated cell type markers (Table 4.8). This is in
contrast to other IHC studies of mature tumours where most tumours were found to express
SP-C or CCSP (Beytut et al., 2008; Platt et al., 2002). 6/21 foci located in respiratory
bronchioles and alveoli labelled positively for SP-C. One of these also showed faint CCSP
expression. Similarly, other IHC studies on OPA have also demonstrated a greater positivity
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for SP-C than CCSP within heterogenous mature tumours (Beytut et al., 2008; Platt et al., 
2002). In contrast, examination o f the K-ras induced mouse model o f lung adenocarcinoma 
found dual positive CCSP and SP-C cells in the centre of tumours, which were continuous 
with the terminal bronchiolar epithelium (Jackson et al., 2001; Kim et al., 2005). This was not 
seen in OPA-E tumours. 3/21 foci labelled positively for synaptophysin were visually assessed 
(Figure 4.25 A), and this is the first demonstration o f neuroendocrine marker expression in 
OPA. It is uncertain whether these represent transdifferentiated tumour cells, or whether the 
tumour has grown around existing NEBS. Although more commonly found in small cell 
carcinomas, neuroendocrine differentiation has been recorded in human adenocarcinomas of 
the lung (Ionescu et al., 2007).
Up until this point, the assumption has been made that all single cells expressing virus 
represent JSRV target cells. However, there is a possibility that not all o f the cells identified 
will continue to support viral protein expression and develop into tumour nodules. Instead 
virus expression may be subsequently repressed, leaving the cell to function normally. 
Alternatively these infected cells could apoptose, although there is no morphological evidence 
o f this on H and E examination. In vitro models for JSRV transformation have demonstrated 
marked variations in transformation efficiency between cell lines (Palmarini et al., 2000a).
This has been attributed to the preferential activity o f JSRV LTRs in specific cell types which 
contain the appropriate transcription factors required for viral replication (McGee-Estrada and 
Fan, 2006, 2007; McGee-Estrada et al., 2002; Palmarini et al., 2000a). Similar requirements 
are likely for successful replication in vivo. In addition as demonstrated for other retroviruses, 
restriction factors may have a role in inhibiting viral expression and transformation in vivo 
(see 1.3.4).
From the data obtained in this study it appears that JSRV can infect multiple cell types in the 
ovine lung. Whether there are variations in the efficiency of virus expression between the 
different cell types is unknown from these experiments, and warrants further investigation.
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CHAPTER 5 JSRV INFECTION AND THE HOST CYTOKINE 
RESPONSE
5.1 Introduction
This chapter continues the investigation into the early stages of OPA pathogenesis by 
examining the host innate response to infection with JSRV in terms o f cytokine expression. 
How a virus interacts with the innate immune system plays a central role in determining the 
eventual outcome o f infection. This is both through the immediate effect o f the innate 
response and by the influence it has on the downstream adaptive response. Ideally for the host, 
Pattern recognition receptors (PRRs) identify viral components (pathogen associated 
molecular patterns), and trigger a cytokine signalling cascade to limit virus spread and attract 
innate immune cells (see section 1.3.5). Antigen presenting cells then prime the adaptive 
immune response and the virus is eliminated (Takeuchi and Akira, 2009). In return, viruses 
have adapted by developing various mechanisms o f immune evasion which include virus 
encoded factors to affect cytokine activities (Haddad, 2002; Hansen and Bouvier, 2009; Lee et 
al., 2009).
The importance o f the innate response in controlling infection by other respiratory viruses 
such as Respiratory Syncytial Virus (RSV) and Influenza is well recognised. Experiments 
show that the balance between virus elimination and disease pathogenesis is dependent on the 
spectrum of cytokine release from infected epithelial cells (Bueno et al., 2008; Julkunen et al., 
2000; Tripp et al., 2005). For retroviruses, there is little information regarding these initial 
stages o f infection in the literature (Browne and Littman, 2008) and the need for further work 
in this area has recently been acknowledged (Mogensen et al., 2010; Pereira and Ansari,
2009). Similarly, for JSRV understanding of this process is incomplete. There have been no 
detailed investigations into the innate response, and studies have been unable to demonstrate 
robust evidence o f a JSRV specific adaptive immune response (Ortin et al., 1998; Summers et 
al., 2002; Summers et al., 2005).
This chapter used quantitative real-time reverse transcriptase polymerase chain reaction 
(qRTPCR) to measure the expression of a number o f inflammatory cytokines and chemokines
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in the lungs and mediastinal lymph nodes of infected animals. Samples were taken at three 
time points post experimental infection of lambs with JSRV21 and from naturally infected 
sheep. Cytokine mRNA levels were compared with age matched controls at each time point, 
and correlated with the stage of disease using histological examination of adjacent tissue 
sections.
5.2 Methods
5.2.1 Sam ple collection and storage
The host response to JSRV infection was assessed in lung samples from experimentally and 
naturally infected animals (see section 2.1). Lung and lymph node tissue was collected from 
SPF lambs inoculated with JSRV 21 at 6 days old, and euthanased 3, 10 and 72-91 days later. 
Age matched mock-infected and non-infected lambs were included as negative controls. 
Naturally infected adult sheep with clinical signs of OPA were collected from local farms, and 
lung samples were chosen from those with minimal gross evidence of secondary lung 
infections on post mortem examination . Adult negative control animals were obtained from a 
flock free of OPA for five years. A total of 12 lungs from experimentally infected lambs and 4 
from naturally infected sheep with age matched controls were examined (Figure 5.1).
B orn
In o c u la te d
1
6 d
Group 1 
JS R W  *  12
Group 2 
293T SN x 8
Group 3 
Non-inoculated x 6
Group 4 
Natural Infections
C lin ica l s ig n s  a n d  tu m o u r s
► A g e
9d 1 6d 7 2 d 7 7 d 9 1 d
□  □ □  □ □ □ □
□  □ □  □ □
□ □ □ □ □
□ □ □
■ ■ ■
■ ■ ■
Figure 5.1 Summary of animals sampled to  investigate cytokine response to infection with JSRV. Each 
co loured  box re p re se n ts  th e  PME of o n e  animal. Red: JSRV infected. Blue: mock  inocula ted . G reen: controls.
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Tissue samples were dissected from 24 fixed sites in each lung (see section 1.4). They were 
immediately placed in labelled cassettes and snap frozen in liquid nitrogen, before long term 
storage at -80 °C.
Figure 5.2 Summary of tissue sampling process before RNA extraction. 24 sites w e re  sam p led  from each  lung, 
an d  sn ap  frozen in liquid n itrogen.
5.2.2 RNA extraction and purification
For each lung, tissue from sample sites la, lb, 2a, 2b and 5a and mediastinal lymph nodes, 
were analysed. RNA was extracted from cryostats using the RNeasy mini kit (Qiagen), and 
any residual DNA was removed with DNase digest kit (Qiagen) (section 1.5). The quality of 
RNA was assessed using Agilent chip technology, and only samples with a RIN > 8 were 
included (appendix). A Nanodrop spectrophotometer was used to confirm the purity of the 
sample and measure the concentration of RNA extracted.
Figure 5.3 Procedure for RNA extraction and analysis. RNA w as ex trac te d  from c ryos ta ts  using an RNeasy kit 
and  ana lysed  using Agilent chip and  n a n o d ro p  systems.
• • • • •  * • • • •  *
QIAGEN
1 5 3
5.2.3 Establishment of reference genes for qRTPCR
For precise comparison o f mRNA transcription levels between samples, results from the 
qRTPCR experiments were normalised to a fixed reference. Firstly, different reference genes 
were compared in order to select two stable reference genes for lung and lymph node tissue 
using the programme geNorm (Vandesompele et al., 2002). The use o f multiple reference 
genes increases the accuracy o f detecting small expression differences in candidate genes.
5.2.2.3 geNorm analysis
geNorm was used to assess the stability o f five common reference genes, with different 
functions, in normal and OPA lung and lymph node (Figure 5.4). RNA for analysis was 
extracted from a variety o f normal and diseased lung and lymph node tissue. qRTPCR was 
performed to determine mRNA levels o f P-actin (ACT B), succinate dehydrogenase (SDHA), 
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta polypeptide 
(YWHAZ), beta-2-microgloublin (M2G1) and glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH).
Ct values were transformed into relative quantification data by subtracting the highest Ct value 
from all other Ct values for each gene measured. This provided a delta Ct value, with the 
highest delta Ct value as 0, and all other values less than this. Then for each data point, the 
equation 2(‘delta Ct) was applied. Therefore all data were expressed relative to the expression of 
the least expressed gene. These values were inserted into the geNorm Excel file, and analysis 
assigned an M (stability) value to each gene based on expression variation between tissues, 
where the lowest M value indicates the least variation/most stable. The two most stable were 
identified for each tissue (Figure 5.4). ACTB and SDHA showed the least expression variation 
in lung tissue, and ACT B and YWHAZ in lymph node tissue. These were therefore chosen as 
reference genes for each tissue type respectively.
154
A
1 7
I 5
1 3
co
a.
<
07
05 -----
GAPDH
SDHA
< ™  L » J '.t  i t a b l t  g » n » i  M o it '.tob l*  g»r>**. :~>
B
08
0 75
2  0 65
0 55
«  045
04
0 35
SDK* M ? glob GAPDH ACT B
VWHAZ
L*ast stobl* g*n#s M o tt stable g en e s
Figure 5.4 geNorm analysis to determine the stability of reference genes in normal and diseased lung (A) and 
lymph node (B) tissue. T hese  charts  ind icate  th e  av e rage  express ion  stabil ity value (M) for re fe re n c e  g e n e s  at 
each  s tag e  during  s tep w ise  exclusion of th e  least s tab le  ex p re s sed  re fe re n c e  gene .  The leas t  s tab le  is on th e  left, 
and  th e  m o s t  tw o  s tab le  on th e  right.
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5.2.4 qRTPCR candidate g en e  analysis.
mRNA levels of JSRV and 15 cytokines were analysed by qRTPCR (Table 6.5). Primer 
sequences were taken from published literature (see Table 2.6) and reaction conditions were 
optimised using RNA from positive control samples (Li et al., 2008; Palmarini et al., 1996). 
These included plasmid DNA constructs, con A stimulated PBMCs and transfected cell lines 
expressing the gene of interest (see section 2.4.1). RNA from lung samples from all eight 
animals at each time point were examined on separate 96 well plates. Five samples were 
analysed per animal, and each was run in duplicate on a single plate (Figure 5.5). A dilution 
series of positive control RNA and water acted as positive and negative controls on every 
plate. All lymph node samples were run in duplicate and fitted onto one plate per primer set.
l a  l a  l b  l b  2a 2a 2b 2b 5a 5a Standards
Infected
Infected
Infected
<§>
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0000000000 ( § ) ( § )  ®®®®®®®®®®®® ®®®®®®®®®®oo
®®®®®®®®®®0O 
® < § > ® ® ® ® ® ® ® < § >  (§)<§)
Figure 5.5 Arrangement of samples on 96 well plate. Each horizontal row  con ta ins  five sam p les  from  on e  
animal. Control (green), mock infected  (blue) and  infec ted  (red) anim als .  Each vertical row co n ta in s  sam p les  
tak en  from th e  s a m e  lung sam pling si te  ( la -5a ) .  An RNA dilution ser ies  (purple) and  w a te r  (clear circles) w e re  
included as positive and  negative  controls .
156
Table 5.1 Summary of cytokines examined and their actions
Cytokine Im m une response 
type
Source in the  lung Action Reference
IFN
gam ma
T h l-c e l lu la r  
immunity
T c e lls , NK cells and 
macrophages
Drives CD 8 cells (Fukuyama et al., 
2007)
IL-2 T h l T  cells, dendritic cells Induces proliferation of CD 4 and CD 8 cells. (Granucci e t al., 
2002; Tripp et al., 
2005)
IL-4 Th 2 -  humoral 
immunity
T-cells, mast cells, bone m arrow  
and stromal cells
Differentiates naive T cells into Th2 cells, 
induces proliferation and isotype switching of B 
cells
(Haddad 2002)
IL-6 Th 2 T-cells, B-cells, 
monocytes/macrophages, 
fibroblasts, endothelial cells, 
stromal cells
Multifunction cytokine, regulates T and B cell 
functions and acute phase reactions. Increases 
malignancy in lung tumours
(Haddad 2002  
(Schafer and 
Brugge, 2007)
IL-10 Th 2 T-cells, monocyte/macrophages, 
B-cells
Blocks cytokine synthesis by T h l cells, activates 
monocytes, NK cells, enhances B cell 
proliferation ie. Im m unostimulatory and 
immunosuppressive
(Hatanaka et al., 
2000)
IL-18 T h l, Th2 Macrophage, T cells, B cells, 
dendritic cells
Enhances IL-12 driven T h l response, can also 
stim ulate Th2 when IL-12 not there.
(Nakanishi e t al., 
2001)
MCP-1 na Tumour Monocyte chemoattractant (Fujimoto et al., 
2009)
TGF-beta M ultifunctional M ultiple cell types Inhibits lymphocyte proliferation. Inhibits 
proliferation and promotes differentiation in 
the lung
(M oreno e t al., 
1998)
TNF
alpha
T h l Monocytes/macrophages, T- 
cells, B-cells fibroblasts, 
neutrophils, NK cells, 
endothelial cells
M ediates inflam m atory and im m une functions. 
Can be pro angiogenic or anti vascular at high 
doses for tumours
(Haddad 2002)
GM-CSF NA Lung cancer epithelial cells, 
endothelial cells, 
fibroblasts,macrophages
Expands immunosuppresive tum our associated 
macrophages, tum our cell proliferation and 
angiogenesis.
(W hiteside 2006)
IDO Anti-
viral/imm unoregula
tory
Multiple cell types Suppresses T cell responses (Whiteside 2006  
M ellor and Munn  
2004)
IFN alpha Anti viral 
/antiangiogenic
T-cells, B-cells, 
monocytes/macrophages, 
fibroblasts, epithelial cells
Anti-viral activity (Persano et al 
2009)
IL-8 Chemokine, 
angiogenic factor
Monocytes, T-cells, fibroblasts, 
endothelial cells, neutrophils 
and epithelial cells
Neutrophil chem oattractant, growth factor for 
lung cancer cells
(Zhu et al., 2004)
IL-1 beta NA Monocytes/macrophages, 
endothelial cells, fibroblasts,, 
keratinocytes, epithelial cells, 
dendritic cells, NK cells, T-cells 
and B-cells
Locally affects cells involved in inflammation, 
injury or infection. Pro- inflam m atory and 
im m unoregulatory
(Fan et al., 2004)
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5.3.1 Histological analysis of experimental samples
In order to understand which cell types might be involved in cytokine production, a basic 
histological assessment on H and E stained sections was made for tissue from each time point. 
Tissue was taken from each animal at the same five locations as those taken for RNA 
extraction and examined histologically. The sections were assessed by eye for desmoplasia, 
tumour area and cellular infiltrates o f lymphocytes, neutrophils and macrophage (Table 5.2). 
These were graded from 0-4 , increasing in intensity.
Table 5.2 Histopathological scoring of lung tissue for evaluation of infiltrating cell types and tumour 
pathology. Absent (-), mild (+), moderate (++), marked (+++).
Desmoplasia Macrophages Lymphocytes Neutrophils Necrosis Tumour
area
3 days PI (-) (-) (-) (-) (-) (-)
10 days PI (-) (-) (-) (-) (-) +
8 weeks PI + + + + (-) ++
Natural
infections
++ +++ ++ ++ (-) +++
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5.3.2 Candidate gene analysis
JSRV RNA was detected in the lung tissue o f all infected animals at 10 days PI, lung tissue 
and lymph nodes o f all at 72-91 days PI, and o f all naturally infected OP A animals. JSRV21 
infected lambs 3 days PI and all mock/control animals were negative for JSRV expression. 
These results correlated with the IHC findings where JSRV SU was identified in lung tissue 
from the same individual animals and sites (section 4.2.2).
A total o f 14 cytokines (Table 5.1) were examined at 3 days, 10 days and 72-91 days PI. 
Exceptions were that IL-2 and IL-4 were not examined at 3 days PI and IFN alpha was not 
examined at 10 and 72-91 days PI. mRNA levels o f cytokines were quantified using the Pfaffl 
method (Pfaffl, 2001). This measures the relative expression of a target gene versus a 
reference gene. The relative expression software tool REST was used to analyse the data as 
this includes multiple reference genes and efficiencies for each candidate gene (Pfaffl et al., 
2002) (see section 2.5.8). The results are based on the permutated expression data, not simply 
the raw Ct values, and are presented in whisker box plots (Figures 5.6-5.9). Each box area 
encompasses 50% of the observations, and the other 50% lies within the whiskers. The dotted 
line represents the median value. If one tail is longer than the other, then data is skewed in that 
direction. For each time point, cytokine expression was initially compared between mock 
infected and uninfected control animals. As no significant differences were seen between these 
groups, they were combined and compared as a single control group to infected animals.
The REST programme also performs a statistical test on the analysed C t values using a Pair- 
Wise Fixed Reallocation Randomisation Test© (Pfaffl, 2001). This provides a P value 
(standard error <0.005 at P=0.05) to assess the significance o f the expression ratio value given. 
The changes in mRNA detected are presented in the legends to Figure 5.6-5.9 and summarised 
in Table 5.3. In addition, IHC was used to identify the cellular location o f IL-8 protein which 
was seen in neutrophils in OPA-E, and tumour cells, neutrophils and macrophages in OPA-N 
cases (Figure 5.10).
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Figure 5.6 Whisker box plots of relative amounts of cytokine mRNA in lung (A) and lymph node (B) of JSRV 
infected vs mock/uninfected animals at 3 days PI. (A) TGF b e ta  mRNA w as  red u ce d  by a m ean  fac tor  of 0.63 
(1.6 x) in lung tissue  (B) No significant ch an ges  d e te c te d  in lymph node .  P lease n o te  d if ference  in scales on th e  Y 
axis b e tw e e n  th e  tw o  graphs .
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Figure 5.7 Whisker box plots of relative cytokine expression in lung (A) and lymph node (B) tissue 10 days PI 
with JSRV2iVS. mock/uninfected animals. (A) Levels of cytokine mRNA w e re  red u ce d  for TGF b e ta  by a m ean  
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in lymph n o d e  tissue. Please n o te  d if ference  in scales on th e  Y axis b e tw e e n  th e  tw o  graphs.
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Figure 5.9 Whisker box plots of relative cytokine expression in lung (A) and lymph node (B) tissue from 
naturally infected animals vs. control group. (A) Increased  cy tokine mRNA w as  found  for GM CSF (xl5), IDO 
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Figure 5.10 IHC showing labelling for IL-8 in lungs from OPA-N and OPA-E . (A) Positive contro l tissue, ovine 
p lacen ta  with Chlamydial infection. Brown labelling indica tes  an tigen ,  OM xlOO. (B-D) T um ou r  from  OPA-N. (B) 
Labelling of neu troph il  c lusters and  p e r i tum ou ra l  m ac ro p h ag es  and  neu troph ils  (arrows) OM xlOO. (C) 
Cytoplasmic labelling of neoplas tic  cells (left) and  m a c ro p h ag es  (arrow) OM x200. (D) Labelling of neoplas tic  
cells (arrow) OM x200. (E and  F) OPA-E show ing  positive labelling of in t ra tum o ura l  neu troph ils  (arrow)(E) OM 
x400, (F) OM x600 .
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5.4 DISCUSSION
This is the first study to describe a preliminary investigation into the innate immune response 
to JSRV. The aim o f the experiment was to see how the host innate response varied at 
different stages o f disease pathogenesis. mRNA levels o f JSRV and 14 inflammatory 
cytokines and chemokines representative o f innate, cell mediated and humoral responses and 
tumour growth regulation were analysed by qRTPCR at early and late time points following 
inoculation. These levels were compared to samples from age matched control animals. 
Corresponding histopathology was also recorded.
There was no change detected in levels of cytokine mRNA at 3 days PI (Figure 5.6 A). By 10 
days, all infected lung samples were positive for JSRV mRNA. No inflammatory cell infiltrate 
was seen on histological examination but decreases in IL-2 and IDO mRNA were detected 
(Figure 5.7A). IL-2 can be produced by activated T lymphocytes and dendritic cells (APCs) 
and is involved in differentiation and survival o f cytotoxic T cells and immune cell 
differentiation (Granucci et al., 2002). IDO is an immunomodulatory enzyme which degrades 
the essential amino acid tryptophan and has the potential to inhibit viral growth (Munn and 
Mellor, 2007). Another retrovirus (HIV) has been shown to modulate IDO expression 
(Maneglier et al., 2009), but the mechanism and effect o f reduced mRNA levels at this time 
point is uncertain.
By 72-91 days PI, increased levels o f JSRV mRNA were detected in all infected samples. 
Histology identified scattered tumour foci with small numbers of peritumoural macrophages, 
intratumoural lymphocytes and occasional neutrophils (Table 5.2). Concomitant increases in 
GMCSF, IL-8 and MCP-1 mRNA, all cytokines known to promote tumour growth through 
angiogenesis and macrophage recruitment, were detected (Figure 5.8A). Macrophages are 
generally regarded as being essential for tumour progression, playing key roles in 
angiogenesis, cell survival and metastasis. Increased numbers in some human tumours 
correlates with a poor prognosis (Lewis and Pollard, 2006; Sica et al., 2008). Levels of 
mRNA for the pro and anti-inflammatory cytokine IL-6 were also increased at this time point. 
Any cytokine with less than a 2-fold change was not regarded as significant in this study. 
However, if  this had been accepted then additional findings were small raises (<2 fold) in TH1 
cytokines IL-2 and IFN gamma mRNA, and a reduction (<2 fold) in TH2 cytokine IL-10.
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These levels of cytokine mRNA could reflect activation and proliferation o f T cells and the 
early stages o f an adaptive response, but whether this is in response to tumour or viral antigen 
is unknown.
In tissue from natural infections histological examination found large areas of tumour, with 
dense patches of infiltrating neutrophils, lymphocytes and peritumoural macrophages. The 
most dramatic change in cytokine mRNA was a 207- fold upregulation o f IL-8 (Figure 5.9A). 
The presence o f neutrophils seen on H and E and their positive IHC labelling for IL-8 (Figure
5.10 A-C), supports the original classification o f IL-8 as a neutrophil chemoattractant with 
inflammatory activity (Baggiolini et al., 1989). However, IL-8 has also been shown to play an 
important role in tumour progression and metastasis (Yuan et al., 2005). In support o f this, 
IHC showed positive labelling for IL-8 in tumour cells and infiltrating macrophages (Figure
5.10 C,D). IL-8 is now recognised as a potent angiogenic factor in several cancers including 
non-small cell lung cancer (NSCLC) in humans, and increased levels are associated with 
angiogenesis, tumour progression and poor survival. IL-8 also stimulates tumour associated 
macrophages to secrete growth factors (Waugh and Wilson, 2008). Studies on OPA conducted 
in the 1980’s were able to identify a factor released by tumour cells into the supernatant, 
which stimulated chemotaxis o f both alveolar macrophages and blood monocytes (Myer et al., 
1987b). When normal alveolar macrophages were cultured with this supernatant the cells were 
stimulated to produce another ‘factor’ (Myer et al., 1987a). It is tempting to speculate that this 
‘factor’ may have been IL-8.
Naturally infected lung samples also showed increased detection o f GMCSF, IDO and IFN
gamma mRNA. In humans IDO activity is increased in lung cancer patients. It is expressed by
cancer cells and tumour infiltrating antigen presenting cells, and increasing sera levels have
been shown to correlate with disease progression (Karanikas et al., 2007; Suzuki et al., 2010).
IDO acts to inhibit T cell proliferation, induce T cell apoptosis, modify natural killer cell
function and enhance local Treg immunosuppression all o f which lead to immune tolerance o f
the tumour (Munn and Mellor, 2007). IFN gamma has a variety o f functions including
antiviral, immunoregulatory and anti-tumour effects. It has also been shown to induce IDO
expression (Mellor and Munn, 2004). There was decreased detection o f IL-1 beta mRNA in
OPA-N, which is an immunoregulatory and proinflammatory cytokine secreted by a variety of
activated immune cells (Fan et al 2004), along with interferon alpha, which has potent
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antiangiogenic properties (Persano et al., 2009). Smaller reductions in mRNA levels of TNF 
alpha, IL-4 and IL-2 suggest a lack of cell mediated or humoral response at this stage of 
disease.
While JSRV mRNA expression was detected in all mediastinal lymph nodes 8 weeks PI and 
naturally infected animals, only those of the naturally infected animals showed changes in 
cytokine mRNA levels (Figure 5.9B). Here there were increases in IL-8 and IL-6 (P<0.06) 
mRNA and a decrease in IL-4 mRNA. IHC showed infiltrating neutrophils in the lymph nodes 
to label for IL-8, and this could explain the increase in detection of IL-8 mRNA. A summary 
of cytokine changes in naturally infected animals, including the stage of disease pathogenesis 
they might be detected in is shown in Figure 5.11.
Figure 5.11 Summary of possible cytokine interactions following JSRV infection of a lung epithelial cell.
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O f the cytokines examined, the biggest changes in mRNA expression ratios were seen in those 
known to promote tumour survival during the later stages o f disease pathogenesis. Early virus 
expression was not accompanied by cytokine release or cellular infiltrate. In fact, at no point 
was there strong evidence of an adaptive immune response being made to viral antigen either 
detected by marked cellular infiltrates or increases in mRNA of cytokines commonly 
associated with TH1 or TH2 responses (Table 5.3).
qRTPCR analysis has been used previously to successfully quantify levels o f cytokine mRNA 
in the sheep (Budhia et al., 2006; Garcia-Crespo et al., 2005; Li et al., 2008; Ryan et al., 2008; 
Smeed et al., 2007). As it involves an exponential amplification o f the gene of interest, the 
capacity to detect small changes in gene expression is maximised (Budhia et al., 2006). 
Sensitivity in this study was also enhanced by the use o f multiple reference genes with tested 
stability, for data normalisation (Vandesompele et al., 2002). To further ensure reliable results, 
the experiment was carried out following the Minimum Information for Publication of 
Quantitative Real-Time PCR Experiments (MIQE) guidelines (Bustin et al., 2009).Despite 
these strict control measures, conclusive interpretation o f mRNA cytokine levels is still a 
challenging task (Tripp et al., 2005), and there are certain limitations o f the technique which 
must be recognised.
Cytokines are produced by a variety o f cell types, frequently as part of a cascade, and act
synergistically or antagonistically with autocrine and paracrine effects (Haddad, 2002).
Measurements must take into account the short half-life and variable timing o f peak
expression post stimulation which is cytokine specific. It may be that the timing o f sampling in
this study did not reflect the maximum fluctuations in mRNA production. In addition, a broad
range of cellular material was included in each tissue sample and it was not possible to assign
changes in cytokine levels to particular cell types (apart from IL-8). This mix o f cell types
could also mean that detected changes in mRNA levels may not be due to upregulation or
downregulation o f mRNA, but simply that a different cell phenotype with a higher or lower
baseline level of mRNA has been sampled. Alternatively, if  only a few cells were affected,
expression changes may have been diluted as RNA extraction was from a whole cross section
of lung. Finally, interpretation o f the qRTPCR data in this study has assumed that levels of
cytokine mRNA correlate with protein production and cytokine release. However, recent work
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has highlighted methods o f post-transcriptional control which act to regulate nuclear export, 
cytoplasmic localisation, translation initiation and mRNA decay (Anderson, 2008). These 
mechanisms are used to coordinate inflammatory responses, turning them on and off more 
rapidly than would otherwise be possible by transcriptional control alone. Post transcriptional 
regulation o f the majority o f cytokines used in this study has already been reported (Anderson, 
2008). Methods to detect protein production eg. IHC would allow accurate correlation of 
mRNA levels with active cytokine release in this study.
To summarise the findings in this chapter, it appears that a majority o f the cytokine response is 
related to tumour survival, with little evidence o f a host response to virus expression. Further 
work should concentrate on looking at expression o f a broader range o f cytokines. Type I 
interferons are the key cytokines produced after a viral infection, and they coordinate 
additional innate responses and subsequent adaptive responses (Kawai and Akira, 2006). 
Future experiments should examine these cytokines in the early stages o f disease, as 
techniques for evasion o f the IFN related innate antiviral response have been reported for other 
viruses (Yoshikawa et al., 2010).
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CHAPTER 6 GENERAL DISCUSSION AND CONCLUSIONS
Ovine pulmonary adenocarcinoma is a fatal respiratory disease o f adult sheep. Since the first 
reports in the 19th century, research has successfully identified many important aspects o f 
disease epidemiology and pathogenesis. However, a detailed analysis o f the early stages of 
infection has not yet been described. The aim o f this thesis was to examine some o f these early 
interactions between JSRV and its ovine host. There were two main objectives. The first was 
to identify the target cell for JSRV infection in the lung, and the second to investigate the 
cytokine response to virus expression and tumour growth.
An experimental model o f OPA was used to provide tissue for analysis which included these 
initial stages o f pathogenesis (see 2.1). 6 day old SPF lambs received an intratracheal 
inoculation with an infectious molecular clone, JSRV2 1 . The lambs were euthanased 3, 10 and 
72-91 days afterwards. IHC techniques to identify the phenotype o f specific cells in the lung, 
and virus expression were then optimised (see 3.2 and 4.2). These methods were combined 
and applied to lung tissue from lambs 10 days post inoculation. Analysis of the phenotype of 
single cells expressing virus indicated that JSRV has multiple target cells in the ovine lung 
(see 4.2). Levels o f cytokine mRNA were then measured in a range o f lung samples (see 5.2). 
These were collected 3 and 10 days post inoculation (pre and post viral expression 
respectively) and between 72-91 days PI when tumour growth was prominent. Tissues from 
advanced field cases of OPA were included for comparison. Levels of cytokine mRNA 
remained unaffected by viral inoculation and early virus expression. However changes were 
seen in samples with prominent tumour growth, particularly in lungs from field cases o f OPA. 
This was primarily noted for cytokines known to promote tumour survival.
The first experimental chapter concentrated on developing IHC techniques for respiratory
epithelial cell identification in the ovine lung. These cells examined were ciliated epithelial
cells, Clara cells, NEBs and type II pneumocytes. The specificity o f antibodies was
determined in several ways. For ciliated epithelial cells and Clara cells histochemical stains
were used to highlight the morphological appearance o f these cells prior to antibody labelling
(Figure 3.2). For type II pneumocytes, SP-C specificity was confirmed by demonstrating
colocalisation o f labelling in the same cells with another published type II marker DC-LAMP
(Salaun et al., 2004). A number o f antibodies were evaluated to label NEBS (Table 2.3), but
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only synaptophysin was successful. A study on human lung tissue also found synaptophysin to 
be the most reliable marker o f neuroendocrine differentiation (Kasprzak et al., 2007). The 
unique morphology o f NEBs, and positive control tissue containing other neuroendocrine 
cells, validated the specificity o f this antibody. Inclusion of anti-aquaporin-5 antibody to label 
type I pneumocytes (Warburton et al., 2000) and anti-surfactant protein B antibody, which is 
expressed by both Clara cells and type II pneumocytes (Beytut et al., 2008), would have made 
this analysis more complete. Unfortunately the timescale of the project did not allow for this.
These techniques were initially developed to provide a tool for analysis of the JSRV target 
cell. However during the optimisation procedure on control lungs from experimental lambs, 
variations in protein expression were noticed between the age groups, and the possibility that 
these cells were undergoing postnatal cytodifferentiation was introduced. These observations 
were confirmed using Image J to numerically quantify IHC labelling for CCSP and beta 
tubulin (Figure 2.4). Protein expression in the bronchi, bronchioles, terminal bronchioles and 
respiratory bronchioles was examined in lung tissue from 9, 16 and 91 day old lambs. 
Increased protein detection was taken as an indicator o f cell maturation, which was found to 
be both age and site specific. Maturation o f ciliated epithelial cells was unchanged between 9- 
16 days, but showed an increase in all regions o f the lung by 91 days. In contrast, Clara cells 
appeared to mature earlier in the proximal airways (bronchioles) than the distal ones (terminal 
and respiratory bronchioles). Populations o f NEBs and type II pneumocytes were counted 
manually, but no significant changes were observed within these time points.
To complement this analysis o f postnatal maturation the same samples were used to assess the 
proliferative state o f different anatomical areas. The number o f cells expressing Ki-67 were 
calculated as a percentage o f the total number o f cells in each of five predefined regions o f the 
lung, to give the proliferative index o f the epithelium in that area. Interestingly the biggest 
change was seen in the alveolar compartment where the proliferation index decreased between 
16 and 91 days. As this calculation included all cell types in the region, it was thought to be 
due to a decrease in microvascular maturation, which has been identified as the final stage of 
lung maturation in other animals (Burri, 2006). Smaller but still significant reductions were 
seen in the bronchi, bronchioles and terminal bronchioles over the same time period. These 
measurements were o f epithelial cells only, and likely reflect a decrease in growth rate o f each
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anatomical structure. However, the lack o f samples between these time points may have failed 
to detect more dramatic changes in the proliferative index o f these regions.
These techniques to identify and quantify epithelial cells in the ovine lung can now be applied 
to aid investigations into the pathogenesis of ovine respiratory disease. They will also be 
helpful for further analysis of progenitor cell types and cell subpopulations using lung injury 
models in the sheep lung, as has been performed in the mouse (Peake et al., 2000; Stevens et 
al., 1997; Stripp et al., 1995). In turn this may lead to a greater understanding of human 
respiratory disease. Recognition o f similarities in lung anatomy and physiology between sheep 
and humans has led to a recent increase in the use o f the sheep as a model for human 
respiratory disease. Lambs are now the leading model for diaphragmatic hernia and premature 
development of the lung (Scheerlinck et al., 2008). They are also used as a model for studying 
RSV infection, one o f the most important infectious respiratory diseases o f children 
(Meyerholz et al., 2004).
The second experimental chapter used immunofluorescent techniques to analyse the 
phenotype o f JSRV target cells in vivo. Previously optimised antibodies which labelled 
respiratory epithelial cells were used in combination with an anti-JSRV SU antibody to 
identify the phenotype of single cells expressing virus. These cells were present in the lamb 
lung 10 days post inoculation, and were located in the distal conducting and respiratory 
airways. Multiple target cells were identified. They included SP-C and CCSP positive cells, 
both of which have been previously suggested as target cells for JSRV (Beytut et al., 2008; 
Palmarini et al., 1995; Platt et al., 2002). More interesting were several cells which labelled for 
JSRV SU but none of the other phenotypic markers. Evidence o f cytodifferentiation in control 
lambs during this developmental period raised the possibility o f JSRV targeting an immature 
type cell with an undifferentiated phenotype.
The ability o f other respiratory viruses to infect their target cells can be affected by the stage
of cell differentiation. For example, the expression o f receptors for influenza virus are
dependent on the state o f differentiation of epithelial cells (Chan et al., 2010). For JSRV it is
not known how Hyal-2 expression varies with cell maturity, but it is possible that the presence
of other permissive and restrictive factors necessary for JSRV replication could be altered by
the differentiation state of the target cell. It is interesting that an age related susceptibility to
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infection has been previously recorded for JSRV (Salvatori et al., 2004). At the time this was 
attributed to a reduction in proliferation, and therefore the number o f dividing (target) cells, 
for JSRV infection in older lambs. However, the present study found only small reductions in 
the proliferative index o f multiple regions in the lung during maturation, suggesting additional 
factors may be involved. There is also a possibility that this undifferentiated cell could be 
similar to a type A Clara cell, previously described in mice following injury o f respiratory 
epithelium (Evans et al., 1978). If the same repair mechanisms were to occur in sheep, then 
these undifferentiated cell types would increase in injured lungs, resulting in increased 
susceptibility to infection with JSRV. One o f the early experiments by Dungal in 1938 found 
that addition o f bacteria or lung worms to viral inoculate resulted in greater disease 
transmission (Table 1.4). Whether this was due to a change in the state o f cell proliferation or 
differentiation needs further investigation.
There is also a possibility that this undifferentiated cell is some kind o f previously undescribed 
stem cell. Respiratory viruses capable of infecting stem cells in the lung have already been 
described. For example, the SARS virus has been shown to replicate in lung progenitor cells in 
vitro (Ling et al., 2006). This could have an important role in the pathogenicity o f infection in 
vivo as damage to these cell types would prevent efficient repair. Other malignant retroviruses 
which induce haematopoietic tumours have also been shown to infect haematopoietic and 
progenitor cell types to generate leukemic stem cells (Baneijee et al., 2010). Undifferentiated 
cells with stem cell characteristics have recently been isolated from lung tumours in humans 
(Eramo et al., 2008). If JSRV were to specifically target a stem cell in the lung, this would 
have huge implications for the field of respiratory research.
At the beginning o f this study, Kim and co-workers reported an experiment using a K-ras
mouse model o f lung adenocarcinoma which identified stem cells in the lung (BASCs)
expressing CCSP and SP-C (Kim et al., 2005). It was proposed that these BASCs were the
progenitor stem cells for tumour growth, and additional experiments confirmed their stem cell
characteristics in vitro. Initially, it was thought that a similar situation might be happening in
the sheep, and JSRV was targeting BASCs. However, dual labelling using
immunofluorescence failed to detect significant numbers o f BASCs in the sheep. In the
mouse, BASCs were detected in the majority o f B ADJ which occur at the junction of the
terminal bronchioles and alveoli. In the sheep lung anatomy is slightly different (Figure 3.IF,
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G). The presence o f respiratory bronchioles effectively increases the number o f B ADJ and 
therefore potential stem cell niches. However, out o f all the sections examined from control 
and infected lambs, only two cells were identified with convincing dual expression o f CCSP 
and SP-C (Figure 4.17). One o f these also expressed JSRV SU. While this does suggest 
primary infection o f a BASC, the low numbers detected imply that variations in this cell type 
will not greatly affect the ability for JSRV to infect the lung. It is still possible that JSRV does 
target the ‘sheep equivalent of a BASC’ but that the cell markers are different to the mouse. 
The variation in anatomy in this region o f the lung gives weight to this theory, but further 
work needs to be done to verify this.
There are several ways in which the phenotype of the JSRV target cell could be further 
analysed. To investigate the immature progenitor cell theory, dual labelling o f normal lung 
sections with beta tubulin and CCSP would demonstrate if  there was a population of 
undifferentiated (ie. unlabelled) cells which diminished with increasing age. If this was the 
case, then the number o f available target cells for JSRV would also decrease and an 
experimental infection would show a reduced number of cells expressing virus in older 
animals. Comparison of the infection o f animals with and without lung injury, and a detailed 
IHC analysis o f the cell types present and infected in both situations would also help target 
cell identification. A more thorough investigation o f these cell types could be possible if  lambs 
were infected with a fluorescently tagged virus and euthanased after 10 days. The target cells 
could be isolated using FACS, and their in vitro properties could then be examined in more 
detail. Methods for live imaging of in vivo virus infection or the use o f in vitro lung tissue 
culture slices would also be helpful. In order to determine the efficiency o f infection within 
this range o f potential target cells, variations in inoculation dose and route o f inoculation 
would be beneficial.
The second aim o f this thesis was to investigate the host innate response to viral inoculation in 
terms of cytokine production. RNA was extracted from adjacent lung samples to those already 
analysed with IHC, and qRTPCR was used to confirm the presence of JSRV mRNA. The 
cytokines analysed were chosen to represent indicators o f innate, cell mediated and humoral 
responses and tumour growth regulation (Table 5.1). Little response, as detected by changes in 
mRNA levels, was seen in samples 3 and 10 days post inoculation. By 8 weeks PI, small 
increases in GMCSF, IL-8 and MCP-1 mRNA were detected. In natural infections, larger
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increases were detected in GMCSF and IL-8 mRNA, which are cytokines previously 
associated with neovascularisation and macrophage recruitment. Evidence of 
immunoregulation was also apparent due to an increase in IDO, and reduction in IL-1 beta. 
IHC was able to detect labelling for IL-8 in tumour cells, neutrophils and infiltrating 
macrophages. These results indicate that the host is responding to tumour growth, but provide 
little evidence of an acute or cell mediated/humoral response to viral infection. Interestingly, 
expression changes in some o f these cytokines have also been recognised during the growth o f 
human lung tumours (Karanikas et al., 2007; Yuan et al., 2005).
These findings are in agreement with much o f the literature on OPA as several studies have 
been unable to detect JSRV specific T cell or antibody responses (Ortin et al., 1998; Summers 
et al., 2002). There are various explanations for this. The first involves a mechanism of central 
tolerance whereby expression o f closely related enJSRV during fetal development results in 
the removal o f any anti-JSRV T cells (see 1.3.7). This would make the sheep immunotolerant 
o f JSRV antigens. Another idea is based on the propensity for JSRV to infect sheep lymphoid 
tissue (Palmarini et al 1996). Viral RNA and proviral DNA have been found in monocytes, 
macrophages, B cells and T cells early on in disease pathogenesis before clinical signs are 
apparent (Holland et al 1999). Although evidence o f transformation is lacking, impairment o f 
the normal function o f these cells is possible and a reduced responsiveness o f lymphoid cells 
to the T-cell mitogen Con A from naturally and experimentally infected animals has been 
reported (Summers et al 2002). Mechanisms o f local immunosuppression have also been 
suggested. Several retroviruses encode an immunosuppressive domain within their Env 
protein which is well conserved between some genera (Haraguchi et al., 1995). Although a 
similar peptide sequence is not present on JSRV, it is still possible that JSRV Env could be 
causing immunosuppressive effects. Another theory is based on the immunoregulatory 
properties of surfactant proteins (SP-A, SP-B and SP-C) produced in large amounts by 
neoplastic cells (Beytut et al., 2008; Summers et al., 2002).
It is also important that the normal immunoregulatory properties o f the respiratory tract and
tumours in general are not overlooked. All previously mentioned surfactant proteins are
constitutively produced by respiratory epithelial cells as immune modulators to limit innate
inflammation and maintain lung homeostasis (Hussell and Goulding, 2010). This could also
limit inflammatory reactions to small amounts o f virus produced during the early stages of
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infection with JSRV. Tumours, like viruses, have developed a multitude o f mechanisms to 
evade rejection by the host immune response (see 1.3.6). One study on OPA reported 
downregulation o f MHC I within tumour nodules (Summers et al., 2005). This study has 
detected increased mRNA levels of the immunoregulatory cytokine IDO in tissues containing 
mature tumours from naturally infected animals. Additional methods of tumour 
immunomodulation by OPA have still to be investigated.
In contrast to these theories, there are occasional reports o f a host response to JSRV infection 
in certain situations. Vaccination trials showed that recombinant JSRV capsid antigen was 
able to induce antibody production and specific T cell responses in vaccinated sheep 
(Summers et al., 2006), and some histological studies found infiltrating lymphocytes within 
tumours (Garcia-Goti et al., 2000). One experiment looked for evidence o f an adaptive 
immune response using IHC and found strong labelling for IFN gamma in macrophages and 
MHC II upregulation in tumour associated cells in advanced clinical cases of OPA (Summers 
et al., 2005). In a more recent investigation (Hudachek et al., 2010) experimentally infected 
lambs showed evidence o f OPA lesion regression as detected using computed tomography. 
Low titres o f serum neutralising antibodies were detected in 4/12 lambs (maximum titre 1:100 
compared to 1:3000 in mice expressing JSRV Env). Two o f these showed partial lesion 
regression and one did not develop tumour during the 3 month course o f the experiment. A 
CD3+ T cell infiltration in association with tumours was also reported. However, all lambs 
were coinfected with M W  which does induce strong antibody responses and could have had a 
role in OPA tumour rejection in these animals. While the ability to detect even a very low anti- 
JSRV Env antibody titre in these lambs (Hudachek et al., 2010) and an anti-CA response 
following vaccination (Summers et al., 2006) does indicate that the central tolerance 
proposition cannot be absolute, it is unlikely that adaptive immunity plays an important role in 
disease control in the majority o f cases in the field.
Further work should include analysis o f samples using a more global gene analysis system
such as SAGE or microarray analysis. This would allow variations in many more cytokines to
be assessed. Samples from additional time points, particularly in the early stages prior to
extensive tumour growth, would provide a more thorough analysis o f the host response to
infection. Other techniques such as in situ hybridisation or laser capture microdissection could
also help to link cytokine production to specific cell phenotypes and reduce the potential for
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signal dilution experienced in this study. Proteomic analysis would allow correlation of 
mRNA levels with protein production, hence identifying any evidence o f post transcriptional 
control.
In summary, these experiments are some o f the first to analyse the early stages o f infection of 
JSRV in the ovine lung. They have been successful in identifying some specifics of disease 
pathogenesis, including the identification o f multiple target cells in vivo. However, o f equal 
importance is the number o f additional questions that have been raised, highlighting the need 
for further work in this area. As well as contributing towards the knowledge of JSRV 
pathogenesis, there have also been advances in the potential for the use o f OPA as a model for 
human lung cancer. Research is this area is hindered by the lack of a good experimental 
model, particularly for examining early stages o f oncogenesis. The infectious model used in 
the study, in combination with the robust IHC techniques developed to identify virus 
expression and cell phenotype, provides a unique and easily manipulated model with which to 
study the early stages o f lung cancer. The similarity in cytokine response to tumour growth 
between sheep and humans, along with a lack o f detectable response to virus, further 
recommends the OPA model as a tool for studying therapeutics for lung cancer.
Original reports of OPA described it as ‘a  rather puzzling disease ’ (McFadyean, 1894). It is 
hoped that this thesis contributes towards addressing some o f these confusing issues.
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Appendix 1
Table Al A summary of experimental animal numbers and their corresponding age of euthanasia and infection 
status.
Animal number Time of euthanasia in days post 
inoculation
JSRV 2 1  infected/mock 
infected/control
2851 3 Control
2849 3 Control
2840 3 Mock
2846 3 Mock
2841 3 JSRV 2i
2848 3 JSRV 2i
2845 3 JSRV 2i
2850 3 JSRV 2i
2857 10 Control
2859 10 Control
2855 10 Mock
2853 10 Mock
2854 10 JSRV 2i
2858 10 JSRV 2i
2852 10 JSRV 2i
2856 10 JSRV 2i
2844 72 JSRV 2i
2842 72 Control
2863 91 JSRV 2i
2864 91 Control
2865 90 JSRV 2i
2861 90 JSRV 2i
2866 91 Mock
2862 91 Mock
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Appendix 2
Figure A1 Alveolar region showing colocalisation of labelling for DC-LAMP and SP-C in type II pneumocytes.
Green, anti-DC-LAMP. Red, anti-SP-C. Blue, DAPI nuclei.
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